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ABSTRACT 
The finfish aquaculture industry relies heavily on fish oil (FO) and fish meal 
(FM), two marine-derived ingredients, for the production of aquafeeds. The demands for 
FO and FM to meet the expansion of the aquaculture industry will exceed the supply from 
forage fisheries (e.g. herring, anchovies, capelin) which are at a static phase. Therefore, 
there is a need to find alternatives such as plant-derived oils and proteins that might 
replace FO and FM, respectively, in aquafeeds. The products from Camelina sativa, 
camelina oil (CO) and camelina meal (CM), are currently considered viable options for 
sustainable aquafeed ingredients.  
Two feeding experiments were conducted to determine the effectiveness of CO as 
an alternative to FO in the diets for two economically important aquaculture species: 
Atlantic cod (Gadus morhua) and Atlantic salmon (Salmo salar). The effect of a low 
level inclusion of CM combined with CO in the salmon diets was also evaluated. Atlantic 
cod growth (e.g. weight gain) was significantly reduced by replacing 100% FO with CO 
(100CO) in the diet after a 13-week feeding trial. In contrast, a 100CO diet did not 
significantly alter the growth performance of Atlantic salmon after a 16-week feeding 
trial. However, salmon fed the other three camelina-containing diets [100CO + solvent-
extracted FM (100COSEFM), 100CO + 10% CM (100CO10CM), or 100CO + SEFM + 
10CM (100COSEFM10CM)], exhibited significantly lower weight gain or weight-
specific growth rate (SGR) compared to control fish. 
In order to study the effect of replacing FO with CO in diets for farmed Atlantic 
cod and Atlantic salmon on long chain polyunsaturated fatty acids (LC-PUFA) 
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biosynthesis, Atlantic cod fatty acyl elongase (elovl) gene family members were 
characterized at the cDNA level and QPCR assays for genes involved in LC-PUFA 
biosynthesis for both species were developed. The QPCR-based transcript expression 
analyses (Chapters 2 and 3) suggest that low LC-PUFA accompanied with high C18 
PUFA in the diet may cause the up-regulation of fatty acyl elongase and desaturase 
genes, critical for controlling the LC-PUFA biosynthetic pathway, in Atlantic cod (elovl5 
and fadsd6) and Atlantic salmon (elovl2, fadsd5 and fadsd6a). In addition, a 44K 
salmonid microarray was used to study the impact of a camelina-containing diet on 
salmon liver global gene expression, and a set of microarray-identified camelina-
responsive biomarker genes was validated using QPCR (Chapter 3). These functional 
genomics studies have contributed significant resources (e.g. cDNA sequences and QPCR 
assays) to the cod and salmonid research communities, and provide valuable information 
for the development of novel aquafeeds using camelina products. 
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CHAPTER 1: General Introduction 
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1.1 Introduction 
The flesh of finfish provides important components of human diets (Morais et al., 
2011). It can provide not only high quality proteins, vitamins, and minerals, but is also the 
main source of essential ω3 long chain polyunsaturated fatty acids (≥C20; LC-PUFA) in 
human diets (Morais et al., 2011). Dietary LC-PUFA, including eicosapentaenoic acid 
(EPA; 20:5ω3) and docosahexaenoic acid (DHA; 22:6ω3), can benefit human health by 
preventing a number of cardiovascular and inflammatory diseases (Calder and Yaqoob, 
2009). Worldwide demand for seafood for human consumption with a large contribution 
from aquaculture (~50% in 2008), continues to climb (FAO, 2009; Bell et al., 2010). 
Consequently, there is great potential for the aquaculture industry to expand. 
The finfish aquaculture industry (e.g. salmonids and cod) relies heavily on fish 
meal (FM) and fish oil (FO), two marine-derived ingredients, for the production of 
aquafeeds (Torstensen et al., 2008; Morais et al., 2011). The demands for FM and FO to 
meet the expansion of the aquaculture industry will exceed the supply from traditional 
fisheries (e.g. herring, anchovies, capelin) which are at a static phase (FAO, 2009). This 
will result in increased prices of FM and FO, and potentially threaten the sustainability of 
fish farming (Espe et al., 2006; Tacon and Metian, 2008). Looking for plant-derived 
proteins and oils that might replace FM and FO, respectively, would be a way to make the 
aquaculture industry more sustainable.  
The products from Camelina sativa are currently considered a viable option as 
aquafeed components due to the relatively high seed oil content and high crude protein in 
the meal (Acamovic et al., 1999). However, many aspects of the potential use of camelina 
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products in fish diet formulations must be examined. My research, as part of a 
collaborative project - Developing Camelina as the Next Canadian Oilseed (referred 
henceforth as The Camelina Project; http://www.genomeatlantic.ca/), aims to determine 
nutritional value of camelina-containing diets in terms of fish growth and to assess the 
effects of camelina-containing diets on the hepatic gene expression responses of two 
economically important aquaculture species: Atlantic cod (Gadus morhua) and Atlantic 
salmon (Salmo salar), using functional genomics tools such as DNA microarrays and 
quantitative reverse transcription - polymerase chain reaction (QPCR). Furthermore, the 
data provided in this research could potentially guide future work on the development of 
optimal fish diet formulations including camelina products.  
1.2 Demand for FO and FM in aquafeeds 
The aquaculture of finfish, especially carnivorous fish (e.g. Atlantic cod and 
Atlantic salmon), has traditionally relied heavily on FM and FO in diet formulation (Espe 
et al., 2006; Torstensen et al., 2008; Bell et al., 2010). The high quality (e.g. essential 
amino acids and fatty acids) and palatability make FM and FO the most preferred 
ingredients in aquafeed (Thiessen et al., 2003; Espe et al., 2006). On the other hand, due 
to the increasing demand for seafood (largely contributed from fish farming), aquaculture 
production has dramatically increased in the past few years (Bell et al., 2010). For 
example, the production of farmed Atlantic salmon, a commonly cultured species, 
increased from approximately 0.9 million metric tonnes in 2000 to 1.5 million metric 
tonnes in 2009 (FAO, 2012). Collectively, this evidence suggests that finfish aquaculture 
production has great potential to expand in the future. However, global yields of FM and 
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FO from traditional fisheries are not likely to increase (Bell et al., 2010). The excessive 
demand on these ingredients by the aquaculture industry will result in increased prices of 
FM and FO and is a major concern about fish farming sustainability (Espe et al., 2006; 
Tacon and Metian, 2008). Therefore, the need to find alternatives to FM and FO for 
aquafeeds has been recognized as one of the most important areas of research in 
aquaculture (Bell et al., 2010). 
1.3 Camelina sativa and its products 
One of the plants that could potentially provide an opportunity to meet the 
demand for plant-based ingredients in the aquaculture feed industry is Camelina sativa. 
Camelina, also known by its common name “false flax”, is an ancient member of the 
Brassicaceae family and has been grown extensively in parts of Europe (e.g. France, 
Belgium, Holland, Russia and Sweden) for human consumption and fuel oil (Zubr, 1997; 
Zubr, 2003). Commercial cultivation of camelina in Canada has occurred since the 1990s 
(Francis and Warwick, 2009). 
As an oilseed crop, camelina has an oil content of about 40%, which is especially 
rich in ω3 fatty acids (Acamovic et al., 1999). The levels of PUFA such as linoleic acid 
(LNA; 18:2ω6) and α-linolenic acid (ALA; 18:3ω3) in camelina oil (CO) are about 15% 
and 40% respectively (Zubr, 1997). The fatty acid profile of CO is distinct from that of 
rapeseed, soybean and flaxseed oils. CO has the highest ALA content among those 
vegetable oils (Zubr, 2003). Compared to FO, however, vegetable oil including CO lacks 
the highly bioactive LC-PUFA, such as DHA and EPA (Glencross, 2009). 
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Camelina has great potential in the bioenergy sector since it can be utilized as a 
green fuel for jets and other engines (Fröhlich and Rice, 2005; Shonnard et al., 2010). 
Some by-products of camelina from the oil extraction process, such as the seed meal, may 
be used ultimately in the aquaculture and livestock (e.g. cow, pig, chicken) feed 
industries. Camelina meal (CM) has a crude protein level of approximately 45%, which is 
similar to canola and other rapeseed meal (Acamovic et al., 1999; Frame et al., 2007). 
Essential amino acids (i.e. amino acids cannot be synthesized de novo) are particularly 
important when plant meals are used as fish feed ingredients. There are at least 18 amino 
acids found in camelina seed, and 9 of them are essential (Zubr, 2003). The most 
dominant essential amino acid in camelina seed is arginine (8.2%), while the content of 
some other essential amino acids (e.g. glycine, proline, and valine) exceed 5.0%. The 
amino acid profile of camelina seed is very similar to that of rapeseed and soybean (Zubr, 
2003). The plant meals are naturally rich in carbohydrates such as oligosaccharides and 
non-starch polysaccharides (Hemre et al., 2002; Leaver et al., 2008a; Panserat and 
Kaushik, 2010). Previous study reported that the carbohydrate content in camelina seed; 
the mean fructose content was 0.04%, stachyose 0.36%, glucose 0.42%, raffinose 0.64%, 
pectin 0.96%, starch 1.21%, sucrose 5.5%, mucilage 6.7%, lignin 7.4%, and crude fibre 
12.8% (Zubr, 2010). In defatted soybean meal, the content of the three main 
oligosaccharides (i.e. stachyose, raffinose and sucrose) were 5-6%, 1-2% and 6-7%, 
respectively (Francis et al., 2001). It is worth noting that a disadvantage for the use of 
most brassica crops (e.g. camelina and rapeseed) as animal feed ingredients is the content 
of glucosinolates (Acamovic et al., 1999; Francis et al., 2001). Glucosinolates may 
negatively affect birds; decreases in weight gain and poor feed conversion were observed 
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in one study of young turkey as the amount of CM increased in the diets (Frame et al., 
2007). In another study, the ingestion of very low amounts of glucosinolates (1.4 µmol/g 
diet) led to a depression of growth in rainbow trout (Oncorhynchus mykiss) (Francis et al., 
2001). 
1.4 FO and FM substitutions in aquafeeds 
Fish nutritionists have tried to incorporate different kinds of terrestrial plant 
proteins and oils to substitute FM and FO due to the relatively low cost and sustainability 
of these plant products compared to traditional ingredients such as FM and FO (Gomes et 
al., 1995; Bell et al., 2001; Thiessen et al., 2003; Espe et al., 2006; Torstensen et al., 
2008; Bell et al., 2010). A number of researchers have made progress on FM substitutions 
with soybean meal (Vilhelmsson et al., 2004; Torstensen et al., 2008), canola meal 
(Thiessen et al., 2003), rapeseed meal (Vilhelmsson et al., 2004), and FO replacement 
with linseed oil (Torstensen et al., 2008), canola oil (Miller et al., 2007) and rapeseed oil 
(Jordal et al., 2005) for a range of fish species including Atlantic cod and Atlantic salmon.  
1.4.1 The effect of plant oils on fish growth, physiology and gene expression 
Dietary lipid and fatty acids are the predominant source of energy for teleost fish 
(Leaver et al., 2008a). Also, essential fatty acids including LC-PUFA (e.g. DHA and 
EPA) in dietary oils play important roles in several physiological functions in fish 
including cell synthesis, neural development, immune function and reproduction 
(Glencross, 2009). Hence, any dietary alternative to FO must satisfy the nutritional needs 
of the fish (e.g. supplying lipids and essential fatty acids used for optimal growth) without 
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having a negative impact on the fish health or quality of the flesh. Studies have 
demonstrated that vegetable oil (either singly or as blends) which is low in LC-PUFA and 
high in C18 PUFA such as ALA and LNA, can be used to replace up to 100% of FO 
without negatively influencing growth in salmonids and marine fish including cod (Bell et 
al., 2001; Torstensen et al., 2005; Bell et al., 2010; Morais et al., 2012; Hixson et al., 
2013). However, as a result of replacing FO, the flesh ω3 LC-PUFA content in fish can 
be reduced significantly if FO is replaced by vegetable oil completely (Bell et al., 2010; 
Morais et al., 2012).  
Replacement of FO with vegetable oil in fish diets has been suggested to affect 
lipogenesis in teleosts (Leaver et al., 2008b). For example, Atlantic salmon fed a FO-
based diet showed lower triacylglycerol levels in liver compared to vegetable oil-fed fish 
(Jordal et al., 2007). Vegetable oil inclusion in gilthead seabream (Sparus aurata) diets 
resulted in significantly increased hepatic lipid deposition, compared to fish fed control 
diet (reviewed in Leaver et al., 2008a). Other lipid metabolic processes in salmonids, for 
example, fatty acid β-oxidation, cholesterol and fatty acid biosyntheses, were also linked 
with the intake of the plant oil based diets (Leaver et al., 2008b; Panserat et al., 2009). 
Beta-oxidation of fatty acids for energy production can be achieved in two different 
organelles in the cells, mitochondria and peroxisomes. The carnitine palmitoyltransferase 
(CPT) system is a limiting step in the mitochondrial β-oxidation of fatty acids (reviewed 
in Leaver et al., 2008a). The transcript encoding Cpt2 (also known as Cpt-II) was shown 
to be significantly down-regulated in the liver of Atlantic salmon fed rapeseed oil diet 
compared to FO-based diet, indicating lower β-oxidation in fish fed plant oil diet (Jordal 
et al., 2005). Moreover, plant oil-containing diets induced several genes (e.g. squalene 
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epoxidase and lathosterol oxidase) involved in the cholesterol biosynthetic pathway 
(Leaver et al., 2008b). 
In vertebrates, biosynthesis of LC-PUFA can be achieved by sequential 
desaturation and elongation of FA precursors such as LNA and ALA (reviewed in Leaver 
et al., 2008a). Genes involved in the pathway are known to be regulated by vegetable oil 
(reviewed in Leaver et al., 2008a). Particularly, delta-5 fatty acyl desaturase (fadsd5) and 
fatty acyl elongase [elongation of very long chain fatty acids (elovl); e.g. elovl2 and 
elovl5] genes are often up-regulated in the liver of Atlantic salmon fed vegetable oil (e.g. 
rapeseed oil), and often down-regulated with high levels of ω3 LC-PUFA content in the 
diets (reviewed in Leaver et al., 2008a). To what extent fish can convert LNA and ALA 
into LC-PUFA varies when fed diets containing plant oil. In general, freshwater fish are 
capable of synthesizing DHA and EPA from ALA (Santigosa et al., 2011). In contrast, 
most marine fish including Atlantic cod are inefficient in the desaturation/elongation of 
FA precursors that are essential for producing EPA and DHA (Santigosa et al., 2011). 
This may be due to apparent deficiencies in one or more enzymes in the biosynthesis 
pathway (Ghioni et al., 1999; Tocher et al., 2006). Hence, there was particular interest in 
this project to study the expression of genes involved in fatty acid biosynthesis in Atlantic 
cod and Atlantic salmon fed CO-containing diets. Prior to the current study, the only fully 
characterized Atlantic cod fatty acyl elongase had been Elovl5, and this enzyme showed 
low elongase activity (Agaba et al., 2005). In contrast, in Atlantic salmon, elovl2, elovl4, 
two elovl5 paralogues were functionally characterized previously; all of these genes 
except elovl4 have been studied at the transcript expression level in response to different 
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dietary treatments containing plant oils (Agaba et al., 2005; Morais et al., 2009; Carmona-
Antoñanzas et al., 2011). 
The changes in the fatty acid profiles of diets due to the replacement of FO by 
vegetable oils may alter fish metabolism, which could potentially affect fish health, 
immune function and pathogen resistance (Montero et al., 2003; Mourente et al., 2005). 
In addition, the inclusion of vegetable oils often alters the ω3/ω6 fatty acid ratio in the 
diet. A well-balanced ω3/ω6 ratio is required for the good health of animals as it will 
affect animal immune cell function and structure, cell signalling and eicosanoid 
production (Yaqoob and Calder, 2007; Montero et al., 2010). There is a large body of 
research on the effect of dietary vegetable oils on fish immunity at different levels 
including the fatty acid composition of immune cells (Thompson et al., 1996; Farndale et 
al., 1999), immune cell function (Sheldon and Blazer, 1991; Kiron et al., 1995), 
alternative complement activity (Montero et al., 2003) and eicosanoid production 
(Mourente et al., 2007). However, the mechanisms involved in the modulation of fish 
immune systems by variations in dietary fatty acids, and the genes involved in these 
mechanisms, are poorly understood. Recently, the transcript expression of genes involved 
in stress response (steroidogenic acute regulatory protein, glucocorticoid receptor and 
phosphoenolpyruvate carboxykinase) were reported to be significantly reduced in 
gilthead seabream larvae fed arachidonic acid (ARA; 20:4ω6) containing diets with ARA 
level above 0.4% (Alves Martins et al., 2012). Another study directly measured the effect 
of dietary vegetable oils on the transcript expression of genes related to inflammation 
(tumor necrosis factor-α and interleukin 1-β) in gilthead seabream after exposure to a 
bacterial pathegen (Photobacterium damselae sp. piscicida) (Montero et al., 2010). Both 
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of the pro-inflammatory genes studied by Montero and colleagues (2010) were up-
regulated in the intestine and head kidney of fish fed complete replacement diets. 
1.4.2 The effect of plant meals on fish growth, physiology and gene expression  
Sustainable alternative protein sources with crude protein content of 20 to 50%, 
for replacement of FM, have been incorporated in aquafeeds for finfish aquaculture 
(Torstensen et al., 2008). However, there are several potential problems associated with 
using such plant protein-based diets (Torstensen et al., 2008). For example, the essential 
amino acid profile in plant protein sources differs from FM, resulting in the need to mix 
different protein sources or add certain crystalline amino acids not represented in plant-
based sources (or present in inadequate amounts), to meet the nutritional requirements of 
fish fed plant-based diets (Espe et al., 2006; Torstensen et al., 2008). The carbohydrate 
fraction of plant meal, as well as anti-nutritional factors, are additional constraints that 
may affect digestion and utilization of nutrients by fish when plant protein sources are 
included in their diets (Francis et al., 2001; Hemre et al., 2002; Krogdahl et al., 2005). 
While some early work in rainbow trout reported that no reduction of fish growth was 
found for diet consisting of 100% plant proteins when replacing fish meal with the 
addition of selected amino acids (Rodehutscord et al., 1995), other studies showed that 
the replacement of fish meal with plant meals (> 50%) reduced the growth of trout 
(Gomes et al., 1995; Kaushik et al., 1995). High plant protein (> 60% replacement of FM) 
diets affected growth performance of Atlantic salmon; however, this may have been 
caused by reduced feed intake and intestinal disorders (Baeverfjord and Krogdahl, 1996; 
Espe et al., 2006; Hevrøy et al., 2008).  
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The role of amino acids in the regulation of genes such as those involved in the 
control of growth, amino acid metabolism and protein turnover has been recognized 
especially in humans (Kimball and Jefferson, 2006). For example, the mammalian target 
of rapamycin (mTOR), involved in the regulation of initiation of translation and protein 
synthesis, is modulated by dietary amino acids either directly or indirectly through insulin 
in mammals (Kimball and Jefferson, 2006; Panserat and Kaushik, 2010). In rainbow trout 
hepatocytes, the branched-chain amino acid leucine combined with insulin can activate 
the TOR pathway, and reduce glucose-6-phosphatase gene expression which is involved 
in gluconeogenesis (Lansard et al., 2011). FM substitution by plant protein is known to 
affect the somatotropic axis in gilthead seabream, which plays a key role in the control of 
the regulation of metabolism and growth (Gómez-Requeni et al., 2004). In vertebrates, 
the somatotropic axis consists of growth hormone, insulin-like growth factors, their 
associated carrier proteins, and receptors (Renaville et al., 2002; Wood et al., 2005). 
Gilthead seabream fed a plant-based diet experienced decreased growth, as well as the 
down-regulation of hepatic transcripts encoding growth hormone receptor and insulin-like 
growth factor 1 (Gómez-Requeni et al., 2004). 
Plant protein sources are naturally rich in carbohydrates, however, the utilization 
of dietary carbohydrates by fish seems limited, particularly in carnivorous species (Hemre 
et al., 2002). A large number of studies have been focused on the impact of plant-
containing diets on mechanisms involved in glucose homeostasis in finfish. Only low 
levels of carbohydrates in fish diets showed improved feed utilization and protein 
retention in rainbow trout, Atlantic cod, European eel (Anguilla anguilla) and Atlantic 
salmon, resulting from a protein sparing effect (Hemre et al., 2002). The enhanced growth 
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and protein sparing are thought to be due to the use of glucose as an oxidative substrate 
for nervous tissue and blood cells, and the diversion of amino acids away from oxidative 
pathways (Hemre et al., 2002).  
Last but not least, the presence of anti-nutritional factors in plant materials, such 
as protease inhibitors, lectins, oligosaccharides, phytates and glucosinolates, is another 
challenge in the development of plant-based aquafeeds (Vilhelmsson et al., 2004). Some 
fish species are known to be sensitive to the presence of anti-nutrients. For example, diets 
containing 10 to 30% of dietary soybean meal caused inflammation and morphological 
changes in distal intestine of Atlantic salmon in a 6-week feeding experiment 
(Baeverfjord and Krogdahl, 1996). In more recent studies, the expression of some 
inflammatory biomarker genes was investigated during the development of soybean meal-
induced enteritis in Atlantic salmon (Lilleeng et al., 2009; Skugor et al., 2011). For 
instance, both transforming growth factor β and interferon-γ inducible lysosomal thiol 
reductase transcripts were significantly down-regulated in the distal intestine of salmon 
fed a soybean-containing diet after 3 days feeding (Lilleeng et al., 2009). Consequently, 
an inflammatory response in fish fed soybean meal-containing diets may result in a higher 
susceptibility to bacterial diseases (Krogdahl et al., 2000). 
1.5 Nutrigenomic approach to study hepatic gene expression response to plant-based 
diets 
DNA microarrays have been shown to be useful tools for the identification of 
genes that are differentially expressed in fish fed altered diets, for example those with FO 
or FM replaced by plant-based ingredients (Jordal et al., 2005; Leaver et al., 2008b; 
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Panserat et al., 2008; Morais et al., 2011). All of these studies focused on the gene 
expression changes in fish liver since this is the main organ involved in metabolizing 
carbohydrates, lipids, and proteins into biologically useful materials in animals, as well as 
other functions such as detoxification and immunity (Vilhelmsson et al., 2004; Panserat et 
al., 2009). Furthermore, QPCR is often used as a more sensitive technique to measure 
changes in the expression of selected transcripts (Pfaffl, 2001), and also to validate the 
results of microarray experiments (Booman et al., 2011; Hori et al., 2012). Therefore, 
functional genomics techniques (e.g. microarray hybridizations, QPCR) are powerful 
tools in the genome-wide characterization of gene expression changes in fish subjected to 
the changes in protein and/or oil sources in their diets. The availability of genomic 
resources for Atlantic cod and Atlantic salmon are discussed in the following section.   
1.5.1 Atlantic cod functional genomics resources 
Two major projects have contributed to the creation of Atlantic cod functional 
genomics resources: the Atlantic Cod Genomics and Broodstock Development Project 
(CGP; a Canadian project; http://codgene.ca/) and the cod genome project (a Norwegian 
project; http://codgenome.no/). Out of the 229,094 Atlantic cod expressed sequence tags 
(ESTs; represent portions of transcribed cDNA sequence) currently in the GenBank EST 
database (http://www.ncbi.nlm.nih.gov/dbEST/), 158,877 ESTs were generated by the 
CGP (Bowman et al., 2011). Additional cod genome resources are made available from 
the Norwegian cod project, which recently published the first draft of the Atlantic cod 
genome (Star et al., 2011). The cod EST database and genome draft, as well as other fish 
genome databases such as zebrafish (e.g. Danio rerio) available in Ensembl 
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(www.ensembl.org), are valuable resources for the discovery and characterization of 
novel genes and gene families in Atlantic cod. 
1.5.2 Atlantic salmon functional genomics resources 
The Atlantic salmon has been extensively examined at the genomic level and, as 
for Atlantic cod genomic resources, the Atlantic salmon resources are also available in 
public databases (Rise et al., 2004b; Koop et al., 2008; Jantzen et al., 2011). At present, 
the Atlantic salmon genome is being fully sequenced through an international 
collaborative project including researchers from Canada, Chile and Norway (Davidson et 
al., 2010). Furthermore, a number of salmonid DNA microarray platforms have been 
generated through different projects for use in global gene expression studies (Rise et al., 
2004a; Rise et al., 2004b; von Schalburg et al., 2005; Rise et al., 2006; Koop et al., 2008; 
Jantzen et al., 2011). The 44K salmonid oligonucleotide (oligo) microarray (GEO 
accession # GPL11299) from Agilent Technologies (Santa Clara, CA) with each slide 
containing four ~44,000-feature (44K) arrays is a newly developed platform by Dr. Ben 
F. Koop's research team (Jantzen et al., 2011). This array comprises about 22,000 60-mer 
oligos that are similar (95%) between rainbow trout and Atlantic salmon, plus 14,866 
additional Atlantic salmon-specific sequences and 5,661 additional rainbow trout-specific 
sequences, resulting in a broad representation of transcripts in salmonids with low 
redundancy (Jantzen et al., 2011). The details on the sequence selection for oligo probe 
design and platform construction have been described previously (Koop et al., 2008; 
Jantzen et al., 2011). This newly developed 44K microarray has been used in salmonid 
gene expression studies (Jantzen et al., 2011; Sahlmann et al., 2013). 
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1.6 Overall objectives 
The overall objectives of the present studies were to: 1) characterize elovl family 
member transcripts as well as measure their basal expression in various tissues in Atlantic 
cod; 2) investigate the effect of changes in the FA composition of diets containing 
different levels of CO on the growth performances and hepatic transcript expression of 
fatty acyl desaturase (fadsd) and fatty acyl elongase (elovl) genes in Atlantic cod and 
Atlantic salmon; and 3) use functional genomics tools to assess the impacts of CO and/or 
CM containing diets on liver of Atlantic salmon at the transcriptome level, and to identify 
candidate molecular biomarkers of responses to camelina-containing diets. I anticipate 
that the molecular biomarkers (i.e. camelina product-responsive genes) identified in this 
study will be useful in the future development of camelina-containing diets. 
In Chapter 2, a variety of molecular tools and techniques [e.g. bi-directional rapid 
amplification of cDNA ends (RACE), TA cloning, DNA sequencing, and sequence 
assembly] were utilized to characterize Atlantic cod elovl family members at the cDNA 
level, and I examined how dietary CO influenced the cod growth performance and the 
transcript expression of genes that regulate LC-PUFA biosynthesis. In Chapter 3, the 
cGRASP-designed Agilent 44K salmonid oligonucleotide microarray followed by QPCR 
were used to examine how camelina product-containing diets affected the liver 
transcriptome and gene expression of potential biomarkers that were microarray-
identified. I also investigated the effect of diets containing different levels of CO on the 
salmon growth performance and the transcript expression of genes involved in LC-PUFA 
biosynthesis.  
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CHAPTER 2: Characterization of fatty acyl elongase (elovl) gene family, 
and hepatic elovl and delta-6 fatty acyl desaturase (fadsd6) transcript 
expression responses to diets containing camelina oil in Atlantic cod 
(Gadus morhua)  
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2.1 Abstract 
For aquaculture to become sustainable, there is a need to substitute fish oil [FO, 
rich in ω3 long chain polyunsaturated fatty acids (LC-PUFA) such as 22:6ω3 (DHA) and 
22:6ω3 (EPA)] in aquafeed with plant oils such as camelina oil [CO, rich in C18 PUFAs 
such as 18:3ω3 (ALA) and 18:2ω6 (LNA)]. The LC-PUFA are essential components in 
fish diets for maintaining optimal health, physiology and growth. However, most marine 
fish including Atlantic cod are inefficient at producing LC-PUFA from precursors. Since 
fatty acyl elongase (elovl) genes encode enzymes that play key roles in fatty acid 
biosynthesis, it was hypothesized that they may be involved in Atlantic cod responses to 
diets rich in ALA and LNA. Ten members of the cod elovl gene family were 
characterized at the mRNA level. RT-PCR was used to study constitutive expression of 
elovl transcripts in fifteen tissues. Some transcripts (e.g. elovl5) were ubiquitously 
expressed, while others had tissue-specific expression (e.g. elovl4a in brain and eye). Cod 
fed a CO-containing diet (100% CO replacement of FO and including solvent-extracted 
fish meal, 100COSEFM) showed significantly lower weight gain, with significant up-
regulation of elovl5 and delta-6 fatty acyl desaturase (fadsd6) transcripts in liver, 
compared with cod on a FO diet after a 13-week trial. The high ALA and/or low ω3 LC-
PUFA levels in the diet may associate with the up-regulation of elovl5 and fadsd6, which 
are involved in LC-PUFA biosynthesis in farmed cod. 
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2.2 Introduction 
Dietary long chain polyunsaturated fatty acids (LC-PUFA) [also referred to as 
highly unsaturated fatty acids (HUFA)], including eicosapentaenoic acid (EPA, 20:5ω3) 
and docosahexaenoic acid (DHA, 22:6ω3), are crucial to maintaining various biological 
processes including development, immunity, and reproduction in vertebrates (Agaba et 
al., 2005). In humans, DHA and EPA are known to benefit health by preventing a number 
of cardiovascular and inflammatory diseases (Calder and Yaqoob, 2009). The very long 
chain fatty acids (VLC-FAs) consist of a group of fatty acids with chain lengths >24 
carbons (Monroig et al., 2010), and are present in various tissues in most animals (e.g. 
saturated VLC-FA in skin; VLC-PUFA in retina, brain, and testis) (Brush et al., 2010; 
Monroig et al., 2010; Carmona-Antoñanzas et al., 2011). In mammals, previous studies 
have shown that VLC-FA play key roles in phototransduction, skin permeability and 
fertility (Agbaga et al., 2010; Monroig et al., 2011). 
The biosynthesis of LC-PUFA, VLC-FA, and VLC-PUFA in mammals is thought 
to be achieved by the elongation and desaturation of fatty acids with chain lengths > 16 
carbons (Jakobsson et al., 2006). The elongation process is catalyzed by fatty acyl 
elongases (ELOVL; Elongation of Very Long chain fatty acids), a family of membrane-
bound enzymes that are predominantly located in the endoplasmic reticulum (ER) 
(Nugteren, 1965; Morais et al., 2009). These enzymes are believed to play a role in the 
first step (condensation of fatty acids) of the elongation pathway of fatty acids. Seven 
fatty acyl elongase family members (ELOVL1 to ELOVL7), with characteristic fatty acid 
substrate specificity, have been identified in human and mouse (Jakobsson et al., 2006; 
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Kitazawa et al., 2009; Monroig et al., 2010). In general, ELOVL1, ELOVL3, ELOVL6 
and ELOVL7 prefer saturated and monounsaturated fatty acids (MUFA) as substrate, 
while ELOVL2, ELOVL4 and ELOVL5 use PUFA as substrate (Monroig et al., 2010). In 
vertebrates, the source of LC-PUFA can be derived directly from the diet or through the 
biosynthesis of LC-PUFA from precursors such as α-linolenic acid (ALA, 18:3ω3) and 
linoleic acid (LNA, 18:2ω6) (Wang et al., 2005).  
Fish products are a major source of LC-PUFA in human diets (Tocher et al., 
2006). With flat or declining global wild fisheries, there is increasing demand for farmed 
fish for human consumption (Agaba et al., 2005; Tocher et al., 2006). Consequently, there 
is great potential for the aquaculture industry to expand. However, the current high 
demand for fish oil (FO) from wild stocks for the production of aquaculture feeds, 
particularly for carnivorous fish, threatens the sustainability of the fisheries and 
aquaculture industries (Tocher et al., 2006). Hence, there is a need to substitute FO, 
which is rich in LC-PUFA, in aquaculture feeds with oils from plants that have abundant 
ALA and LNA (Bell et al., 2010). As an oilseed crop, camelina (Camelina sativa), has 
several characteristics that make it desirable for the aquaculture feed industry. The oil 
content of camelina seed is about 40%, and camelina oil (CO) is especially rich in LC-
PUFA precursors ALA and LNA; the levels of these fatty acids in CO are approximately 
40% and 15%, respectively (Zubr, 1997; Hixson et al., 2013).  
Fish species differ in the extent to which they can tolerate diets high in PUFA and 
low in LC-PUFA, and this trait appears to be evolutionarily related to the fatty acid 
profiles of their natural diets (Agaba et al., 2005). For example, most marine fish, 
including Atlantic cod (Gadus morhua), are inefficient at producing LC-PUFA from 
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shorter chain precursors as the LC-PUFA are abundant in their natural habitat (Agaba et 
al., 2005; Tocher et al., 2006). This may be due to limited elongation of C18 to C20 fatty 
acids as indicated by an in vitro study of the LC-PUFA synthetic pathway in turbot 
(Scophthalmus maximus) cell lines (Ghioni et al., 1999). Prior to the current study, the 
only Atlantic cod elovl transcript to be fully characterized was elovl5; the cod Elovl5 
protein showed the lowest elongase activity (i.e. 7.4% and 0.8% conversion of 18:4ω3 to 
20:4ω3 and 20:5ω3 to 22:5ω3, respectively) compared with freshwater fish, salmonids, 
and other marine species studied therein (Agaba et al., 2005). Elovl4 transcripts have been 
studied in zebrafish (Danio rerio) (Monroig et al., 2010), Atlantic salmon (Salmo salar) 
(Carmona-Antoñanzas et al., 2011) and cobia (Rachycentron canadum) (Monroig et al., 
2011), and the encoding enzymes demonstrated capacity to convert C20 LC-PUFA to 
longer products including DHA and EPA. 
The publicly available Atlantic cod genomic resources, including a draft genome 
assembly (gadMor1 v73.1) and transcriptome (Star et al., 2011), as well as over 150,000 
expressed sequence tags (ESTs) arising from cDNA libraries representing various tissues 
and developmental stages (Bowman et al., 2011), allowed me to use bioinformatic 
techniques to mine sequence databases to identify partial sequences for the following 
Atlantic cod fatty acyl elongase transcripts: elovl1a, elovl1b, elovl4a, elovl4b, elovl4c-1, 
elovl4c-2, elovl5, elovl6a, elovl6b, and elovl7. The objective of the study was to use bi-
directional rapid amplification of cDNA ends (RACE), TA cloning, DNA sequencing, 
and sequence assembly to characterize Atlantic cod elovl family member transcripts in 
order to study their evolutionary relationships and expression profiles. Also, as part of a 
large nutritional feeding trial, this study evaluated the effect of changes in the FA 
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composition of diets containing different levels of CO on the hepatic transcript expression 
of elovl family members and delta-6 fatty acyl desaturase (fadsd6, also involved in LC-
PUFA biosynthesis). 
2.3 Materials and methods 
2.3.1 Experimental animals 
This research project was conducted through a large collaborative project (The 
Camelina Project; http://www.genomeatlantic.ca/), and protocols were approved by the 
Institutional Animal Care Committee of Memorial University of Newfoundland, protocol 
number 12-50-MR. The tissue panel used for elovl transcript characterization and tissue 
distribution studies (described in detail below) was collected from two juvenile Atlantic 
cod (~13 g, ~7 months old) reared at the Dr. Joe Brown Aquatic Research Building 
(JBARB) at the Ocean Sciences Centre (Memorial University of Newfoundland, Canada). 
Fish were kept in a 6,000 L tank with flow-through seawater supply (~10°C, dissolved 
oxygen ≥ 90% saturation). Fifteen tissues (skeletal muscle, skin, eye, brain, head kidney, 
posterior kidney, spleen, pyloric caecum, midgut, hindgut, stomach, liver, blood, heart, 
and gill; 50-100 mg tissue-1) were rapidly dissected from each fish, placed in RNase-free 
1.5 mL tubes, flash-frozen in liquid nitrogen, and stored at -80°C until RNA extraction. 
Fish used in the feeding trial (see section 2.3.2) were obtained from the same group as the 
fish used for the tissue panel.  
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2.3.2 Experimental design and sampling: cod fed diets containing camelina oil 
All diets were formulated as isonitrogenous and isolipidic practical diets 
according to the nutritional requirements of marine fish (National Research Council, 
2011). The current study involved a control diet with FO, 100% FO replacement with CO 
(100CO), and 100% FO replacement with CO and including solvent extracted fish meal 
(100COSEFM) to remove residual FO from the meal (Table 2-1); an additional 
experimental diet was included in this feeding trial (Hixson and Parrish, 2014), but was 
not part of the current transcript expression study. The experimental diets involved in this 
study were tested on Atlantic cod to determine the nutritional value of CO in terms of fish 
growth, and to assess the effect of CO-containing diets on the hepatic transcript 
expression responses of four elovl genes and fadsd6 (see section 2.3.8). Further details on 
formulation, proximate and fatty acid compositions of the diets are described elsewhere 
(Hixson and Parrish, 2014).  
Juvenile Atlantic cod (14.4 ± 1.6 g) were randomly distributed among twelve 500 
L experimental tanks (70 fish tank-1) supplied with flow-through seawater (~10°C, 
dissolved oxygen ≥ 90% saturation). The fish were gradually weaned from a commercial 
diet (Europa 15, 2 mm, Skretting Canada) to the experimental diets for one week before 
the feeding trial started. Triplicate tanks of fish were fed experimental or control diets to 
apparent satiety, twice each day for a period of 13 weeks. At the starting point (i.e. when 
fish were first fed an experimental diet), week 1, week 6 and week 13 of the feeding trial, 
seven fish from each tank at each time point were euthanized with a lethal dose (400 mg 
L-1) of tricaine-methane-sulfonate (TMS; Syndel Laboratories, Vancouver, BC) after 24h 
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Table 2-1. Composition of experimental diets used in juvenile cod feeding trial 
(percentage of total weight as fed)1. 
Ingredient FO (control) 100CO 100COSEFM 
Fish oil 5.43 - - 
Camelina oil - 5.43 9.7 
Herring meal 50.5 50.5 - 
SEFM2 - - 47.6 
Wheat middlings 27.1 27.1 25.7 
Wheat gluten meal 5 5 5 
Whey powder 5 5 5 
Krill hydrolysate 2.5 2.5 2.5 
Corn starch (pre-gelatized) 0.25 0.25 0.25 
Vitamin mixture3 1.95 1.95 1.95 
Mineral mixture4 1.95 1.95 1.95 
Choline chloride 0.3 0.3 0.3 
Total 100 100 100 
 
Proximate composition analyzed, as-fed basis5 
Moisture 10.9 ± 0.02 10.7 ± 0.03 10.2 ± 0.02 
Ash 2.8 ± 0.1 2.9 ± 0.2 3.1 ± 0.6 
Protein 46.8 ± 0.1 47.3 ± 0.04 46.1 ± 0.01 
Lipid 8.8 ± 0.2 9.1 ± 1.3 9.9 ± 1.4 
1Note that the diet composition data presented here were previously published (Hixson 
and Parrish, 2014); we include them herein as they pertain to the current study as well. 
2SEFM = Solvent-extracted fish meal (herring meal). 
3Vitamin Premix contains per kg: Vitamin A 0.9 g, Vitamin D3 8.0 g, Vitamin E 50.0 g, 
Vitamin K 3.0 g, Thiamin 2.8 g, Riboflavin 4.0 g, Pantothenic acid 24.0 g, Biotin 0.1 g, 
Folic acid 26.7 g, Vitamin B12 0.03 g, Niacin 15.1 g, Pyridixine 3.3 g, Ascorbic acid 10.8 
g, Wheat middlings (carrier) 851.3 g. 
4Mineral Premix contains per kg: Manganese oxide 12.3 g,  Zinc oxide 20.6 g, Copper 
sulphate 6.1 g, Iodine 15.8 g, Wheat middlings (carrier) 954.2 g. 
5Proximate composition are percentage of total weight and are means ± standard 
deviation (n = 3). 
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of fasting. Body weight, total length and liver weight of fish as well as feed intake were 
measured. Liver samples (50-100 mg tissue-1) were rapidly dissected from the fish, placed 
in RNase-free 1.5 mL tubes, flash-frozen in liquid nitrogen, and stored at -80°C until 
RNA extraction. Further details on fish rearing conditions and sampling for lipid analysis 
are described elsewhere (Hixson and Parrish, 2014). 
2.3.3 RNA extraction and column purification 
Tissue samples representing the cod tissue panel, and liver samples collected from 
the feeding experiment, were homogenized in 2.0 mL tubes containing TRIzol reagent 
(Invitrogen, Carlsbad, CA) with a volume of 0.8 mL sample-1 and a stainless steel bead 
(2.5 mm; QIAGEN, Mississauga, ON) using a TissueLyser (QIAGEN) at 25 Hz for 3 
min, further disrupted using QIAshredder spin columns (QIAGEN), and subjected to 
RNA extraction according to the manufacturers' instructions. After extraction, the quality 
of total RNA was examined by 1% agarose/ethidium bromide gel electrophoresis, and 
RNA quantity and purity were measured by NanoDrop spectrophotometry 
(ThermoFisher, Mississauga, ON). Total RNA of each sample was treated with DNase I 
(QIAGEN) to degrade residual genomic DNA, and all samples were purified from salts, 
proteins and nucleotides using the RNeasy Mini Kit (QIAGEN) following the 
manufacturer's protocols. The quantity and quality of cleaned RNA samples were 
assessed as previously described. Only high quality (260/280 ratio > 2.0, 260/230 > 1.9, 
with tight 18S and 28S ribosomal RNA bands) total RNA samples were used for 
transcript characterization and expression studies.  
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2.3.4 Genomic screening for members of Atlantic cod elovl gene family 
In order to identify putative Atlantic cod Elovl-encoding transcripts, zebrafish 
Elovl protein sequences obtained from NCBI (see Appendix I for accession numbers) 
were used to tBLASTn query the Atlantic cod genome (gadMor1 v73.1) or the cDNA 
collection predicted based on their genomic sequences (i.e. GeneScaffolds; available 
through Ensembl website: http://www.ensembl.org) and transcriptome (available through 
the ViroBlast server at http://www.codgenome.no/viroblast/viroblast.php) databases (Star 
et al., 2011). This approach allowed the identification of sequence fragments that 
represent putative Atlantic cod Elovl-encoding transcripts. To obtain full-length Atlantic 
cod Elovl-encoding transcripts, 5' and 3' RACE reactions (see section 2.3.5) were 
performed using gene-specific primers designed based on these sequences (Appendix II). 
2.3.5 Elovl cDNA cloning, sequencing, and sequence assembly 
The full-length cDNA sequences of cod elovl transcripts were obtained using 
RACE. Full-length 5' and 3' RACE cDNAs were synthesized using the SMARTer RACE 
cDNA Amplification Kit following the manufacturer's instructions (Clontech, Mountain 
View, CA). The poly(A)+ RNA (i.e. mRNA) was isolated from an RNA pool that 
included an equal quantity of each cleaned total RNA from 15 different tissues of two 
juvenile Atlantic cod, using the MicroPurist mRNA isolation kit (Ambion, Austin, TX) 
and following the manufacturer's instruction. This mRNA template was used for the 
RACE cDNA synthesis. Ten µL of 5' and 3' RACE cDNA (corresponding to 1 µg of input 
mRNA) was diluted into a final volume of 260 µL with nuclease-free water (Invitrogen). 
Based on sequence information obtained from public databases, gene specific primers 
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(GSPs) for each cod elovl transcript were designed using the Primer3 program (available 
at http://frodo.wi.mit.edu) (Rozen and Skaletsky, 2000). RACE involved a touch-down 
PCR followed by a nested PCR. Using 2.5 µL of the diluted cDNA (representing ~ 4 ng 
of input mRNA) as template, both 5' and 3' RACE PCRs (including first-round and nested 
PCR) were performed using the Advantage 2 Polymerase (Clontech) following the 
manufacturer's instructions. The cycling parameters for touch-down PCR consisted of an 
initial denaturation period of 1 min at 95°C, followed by 5 cycles of (95°C for 30 s, 72°C 
for 30 s, 72°C for 3 min), 5 cycles of (95°C for 30 s, 70°C for 30 s, 72°C for 3 min), 20 
cycles of (95°C for 30 s, 68°C for 30 s, 72°C for 3 min), and 1 cycle at 68°C for 10 min. 
For the nested RACE PCR, cycling parameters consisted of 1 min at 95°C, followed by 
20 cycles of (95°C for 30 s, 68°C  for 30 s, 72°C for 3 min), and 1 cycle at 68°C for 10 
min. 
All PCR products were gel-extracted from 1% agarose gel stained with ethidium 
bromide, using the QIAQuick Gel Extraction kit (QIAGEN) following the manufacturer's 
protocol. The extracted products were then ethanol precipitated, washed, and TA cloned 
into a pGEM-T-Easy vector (Promega, Madison, WI) at 4°C overnight using standard 
techniques. The recombinant plasmids were transformed into Subcloning Efficiency 
DH5α Competent Cells (Invitrogen) following the manufacturer's instructions. After 
transformation, 300 µL of SOC medium (Invitrogen) were added to the ligation reaction 
and incubated for 1 h at 37°C with shaking (~225 rpm), and the cells were grown for 16 h 
at 37°C on Luria broth (LB)/agar with 100 µg mL-1 ampicillin. Individual colonies were 
cultured for 16 h at 37°C in LB/ampicillin (100 µg mL-1), and the plasmid DNA was 
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purified and isolated in the 96-well format using standard molecular techniques. Prior to 
sequencing, the insert sizes of recombinant plasmids were estimated either by EcoRI 
(Invitrogen) digestion followed by agarose gel electrophoresis, or by PCR using TopTaq 
DNA Polymerase (QIAGEN) with M13 primers (forward and reverse) following the 
manufacturer's instructions. For each PCR product, three individual clones were 
sequenced [by the ABI 3730 DNA Analyzer using the BigDye Terminator chemistry 
(Applied Biosystems, Foster City, CA)] at the Genomics and Proteomics facility of 
Memorial University; clones were sequenced as many times as required to give at least 6-
fold coverage for elovl sequences. 
Overlapping sequence fragments obtained from 5' and 3' RACE were assembled 
using Lasergene 7.20 software (DNASTAR, Madison, WI). To verify each sequence 
assembly, GSPs flanking the overlapping region of 5' and 3' RACE products [and 
designed to flank the entire open reading frame (ORF) if possible] were used to amplify 
each elovl. PCR was carried out using the TopTaq polymerase kit (QIAGEN) in a 25 µL 
reaction volume that contained 2 µL of 5' RACE cDNA (representing ~3.2 ng of input 
mRNA), 0.5 µM each of forward and reverse GSP (Appendix II), 0.625 U of TopTaq 
DNA Polymerase, 2.5 µL of TopTaq PCR buffer and 100 µM of each dNTP. The cycling 
parameters for PCR consisted of an initial denaturation period of 3 min at 94°C, followed 
by 30 cycles of (94°C for 30 s, 60°C for 30 s, 72°C for 3 min), and 1 cycle at 72°C for 10 
min. The resultant PCR products were analyzed by agarose gel electrophoresis to verify if 
the sequences were correctly assembled, and to confirm that the assembled cDNAs 
represented bona fide transcripts. 
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2.3.6 Sequence analysis 
The amino acid (AA) sequences of putative Atlantic cod Elovls were predicted 
based on full-length elovl cDNA sequences using the SeqBuilder function of Lasergene 
software (DNASTAR). Using the same software, the cDNA sequences obtained from 
RACE were mapped to the Atlantic cod genomic sequence downloaded from the Ensembl 
website (http://www.ensembl.org) to determine gene structure. By using the AA 
sequences of zebrafish Elovls, homologous Elovl sequences from other fish species [e.g. 
Atlantic salmon and pufferfish (Takifugu rubripes)] were collected from the NCBI 
database using the tBLASTx alignment search tool. The predicted AA sequences of cod 
Elovls were aligned with homologous Elovl sequences using the MUSCLE function of 
MEGA5 software (Edgar, 2004; Tamura et al., 2011). Pair-wise sequence comparisons 
were carried out with the MegAlign function of Lasergene software (DNASTAR). An 
unrooted phylogenetic tree was constructed based on the alignment results of the deduced 
amino acid sequences, using the Maximum Likelihood method implemented in MEGA5, 
bootstrapped 1000 times. 
2.3.7 Tissue distribution of cod elovl gene family transcripts 
Two sets of GSPs for each elovl transcript [except elovl5, which had been 
previously characterized (Agaba et al., 2005)] were designed using the Primer3 program 
based on the sequence information arising from the RACE studies (Appendix II). For 
each individual sample, 1 µg of DNase I-treated and column purified total RNA was 
reverse-transcribed using random primers (250 ng, Invitrogen) and Moloney murine 
leukemia virus (M-MLV) reverse transcriptase (200 U, Invitrogen) at 37°C for 50 min in 
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a 20 µL reaction volume, which also contains 10 mM of each dNTPs, 0.2 M DTT, and 4 
µL 5× first-strand buffer, following manufacturer’s instructions. The resulting cDNA was 
diluted with nuclease-free water (Invitrogen) to a volume of 200 µL. Reverse 
transcription - polymerase chain reaction (RT-PCR) amplifications were carried out using 
the same chemistry as ORF PCR, but with a set of templates from the cod tissue panel 
(for complete list of tissues see section 2.3.1; 2 µL of diluted cDNA representing 10 ng of 
input total RNA for each tissue sample) and RT-PCR GSPs (Appendix II). The cycling 
parameters for RT-PCR were also identical to ORF PCR except for the extension period, 
which was decreased to 1 min. The reference gene used in this study was elongation 
factor 1α (eef1α), and was included in the same PCR run as the GOI. Negative (“no-
template”) controls were also included for each gene of interest (GOI) to confirm the 
absence of template contamination. PCR products were electrophoretically separated in 
1.5% agarose/ethidium bromide gels along with a 1Kb plus ladder (Invitrogen), and 
visualized under UV light in a G:BOX gel imaging system (Syngene, Frederick, MD).  
2.3.8 QPCR: hepatic transcript expression responses of four elovls and fadsd6 to 
diets containing camelina oil 
The transcript expression responses of elovl1b, elovl4c-2, elovl5, elovl6a and 
fadsd6 to the three diets (Table 2-1; FO, 100CO and 100COSEFM) were studied in 
juvenile cod liver tissue at week 13 of the feeding trial, using quantitative reverse 
transcription - polymerase chain reaction (QPCR). QPCR primers for the five GOIs, and 
the normalizer gene 60S acidic ribosomal protein P1 [rplp1; 20K cod microarray probe 
identifier (ID) #35667 (Booman et al., 2011)], are shown in Appendix II. All QPCR 
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primer sets were assessed for quality using dissociation curves to ensure that the primer 
pairs amplified single products with no primer dimers. The amplification efficiencies of 
primer pairs (Pfaffl, 2001) were determined using a 5-point 1:5 (rplp1), 1:3 (elovl1b, 
elovl4c-2, and elovl5), or 1:2 (elovl6a and fadsd6) dilution series starting with pooled 
cDNA (corresponding to 10 ng of input total RNA) with equal contributions of all 
individuals involved in the QPCR study. For a given primer pair, quality control was 
performed in triplicate. 
For each experimental treatment, nine individuals (three from each triplicate tank) 
were involved in the QPCR study. For each liver template, 1 µg of DNase I-treated and 
column purified total RNA was reverse-transcribed using random primers (250 ng, 
Invitrogen) and Superscript II reverse transcriptase (200 U, Invitrogen) at 42°C for 50 
min in a 20 µL reaction volume following the manufacturer's instructions. The resulting 
cDNA was diluted with nuclease-free water (Invitrogen) to a volume of 200 µL. QPCR 
reactions were performed using Power SYBR Green I dye chemistry on the ViiA™ 7 
Real-Time PCR System (Applied Biosystems, Foster City, CA). The PCR reactions 
contained 2 µL of diluted cDNA (10 ng input total RNA), 50 nM each of forward and 
reverse primer, and 1× Power SYBR Green PCR Master Mix (Applied Biosystems) in a 
final volume of 13 µL. The PCR program consisted of 1 cycle of 50°C for 2 min, 1 cycle 
of 95°C for 10 min, followed by 40 cycles of (95°C for 15 s and 60°C for 1 min), with the 
fluorescent signal data collection after each 60°C step. GOI and normalizer (rplp1) for a 
given template were run in triplicate on the same 96-well plate. Rplp1 was chosen as the 
normalizer gene due to its stable transcript expression in other cod liver microarray 
experiments (data not shown). In addition, rplp1 was tested with QPCR in a subset of 
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individuals (three from each condition) and had the lowest threshold cycle (CT) range 
(0.7) compared to two other candidate normalizers [eef1α and tubulin α]. In every multi-
plate study, a linker control (a pooled cDNA sample from all samples involved in the 
study) was used to check the variability between plates. All thresholds were set 
automatically, and relative quantity (RQ) of each QPCR target transcript for each 
individual was calculated using actual amplification efficiencies (see Supplemental Table 
2) for GOI and normalizer primer pairs using the the ViiA™ 7 Software v1.2 (Applied 
Biosystems). The individual with the lowest GOI expression regardless of treatment was 
used as the calibrator sample (i.e. RQ = 1) for each GOI study. The underlying algorithm 
for calculating RQ (i.e. the 2-ΔΔCT method for relative quantification) was described 
previously (Livak and Schmittgen, 2001). 
2.3.9 Statistical analyses of growth and QPCR data 
All statistical analyses of growth-relevant and QPCR data were performed using 
Minitab (v16; State College, PA) with one-way ANOVA, followed by the Tukey post-hoc 
test for multiple comparisons at the 5% level of significance, to detect differences 
between dietary treatments. All data were subjected to normality testing using the 
Anderson-Darling method. The growth-relevant data (as shown in Table 2-3) were 
presented as mean ± standard deviation (SD). RQ data were log2 transformed in Excel in 
order to meet with statistical assumptions (i.e. normality), and were presented as mean ± 
standard error (SE). However, such data transformation on some data sets (e.g. elovl5 of 
FO) was still not able to meet the normality assumption (p < 0.01; Anderson-Darling 
method). The transformed RQ data were also subjected to outlier tests (i.e. Grubbs' test; 
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available at http://graphpad.com/quickcalcs/grubbs1/) to identify potential outliers. Two 
outliers, one fish of elovl5 from FO (4.22× higher than the group average) and one fish of 
elovl4c-2 from 100COSEFM (4.42× lower than the group average), were identified (p < 
0.01; Grubbs' test); thus they were excluded from the data analyses. For QPCR fold-
change calculation, overall fold up-regulation was calculated as 2A-B, where A is the mean 
of log2 transformed RQ from an experimental group (i.e. 100CO or 100COSEFM), and B 
is the mean of log2 transformed RQ from the FO group (Cui and Churchill, 2003). 
2.4 Results 
2.4.1 Elovl gene family characterization and molecular phylogenetics 
In this study, bioinformatic and molecular techniques (mining sequence databases, 
RACE, and sequencing) were used to characterize ten members of the elovl gene family 
(elovl1a, elovl1b, elovl4a, elovl4b, elovl4c-1, elovl4c-2, elovl5, elovl6a, elovl6b, and 
elovl7) in Atlantic cod. All cDNA sequences of the cod elovl gene family obtained 
through the current study were deposited in GenBank under the accession numbers 
KF964005 - KF964015 (Table 2-2). The details of transcript structure, including 
untranslated regions (UTRs), open reading frames (ORFs) and sequence lengths, as well 
as associated genomic sequences (i.e. GeneScaffolds), are shown in Table 2-2 and 
Appendices IV-XIII. In addition, the full-length elovl cDNA sequences obtained from 
RACE were mapped to the corresponding Atlantic cod genomic sequences to determine 
the genomic organization of the elovl gene family members as shown in Fig. 2-1.  
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Table 2-2. Atlantic cod elovl transcript analyses and associated genomic sequences. 
Gene1 Transcript Genomic sequences2 5' UTR (nt) 
ORF 
(nt/AA)3 
3' UTR 
(nt) 
Sequence 
length (bp) 
elovl1a KF964005 GeneScaffold_4551 92 921/306 459 1472 
elovl1b KF964007 or KF964006 
GeneScaffold_1484;	  
contig 52498 
129 960/319 552 or 1178 
1641 or 
2267 
elovl4a KF964008 GeneScaffold_3464; contig 129825 209 810/270 - 1019 
elovl4b KF964009 GeneScaffold_2661 252 903/301 - 1155 
elovl4c-1 KF964010 
GeneScaffold_1484; 
contig 70127; contig 
70123 
180 795/264 651 1626 
elovl4c-2 KF964011 GeneScaffold_1484 449 795/264 96  1340  
elovl5 KF964012 GeneScaffold_1260 86 867/288 1240 2193 
elovl6a KF964013 GeneScaffold_3464 34 846/281 757 1637 
elovl6b KF964014 GeneScaffold_2788 109 822/273 1129 2060 
elovl7 KF964015 GeneScaffold_1288 164 882/293 996 2012 
1All genes including transcript variants presented here were identified through the current 
RACE studies. Numbers in italics represent incomplete sequences. Elovl1b has two full-
length cDNA variants (GenBank accession numbers KF964007 and KF964006) as shown 
in the table; transcript variant KF964006 has a longer 3' UTR. 
2Putative cod elovl transcript-associated genomic sequences (i.e. GeneScaffolds and 
contigs; available through Ensembl website: http://www.ensembl.org) identified using 
BLASTn with cod elovl transcript sequences. 
3Nucleotide and amino acid lengths of open reading frame of the transcript. 
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Fig. 2-1. Schematic representation of gene organisation for the Atlantic cod elovl gene 
family. Boxes represent exons, while lines represent introns. The grey and black colours 
are used to distinguish non-coding and coding portion of exons, respectively. The gene 
structure and full-length cDNA for cod elovl4a and elovl4b have not yet been fully 
determined. The alignment of the current RACE-identified elovl4c-2 cDNA (GenBank 
accession number KF964011) and CGP contig all_v2.0.1432.C1, represented by ESTs 
ES779567 and FG329933 (Bowman et al. 2011), suggest the existence of an elovl4c-2 
transcript variant with a longer 3' UTR. The alignment of elovl5 cDNA (KF964012) and 
the previously identified elovl5 (AY660881) showed some differences in both 5' and 3' 
UTR sequences as demonstrated in this figure. The open box within elovl5 shows the first 
exon (111 bp) of the transcript variant represented by AY660881. A question mark within 
an intron indicates that the entire intron was not identified due to the lack of, or 
discontinuous, genomic sequences.  
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Full-length cDNA sequences including the 5' and 3' UTR regions were identified 
for two elovl1 paralogues (elovl1a, elovl1b). Elovl1a and elovl1b encode 306 and 319 AA 
proteins, respectively (Table 2-2). Elovl1b demonstrated two full-length cDNA variants 
(1641 and 2267 bp) that showed 100% identity over the 1639 bp aligned at the 5' end 
(Fig. 2-1, Table 2-2, and Appendix V). The longer variant had an additional sequence of 
628 bp excluding the poly (A) tail in the 3' UTR (Appendix V). Both elovl1a and elovl1b 
genes consist of 8 exons and 7 introns based on the genome assembly (Fig. 2-1, 
Appendices IV and V). The overall similarity between these two paralogues (i.e. Elovl1a 
and Elovl1b) is 55% at the amino acid level based on sequence alignment (Appendix III). 
Four Atlantic cod elovl4 paralogues were identified in publically available 
sequence databases and further characterized by RACE and sequencing. Of these, only 
elovl4c-1 and elovl4c-2 transcripts were fully characterized. Elovl4c-1 and elovl4c-2 are 
1626 and 1340 bp long, respectively, and both encode 264 AA proteins which share 86% 
identity (Table 2-2, Appendices III, VIII, and IX). Both of these cod genes consist of 8 
exons and 7 introns, and are located in the same GeneScaffold (1484) (Table 2-2 and Fig. 
2-1). In addition, a contig (all_v2.0.1432.C1, represented by ESTs with GenBank 
accession numbers ES779567 and FG329933) from the Atlantic Cod Genomics and 
Broodstock Development Project (CGP, http://codgene.ca) (Bowman et al., 2011) 
revealed a second elovl4c-2 transcript variant with a longer 3' UTR compared with the 
elovl4c-2 transcript variant characterized in the current study (Fig. 2-1). Partial coding 
sequences (containing incomplete ORFs) for two additional elovl4 paralogues (elovl4a 
and elovl4b) were obtained in the current study (Fig. 2-1). The partial sequences of 
elovl4a and elovl4b are 1019 and 1155 bp in length, encoding partial predicted proteins of 
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270 and 301 amino acid residues, respectively (Table 2-2, Appendices VI and VII). The 
analysis of elovl4a and elovl4b gene structure showed at least 7 exons and 6 introns (Fig. 
2-1). Elovl4a and Elovl4b are 70% identical at the predicted amino acid level (Appendix 
III). Attempts to extend the 3' RACE sequences of elovl4a and elovl4b with various 
primer sets (data not shown) were not successful.  
The cod elovl5 cDNA consensus sequence obtained from the current RACE-based 
research and the full-length Atlantic cod elovl5 cDNA sequence in GenBank (accession 
number AY660881) are different at their 5' and 3' ends. While both variants have 8 exons 
and 7 introns according to genome sequence mapping (Fig. 2-1 and Appendix X), the first 
exon (79 bp) in the current RACE-identified elovl5 cDNA sequence is 262 bp upstream 
of the first exon (111 bp) of the cod elovl5 transcript variant represented by GenBank 
accession number AY660881; this results in a longer intron 1 (i.e. between exon 1 and 
exon 2) by 373 bp in the current RACE-identified elovl5 cDNA sequence (Fig. 2-1). Both 
of the elovl5 variants' intron 1 have a classic “GT-AG” intron splicing motif (Appendix 
X). The coding sequences (288 AA) for both elovl5 variants are 100% identical at the 
nucleotides level. However, the last exon (i.e. exon 8) from the current RACE study 
possessed an additional sequence of 753 bp in the 3' UTR compared with AY660881 
(Fig. 2-1). 
Complete cDNA sequences were determined for Atlantic cod elovl6a, elovl6b, 
and elovl7. Elovl6a and elovl6b had similar cDNA and protein lengths (2060 vs. 2012 bp; 
281 vs. 273 AA, respectively) (Table 2-2). Interestingly, both elovl6a and elovl6b were 
encoded by 4 exons and 3 introns, which is different from the other members of the 
Atlantic cod elovl family (Fig. 2-1, Appendices XI and XII). The overall similarity 
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between these two paralogues based on the aligned predicted protein sequences is 70% 
(Appendix III). Elovl7 cDNA is 2012 bp long excluding the poly(A) tail, and encodes 264 
AA protein (Table 2-2 and Appendix XIII). The analysis of elovl7 transcript and genomic 
sequences revealed a gene structure including 8 exons and 7 introns (Fig. 2-1).  
Multiple alignment of Atlantic cod Elovl amino acid sequences with putative 
orthologous sequences from zebrafish using the MUSCLE algorithm built into MEGA5 
(Tamura et al., 2011) revealed four different conserved motifs (KXXEXXDT, 
QXXFLHXXHH, NXXXHXXMYXYY, and TXXQXXQ) in all cod and zebrafish 
Elovls [as shown in (Agaba et al., 2005)]. A single histidine box motif (contained within 
the QXXFLHXXHH motif), five putative transmembrane domains [as predicted by 
(Zhang et al., 2003)], and C-terminal lysine or arginine residues (i.e. KXKXX, KXRXX, 
or KKXX) were found in most Elovls that were included in the multiple sequence 
alignment (Fig. 2-2). An unrooted phylogenetic tree was constructed based on the 
putative protein sequences of cod Elovls, and the Elovls from other fish species (i.e. 
zebrafish, pufferfish, and Atlantic salmon), which were aligned using MUSCLE. In the 
molecular phylogenetic tree, all fish Elovl proteins were classified into three major 
clusters (Fig. 2-3). All Elovl2, Elovl4 and Elovl5 sequences were grouped together 
sharing a single branch, while all Elovl7 and Elovl1 sequences grouped together and 
shared a single branch in the tree (Fig. 2-3). Elovl6 proteins were grouped separately from 
all other Elovl family members for fish species included in the tree (Fig. 2-3). Moreover, 
all cod Elovls cluster with their putative orthologues of other fish species (Fig. 2-3). It is 
noteworthy that all cod, zebrafish, and pufferfish Elovl4c proteins were separated from 
Elovl4a and Elovl4b from these species in the phylogenetic tree, with cod elovl4c-1 and 
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Fig. 2-2. Multiple alignment of predicted Elovl proteins of Atlantic cod with orthologous 
sequences from zebrafish retrieved from the NCBI protein database. Black shading with 
white font is used to denote identical residues. For residues with conservative substitution 
(i.e. 80% conserved as defined by GeneDoc), grey shading with white font is used. Light 
grey with black font specifies that semi-conservative substitutions (i.e. 60% conserved as 
defined by GeneDoc) have been observed. Four different motifs (KXXEXXDT, 
QXXFLHXXHH, NXXXHXXMYXYY, and TXXQXXQ) are highly conserved in all 
Elovls presented in this figure (as shown in Agaba et al., 2005). A single histidine box 
which is contained within the QXXFLHXXHH motif, and five putative transmembrane 
domains (solid underlines) predicted by Zhang and colleagues (2003), were indicated for 
most of the Elovls. 
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Fig. 2-3. Phylogenetic analysis of the Atlantic cod Elovl family. The predicted proteins of 
cod Elovls were aligned against homologous proteins from other fish species [i.e. 
zebrafish (Danio rerio), pufferfish (Takifugu rubripes), and Atlantic salmon (Salmo 
salar)] using MEGA5 (v5.10). Based on the multiple sequence alignment, all sequences 
used in this figure were trimmed in order to eliminate technical bias, and an unrooted 
phylogenetic tree was constructed by the Maximum likelihood method. The tree was 
bootstrapped 1,000 times, and the bootstrap values are shown at the branch points. Any 
branches that present in less than 50% of bootstrap replicates are not shown. Zebrafish 
Elovl1a (NP_001005989), Elovl1b (NP_998581), Elovl2 (NP_001035452), Elovl4a 
(NP_957090), Elovl4b (NP_001191453), Elovl4c (AAH60897), Elovl5 (NP_956747), 
Elovl6a (NP_955826), Elovl6b (AAH46901), Elovl7a (AAH46901) and Elovl7b 
(AAH45481); Salmon Elovl1 (NP_001139865), Elovl2 (NP_001130025), Elovl4 
(NP_001182481), Elovl5a (NP_001117039) and Elovl5b (NP_001130024); Pufferfish 
Elovl1a (XP_003975604), Elovl1b (XP_003974086), Elovl4a (XP_003966009), Elovl4b 
(XP_003971605), Elovl4c (XP_003974148), Elovl5 (XP_003964216), Elovl6a 
(XP_003970691), Elovl6b-1 (XP_003976166), Elovl6b-2 (XP_003961164) and Elovl7 
(XP_003974898). 
 
 
 
 54 
 
 
 
  
 55 
 
elovl4c-2 appearing to have arisen from a gene duplication event in the cod lineage (Fig. 
2-3). Based on the phylogenetic tree, elovl1 and elovl6 gene duplication events preceded 
the divergence of cod, pufferfish, and zebrafish (Fig. 2-3). 
2.4.2 Elovl gene family constitutive transcript expression 
Qualitative RT-PCR was used to study constitutive expression of elovl transcripts 
in fifteen tissues (skeletal muscle, skin, eye, brain, head kidney, posterior kidney, spleen, 
pyloric caecum, midgut, hindgut, stomach, liver, blood, heart, and gill; Fig. 2-4). All PCR 
products ranged between 100 to 200 bp (Appendix II). There was no amplification in the 
“no-template controls” for all GSP pairs, and all individual samples exhibited bands of 
170 bp with comparable intensity for the reference gene, eef1α. For each gene except 
elovl5 and eef1α, two primer pairs were used to examine the elovl gene family 
constitutive transcript expression; the results using the first primer pair per gene are 
shown in Fig. 2-4, and the results for the second primer pair per gene are shown in 
Appendix XIV. 
For each elovl family member, constitutive transcript expression profiles across 
the 15-tissue panel were very similar for the two juvenile cod included in the study (Fig. 
2-4 and Appendix XIV). Elovl1a and elovl1b constitutive transcript expression profiles 
were very different from one another; elovl1b was ubiquitously expressed in the 15 
tissues tested, whereas elovl1a expression appeared to be more tissue-specific with 
highest transcript levels observed in posterior kidney, stomach gill, skin, and eye (Fig. 2-
4A,B). The constitutive transcript expression of the four cod elovl4 paralogues (elovl4a, 
elovl4b, elovl4c-1 and elovl4c-2) exhibited various profiles across the tissues examined 
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Fig. 2-4. RT-PCR assessment of tissue distribution of elovl1a, elovl1b, elovl4a, elovl4b, 
elovl4c-1, elovl4c-2, elovl5, elovl6a, elovl6b and elovl7 transcripts in Atlantic cod for 
various tissues including skeletal muscle (Mu), skin (Sk), eye (Ey), brain (Br), head 
kidney (HK), posterior kidney (PK), spleen (Sp), pyloric caecum (PC), midgut (Mg), 
hindgut (Hg), stomach (St), liver (Li), blood (Bl), heart (He), and gill (Gi). These tissues 
were collected from two juvenile cod. Expression of the reference gene, elongation factor 
1α (eef1α) is shown in the bottom row. NT, no-template control. 1Kb plus ladder 
(Invitrogen) was included in each panel to show the size of the PCR amplicon. The 
primer pairs used in these RT-PCRs were elovl1a (f5, r5), elovl1b (f4, r4), elovl4a (f5, 
r5), elovl4b (f4, r4), elovl4c-1 (f5, r5), elovl4c-2 (f5, r5), elovl5 (f4, r4), elovl6a (f4, r4), 
elovl6b (f5, r5) and elovl7 (f4, r4) as listed in Appendix II. 
 57 
 
 
 
 58 
 
(Fig. 2-4C,D,E,F). For example, the transcript expression of elovl4a was tissue-specific 
(eye and brain; Fig. 2-4C). In contrast, the expression of elovl4b was not limited to eye 
and brain, but was also seen in skin, head kidney, posterior kidney and spleen (Fig. 2-4D). 
Elovl4c-1 transcript expression appeared to be tissue-specific (gill and skin, with 
relatively higher expression in gill; Fig. 2-4E); in contrast, elovl4c-2 transcript expression 
was detected in several tissues (brain, pyloric caecum, liver, posterior kidney, midgut, 
hindgut and gill; Fig. 2-4F). Elovl5 transcript was found to be expressed in all tissues 
tested although with relatively low levels in muscle and blood (Fig. 2-4G). The 
constitutive transcript expression profiles of elovl6a and elovl6b were somewhat similar, 
with both transcripts expressed in skin, eye, brain and gill; however, of these two 
paralogous transcripts only elovl6a had detectable expression in liver tissue (Fig. 2-4H), 
and only elovl6b had detectable expression in stomach tissue (Fig. 2-4I). The transcript 
expression of elovl7 appeared to be tissue-specific (stomach, gill, skin, and posterior 
kidney, with highest expression in stomach and gill; Fig. 2-4J). The RT-PCR qualitative 
transcript expression study showed that elovl1b, elovl4c-2, elovl5 and elovl6a were 
expressed in juvenile cod liver, which is functionally important for fatty acid metabolism. 
Hence, these four elovl transcripts were selected for the QPCR experiment designed to 
study hepatic transcript expression responses to diets containing CO. 
2.4.3 Growth performance of cod fed CO-containing diets versus FO control diet 
The growth performance and fatty acid data for this feeding trial were reported in 
Hixson and Parrish (2014). However, since the growth data are also relevant to the 
current study, they are briefly described and included in this chapter (Table 2-3). 
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Table 2-3. Growth performance of juvenile Atlantic cod (week 13)1. 
 FO (control)  100CO  100COSEFM  
Initial weight (g) 14.3 ± 1.2  14.6 ± 1.0 14.5 ± 1.4 
Final weight (g) 50.8 ± 10.3a  43.6 ± 8.9b 46.6 ± 10.7b 
Weight gain (g) 36.6 ± 1.4a  29.0 ± 1.2b 32.1 ± 1.0b 
Initial length (cm) 11.3 ± 0.3  11.2 ± 0.3 11.2 ± 0.4 
Final length (cm) 17.0 ± 1.1a  16.4 ± 1.0b 16.8 ± 1.1a 
SGR2  1.31 ± 0.03a  1.13 ± 0.05b 1.21 ± 0.10ab  
Condition factor3  1.01 ± 0.1a  0.98 ± 0.1ab  0.97 ± 0.1b 
HSI4 (%)  6.8 ± 1.5  6.9 ± 1.4 7.6 ± 1.5 
AFI5  33.0 ± 1.8a  28.2 ± 1.4b 29.3 ± 1.0b  
FCR6  0.90 ± 0.03  0.97 ± 0.03 0.91 ± 0.05 
1Data are presented as mean ± standard deviation. Means with different letters are 
significantly different (p < 0.05), determined by one-way ANOVA (Minitab v16). Initial 
measurements, n = 9. n is variable depending on number of fish remaining in tank for 
final measurements: FO = 99, 100CO = 104, 100COSEFM = 105. Note that all data here 
were presented in Hixson and Parrish (2014), however, all statistics were re-run due to the 
exclusion of a dietary treatment in the current study. 
2SGR, Specific growth rate (%/day) = 100*[ln(final weight) - ln(initial weight)]/days.  
3Condition factor = 100*final weight/final length3.  
4HSI, Hepatosomatic index = 100*(liver weight/body weight).  
5AFI, Apparent feed intake (g/fish).  
6FCR, Feed conversion ratio = AFI/weight gain. 
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Initially, cod were 14.4 ± 1.6 g and grew to 43.6 to 50.8 g (average final weight in 
different diet groups) after 13 weeks of feeding experimental diets (Table 2-3). Initially, 
there were no significant differences in weights or lengths of fish in the three diet groups 
(Table 2-3). Cod fed either 100CO or 100COSEFM had significantly lower final weight 
than cod fed the FO control diet (Table 2-3). The same result was observed in weight 
gain. In terms of changes in the length of fish, cod fed FO and 100COSEFM were 
significantly longer than cod fed 100CO. The apparent feed intake (AFI) per fish through 
the feeding trial was affected by diet, with fish fed the FO diet consuming more than fish 
fed either of the CO-containing diets (Table 2-3). Furthermore, cod fed 100CO had a 
significantly lower specific growth rate (SGR; 1.13% day-1) than FO fed cod (1.31% day-
1). However, fish fed all three diets had comparable feed conversion ratios (FCR) after 13 
weeks of feeding, and the hepatosomatic index (HSI) of cod was not significantly affected 
by diet (6.0 to 7.6%) (Table 2-3). 
2.4.4 Hepatic transcript expression responses to diets containing camelina oil 
The QPCR experiment included four elovl transcripts shown from the tissue panel 
RT-PCR to be expressed in liver tissue (elovl1b, elovl4c-2, elovl5, and elovl6a). An 
additional transcript, fadsd6, also involved in LC-PUFA biosynthesis, was also evaluated 
with Atlantic cod liver templates from fish fed three diets (FO, 100CO and 100COSEFM) 
from week 13 of the feeding trial. The transcript expression of elovl1b (p = 0.552), 
elovl4c-2 (p = 0.426), and elovl6a (p = 0.349) in cod liver was not significantly affected 
by feeding either of the CO-containing diets (i.e. 100CO and 100COSEFM) compared 
with the FO diet (Fig. 2-5A,B,D). While the overall fold-change values of elovl4c-2 and
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Fig. 2-5. QPCR analysis of elovl1b, elovl4c-2, elovl5, elovl6a and fadsd6 transcript 
expression in liver of cod fed 100CO, 100COSEFM, or FO diets at week 13. Gene 
expression data, presented as mean log2 transformed relative quantity (RQ) ± standard 
error, was normalized to 60S acidic ribosomal protein P1 (rplp1). RQ values were 
calibrated to the individual with the lowest normalized gene expression. Within a given 
gene of interest study, different letters indicate significant difference (p < 0.05) between 
groups. For each condition (i.e. diet), fold up-regulation was calculated as 2A-B, where A 
is the mean log2 transformed RQ from an experimental group (i.e. 100CO or 
100COSEFM), and B is the mean log2 transformed RQ from the FO group (Cui and 
Churchill, 2003). As noted in the Methods, two outliers (one 100COSEFM fish for 
elovl4c-2, and one FO fish for elovl5) from were identified (p < 0.01; Grubbs' test) and 
excluded from the data analyses.  
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elovl6a were 1.80 and 2.13, respectively, in 100COSEFM compared with FO fed cod, this 
up-regulation was not statistically significant (Fig. 2-5B,D). However, elovl5 transcript 
was significantly up-regulated (1.31-fold) in the 100COSEFM group compared with the 
FO group, with no difference between 100CO and FO groups (Fig. 2-5C). Fadsd6 
transcript was significantly up-regulated (7.17-fold) in cod fed 100COSEFM compared 
with cod fed the FO diet, with no significant different between 100CO and FO groups 
(Fig. 2-5E). 
2.5 Discussion 
In this study, ten putative Elovl-coding transcripts were identified in Atlantic cod 
by mining the Atlantic cod genome database with the aid of other databases such as the 
cod transcriptome assembly, CGP EST, and NCBI nr databases. For cod elovl1a, elovl1b, 
elovl4c-1, elovl4c-2, elovl5, elovl6a, elovl6b, and elovl7, I sequenced the full-length 
cDNA and resolved the gene structure. I also obtained the partial cDNA sequences and 
partially resolved the gene structures of Atlantic cod elovl4a and elovl4b (Fig. 2-1). In 
addition, I studied the constitutive expression of all ten elovl transcripts across fifteen 
tissue types from juvenile cod. Furthermore, I investigated growth performance and 
hepatic transcript expression of four elovls and fadsd6 in a metabolically important tissue 
(liver) of cod fed CO-containing diets (i.e. 100CO and 100COSEFM) versus cod fed a 
FO-based diet.  
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2.5.1 Elovl gene family characterization and molecular phylogenetics 
The full-length cDNAs of cod elovl1a, elovl1b, elovl4c-1, elovl4c-2, elovl5 and 
elovl7 each include eight exons, while the full-length cDNA of cod elovl6a and elovl6b 
each include four exons. Zebrafish gene structure of both elovl6a and elovl6b matches the 
pattern observed in cod. From the analysis of cod elovl transcript sequences (Fig. 2-1), 
both elovl1b and elovl4c-2 have two transcript variants that only differ at the 3' UTR, 
resulting from alternative polyadenylation. Interestingly, the cod elovl5 transcript 
sequence obtained from the current RACE study is different at the 5' and 3' ends from the 
cod elovl5 cDNA sequence (GenBank accession number AY660881) that was previously 
characterized (see section 2.4.1) (Agaba et al., 2005). The two different elovl5 transcript 
variants may arise from different transcript splicing events. 
All cod Elovl members exhibit characteristic features of microsomal-bound 
enzymes from other systems (Agaba et al., 2005), including four different conserved 
motifs (i.e. KXXEXXDT, QXXFLHXXHH, the tyrosine box NXXXHXXMYXYY, and 
TXXQXXQ), several predicted transmembrane domains and a single histidine box 
contained within the QXXFLHXXHH motif. In addition, the C-terminal lysine or 
arginine residues (i.e. KXKXX, KXRXX, or KKXX) found in most cod Elovl members, 
as well as in zebrafish Elovl proteins, may function as ER retention signals (Jakobsson et 
al., 2006; Morais et al., 2009). It is worth noting that both zebrafish and cod Elovl6 
proteins are very different from other Elovl family members based on the multiple 
sequence alignment (Fig. 2-2). This is also seen in the molecular phylogenetic analysis 
since Elovl6 proteins were grouped separately from any other Elovl family members for 
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all fish species included in the tree (Fig. 2-3). Overall, however, the conservation of 
protein sequence across the Elovl family is remarkably high (Appendix III). 
The phylogenetic tree indicated that the Elovl proteins can be grouped into three 
subfamilies (Fig. 2-3). In terms of one of the PUFA-responsive elongases Elovl2, which 
has shown capacity in elongating C20 and C22 PUFA with low activity towards C18 as seen 
in Atlantic salmon and zebrafish (Morais et al., 2009), a tBLASTn search of the cod 
genome assembly (gadMor1 v73.1) in the Ensembl database using the AA sequence of 
zebrafish Elovl2 as query showed hits [e.g. 70.7% identity over 58 aligned AA with E-
value of 2.0e-60 (most significant)] against the regions of GeneScaffold 1260 which 
encode elovl5, rather than a potential elovl2 family member. Moreover, Morais et al. 
(2009) previously performed searches of other marine fish genomes such as pufferfish, 
stickleback (Gasterosteus aculeatus), and medaka (Oryzias latipes) (all of which are 
members of superorder Acanthopterygii) for evidence of elovl2 genes with negative 
results. Hence, it is reasonable to speculate that the elovl2 gene might have been lost (e.g. 
silenced) in Atlantic cod (superorder Paracanthopterygii) as well as in fish belonging to 
superorder Acanthopterygii (Morais et al., 2009; Monroig et al., 2011). In contrast, elovl2 
genes are present in Atlantic salmon (superorder Protacanthopterygii) and zebrafish 
(superorder Ostariophysi) (Morais et al., 2009). Previous studies reported that Elovl4 acts 
in the biosynthesis of LC-PUFA in cobia and Atlantic salmon (Carmona-Antoñanzas et 
al., 2011; Monroig et al., 2011). It may be speculated that the loss of elovl2 from the cod 
genome may have altered LC-PUFA biosynthetic capacity, and thereby influenced the 
evolution of cod elovl4 paralogues. The molecular phylogenetic analysis revealed that 
Atlantic cod elovl4 has expanded into 4 different paralogues (Fig. 2-3); the cod elovl4c-1 
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and elovl4c-2, which encode proteins that clustered along with their homologue from 
zebrafish (i.e. Elovl4c), appears to have arisen from a gene duplication event in the cod 
lineage. 
2.5.2 Elovl gene family constitutive transcript expression 
Qualitative RT-PCR analysis revealed that elovl1b transcript is ubiquitously 
expressed in all tissues tested. Unfortunately, there is no available tissue expression 
distribution data on elovl1b transcript in any other teleost species. However, in agreement 
with the current cod elovl1b transcript expression results, a previous study on ELOVL1 in 
humans also exhibited a broad range of transcript expression including 16 different 
tissues (Ohno et al., 2010). This evidence supports the hypothesis that cod elovl1b is an 
orthologue of human ELOVL1. In in vitro studies, human ELOVL1 protein showed high 
activity toward both saturated and monounsaturated C20 and C22 acyl-CoAs. These fatty 
acyl-CoAs are important for the production of C24 sphingolipids in mammals (Ohno et al., 
2010). The ubiquitous expression of cod elovl1b transcript suggests that the encoded 
protein may be required as a 'housekeeping elongase' to prevent the fluctuation of specific 
fatty acids as proposed in mammals (Jakobsson et al., 2006; Guillou et al., 2010). In 
contrast to cod elovl1b, elovl1a transcript was expressed in a more narrow range of 
tissues (posterior kidney, stomach, gill, skin, eye). Since elovl1 is a single copy gene in 
mouse (Asadi et al., 2002), whereas there are two elovl1 paralogues in evolutionarily 
diverged fish species (e.g. Atlantic cod, pufferfish, zebrafish; Fig. 2-3), the elovl1 gene 
likely duplicated early in the teleost lineage. The different constitutive transcript 
expression profiles of cod elovl1a and elovl1b suggest that these paralogues have 
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undergone regulatory (and potentially functional) divergence. However, the physiological 
roles of these cod elovl1 paralogues are not known and require further investigation. 
The four paralogous cod elovl4 transcripts (i.e. elovl4a, elovl4b, elovl4c-1 and 
elovl4c-2) displayed very different constitutive transcript expression profiles across the 
fifteen tissues examined. Cod elovl4a transcript showed tissue-specific expression in 
brain and eye (Fig. 2-4C). Those two tissues are generally thought to have high 
requirements for VLC-FA and are prominent metabolic sites for the biosynthesis of these 
fatty acids (Carmona-Antoñanzas et al., 2011). The current cod elovl4a transcript 
expression results do not agree with a previous study on zebrafish elovl4a, which was 
abundantly expressed in a variety of tissues in addition to brain and eye (e.g. intestine, 
gill, testis, ovary, posterior kidney, heart, spleen, skin, liver, anterior kidney) (Monroig et 
al., 2010). Unlike the tissue-restricted expression of cod elovl4a, transcript expression of 
cod elovl4b was seen in several different tissues (skin, brain, head kidney, posterior 
kidney, spleen, and eye; Fig. 2-4D). Zebrafish elovl4b transcript was shown to be 
expressed in testis, ovary, eye, and posterior kidney, but not in brain tissue (Monroig et 
al., 2010), and Atlantic salmon elovl4 transcript expression was seen in eye, brain and 
testis (Carmona-Antoñanzas et al., 2011). While the current cod study did not include 
gonad tissues, a comparison of the current results with those of Monroig et al. (2010) and 
Carmona-Antoñanzas et al. (2011) suggests that some aspects of elovl4 transcript 
expression may be conserved in teleost fishes (e.g. elovl4b expression in eye), with other 
constitutive transcript expression characteristics being different between lineages (e.g. 
elovl4a transcript expression in several tissues in zebrafish where expression was not 
observed in cod). Functional characterization of zebrafish Elovl4a suggests that this 
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enzyme is capable of elongating saturated VLC-FA up to C36, with C26 as the most 
preferred substrate (Monroig et al., 2010). In contrast, zebrafish Elovl4b shows 
preferences toward both C20 and C22 fatty acids as substrates in the elongation process 
(Monroig et al., 2010). In a more recent study, elovl4 has been cloned from marine fish 
cobia and its expression was detected in a wide range of tissues except red muscle, skin 
and pyloric caecum; cobia elovl4 was shown to have a closer evolutionary relationship to 
zebrafish elovl4b than to zebrafish elovl4a (Monroig et al., 2011). The cobia Elovl4 is 
able to synthesize VLC-FA including saturated and polyunsaturated FAs with chain 
lengths of more than 24 carbons. This enzyme is also involved in the elongation of 
20:5ω3 and 22:5ω3, which is a critical step for the production of DHA (Monroig et al., 
2011). In the Atlantic cod lineage, the elovl4c gene apparently duplicated, giving rise to 
two paralogues (elovl4c-1 and elovl4c-2) with very different constitutive transcript 
expression profiles (Fig. 2-3; Fig. 2-4E,F). While cod elovl4c-1 transcript expression was 
only seen in two tissues (higher in gill, lower in skin; Fig. 2-4E), cod elovl4c-2 transcript 
expression was seen in several tissues including brain, pyloric caecum and liver (Fig. 2-
4F). These differences in basal transcript expression profiles suggest that cod elovl4c-1 
and elovl4c-2 may have diverged (e.g. undergone neofunctionalization or 
subfunctionalization) after the gene duplication event that gave rise to these paralogues. 
In addition, my results suggest that Atlantic cod Elovl4 members (especially Elovl4a and 
Elovl4b) might play roles in the biosynthesis of VLC-FA as well as LC-PUFA in specific 
tissues that have high constitutive expression (e.g. eye and brain). Whether or not cod 
Elovl4 members are involved in the production of VLC-FA and LC-PUFA requires 
further investigation. 
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The cod elovl5 transcript was detected in all fifteen tissues tested (Fig. 2-4G). The 
expression of cod elovl5 transcript appeared to be higher in some tissues (e.g. brain and 
gill) than others (e.g. muscle, blood, liver and heart), in agreement with previous work on 
the tissue distribution of cod elovl5 transcript (Tocher et al., 2006). In Atlantic salmon, 
the transcript expression levels of both elovl5a and elovl5b were highest in intestine (i.e. 
pyloric caecum), liver and brain (Zheng et al., 2005; Morais et al., 2009). The cloning of 
the cod elovl5 gene was first reported in 2005, and the functional characterization study 
of Elovl5 showed lowest capacity to lengthen ω3 and ω6 PUFA with chain lengths from 
C18 to C22, compared to two other marine species (turbot and sea bream) and other 
freshwater fish species (Agaba et al., 2005; Monroig et al., 2009). Since cod Elovl5 has 
limited LC-PUFA biosynthetic capacity (Agaba et al., 2005), the observed relatively high 
constitutive transcript expression levels of elovl5, elovl4a and elovl4b in cod brain may be 
needed to maintain sufficient LC-PUFA (e.g. DHA) supply. 
Our qualitative RT-PCR analyses of cod elovl6a and elovl6b transcripts revealed 
that both paralogues were expressed in skin, eye and brain (Fig. 2-4H,I). Interestingly, 
elovl6a transcript was also detected in liver (Fig. 2-4H), whereas elovl6b transcript was 
expressed in stomach and gill (Fig. 2-4I). This is the first elovl6 transcript expression 
study in any teleost species. In rat, elovl6 transcript was found by RT-PCR to be highly 
expressed in brain, with lower levels of expression in other tissues including kidney, liver, 
skin and heart (Wang et al., 2005). In addition, semi-quantitative RT-PCR showed that 
human elovl6 transcript was ubiquitously expressed (i.e. in all fifteen tissues examined) 
(Ohno et al., 2010). The functions of cod Elovl6a and Elovl6b, and the physiological 
significance of paralogue-specific differences in basal transcript expression profiles in 
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cod as well as differences in putative orthologous transcript expression between species, 
remain to be studied. 
The transcript expression of elovl7 was highest in stomach and gill tissues with 
relatively low levels of expression in skin and posterior kidney (Fig. 2-4J). Prior to the 
current study, there was no available information on elovl7 transcript tissue expression 
distribution in any teleost species. As noted for elovl6, there are differences between the 
observed cod elovl7 basal transcript expression profile and previously published human 
ELOVL7 transcript expression results. For example, cod elovl7 transcript was detected in 
only four of the fifteen tissues tested (stomach, gill, skin, and posterior kidney), semi-
quantitative RT-PCR showed that human ELOVL7 expression could be detected in almost 
all of the fifteen tissues examined (i.e. all except heart and skeletal muscle) (Ohno et al., 
2010). Human ELOVL7 transcript is expressed at high levels in the kidney, pancreas, 
adrenal gland, and several other tissues based on a Northern blot analysis, in agreement 
with the RT-PCR results (Tamura et al., 2009). Purified human ELOVL7 enzyme 
exhibited high activity toward C18 acyl-CoAs (Naganuma et al., 2011). This enzyme was 
confirmed to be involved in the elongation of saturated fatty acids up to C24 through the 
over-expression of ELOVL7 in microsomes (Tamura et al., 2009; Guillou et al., 2010). 
The physiological importance of the observed high constitutive expression of cod elovl7 
transcript in stomach and gill, and the roles of Elovl7 enzyme in these tissues, remain to 
be investigated. 
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2.5.3 Growth performance of cod 
The feeding experiment conducted in this study was to evaluate the growth 
performance of Atlantic cod fed diets containing CO and/or SEFM. Juvenile cod fed 
either 100CO or 100COSEFM had a significantly lower weight gain than cod fed FO, by 
21% and 12% respectively. It is worth noting that fish fed 100CO showed significant 
lower SGR (1.13% day-1) than fish on FO diet (1.31% day-1), while the SGR of fish fed 
100COSEFM (1.21% day-1) was not significantly different from either FO or 100CO. 
Two previous studies evaluating the replacement of dietary FO with CO, one replacing 
80% (Hixson et al. 2013) and the other replacing 100% (Morais et al. 2012), showed no 
significant differences in growth of cod fed CO-containing diets versus cod fed FO 
control diets. The growth performance results of Morais et al. (2012) differ from those of 
the current cod feeding experiment for fish fed diets with 100% of FO replaced by CO. It 
is possible that the differences in growth results from these studies can be explained by 
the different amounts of DHA and EPA present in the diets. In the Morais et al. (2012) 
study, the C100 diet (CO replacing 100% of FO) that was tested had more DHA (6.2% of 
total fatty acids) and EPA (4.6%), which exceeded essential fatty acid requirements for 
optimal growth, compared to the DHA (3.8%) and EPA (3.0%) in the 100CO diet in this 
study (Hixson and Parrish, 2014). In addition, the significant differences in growth 
observed in the current study could also be due to differences in apparent feed intake 
between diet groups, as fish fed the FO diet consumed significantly more than fish fed the 
CO-containing diets (Table 2-3).  
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2.5.4 Hepatic transcript expression responses to diets containing camelina oil 
In order to assess if the elongase and desaturase transcripts in cod liver were 
inducible by feeding CO-containing diets (i.e. 100CO and 100COSEFM), which contain 
low amounts of LC-PUFA but are high in C18 PUFA, the expression levels of transcripts 
encoding fatty acyl elongases (Elovl1b, Elovl4c-2, Elovl5 and Elovl6a) and desaturase 
(Fadsd6) were investigated using QPCR. The selection of these elovl family members for 
the QPCR study was based on their constitutive expression in liver tissue as detected by 
qualitative RT-PCR (Fig. 2-4). Among elovl family members selected for the current 
QPCR study, at least in mammals including humans, ELOVL1 and ELOVL6 are 
considered to be preferred for saturated and monounsaturated fatty acids while ELOVL4 
and ELOVL5 use PUFA as substrates (Monroig et al., 2010). Hence, the following 
discussion is divided into two categories: metabolism of non-essential fatty acids, and 
metabolism of essential PUFA. 
The biological significance of non-essential fatty acids, particularly saturated fatty 
acids, has been linked to some undesirable health effects including obesity, heart failure, 
and peroxisomal disorders (Guillou et al., 2010). The precise function and preferred 
substrate of Elovl1 enzymes have not been investigated in any fish species. Since cod 
elovl1b transcript is constitutively expressed in the liver (as well as in several other 
tissues, Fig. 2-4B), the present study evaluated the hepatic elovl1b transcript expression 
response to diets containing different levels of CO. The transcript expression of elovl1b in 
cod liver was not significantly affected by feeding either of the CO-containing diets (i.e. 
100CO and 100COSEFM). A similar result was reported in rats fed olive oil compared to 
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rats fed FO (Wang et al., 2005); however, in the same study, the transcript expression of 
elovl1 in rat liver was induced 2-fold after administration of the peroxisome proliferator-
activated receptor alpha (PPARα) agonist Wy14,643. which activated PPARα through 
binding. Endogenous ligands include fatty acids and some of their eicosanoid metabolites 
(reviewed in Leaver et al., 2008). This suggests that the transcript expression of rat elovl1 
is under certain nutritional regulation. 
It has been shown that in rat, the hepatic elovl6 transcript expression is regulated 
by nutritional factors including fasting and refeeding, high-fat diets, and high-PUFA diets 
(Rodriguez-Cruz et al., 2012). The potential function and preferred substrate of Elovl6 
have not been investigated in any fish species. The current study investigated the hepatic 
gene expression response of elovl6a to diets containing different levels of CO, based on 
the fact that this transcript was constitutively expressed in cod liver (Fig. 2-4H) and 
therefore may play a role in metabolism. From QPCR analysis, elovl6a was 2.13 fold up-
regulated (not statistically significant) in cod fed 100COSEFM compared to cod fed FO 
diet. A previous study in rat showed that elovl6 transcript was significantly reduced in 
liver by feeding a diet supplemented with FO (Wang et al., 2005). Additionally, a 
suppression in the elongation activity of palmitic acid (16:0) was correlated with an 
decrease in elovl6 transcript expression in rats fed a FO supplemental diet (Wang et al., 
2005). Further studies are needed in regard to elovl6 gene expression regulation and the 
function of the Elovl6 enzyme in cod. 
The biosynthesis of EPA in vertebrates involves desaturation of 18:3ω3 to 
18:4ω3, which is further elongated to 20:4ω3 followed by desaturation to obtain EPA 
(Zheng et al., 2009; Monroig et al., 2011). The synthesis of DHA from EPA requires two 
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further elongation processes, an additional desaturation, and a peroxisomal chain 
shortening step (Sprecher, 2000). In the current QPCR study, the transcript expression of 
elovl5 in cod liver did respond to the inclusion of camelina oil in the 100COSEFM fed 
group by approximately 1.3-fold up-regulation compared to FO. The increase in elovl5 
transcript expression in cod liver (but not pyloric caecum) corresponding to the increased 
level of C18 PUFA in the diet was also shown in a previous feeding trial involving the 
substitution of vegetable oil blend (i.e. rapeseed, linseed and palm oils) for FO (Tocher et 
al., 2006). All fish Elovl5 enzymes as functionally characterized by heterologous 
expression of ORFs in yeast (e.g. Saccharomyces cerevisiae), including freshwater fish 
[zebrafish, African catfish (Clarius gariepinus), Nile tilapia (Oreochromis niloticus)], 
salmonids [Atlantic salmon and rainbow trout (Oncorhynchus mykiss)], and marine 
species (cod, turbot, sea bream, and cobia), demonstrated capacity to lengthen ω3 and ω6 
PUFA with chain length from C18 to C22; Atlantic cod Elovl5 showed the lowest activity 
of all the species studied (i.e. 7.4% and 0.8% conversion of 18:4ω3 to 20:4ω3 and 20:5ω3 
to 22:5ω3, respectively) (Hastings et al., 2004; Meyer et al., 2004; Agaba et al., 2005; 
Monroig et al., 2009; Morais et al., 2009). Generally speaking, most marine fish species 
including cod have low LC-PUFA biosynthetic capacity using FA precursors (Agaba et 
al., 2005; Tocher et al., 2006). The limited ability to produce LC-PUFA in marine fish 
may be due to both low enzymatic activity of Elovl5 and the absence of elovl2 genes (as 
discussed previously). The difference in LC-PUFA biosynthetic capacity between 
freshwater fish and marine fish may be a reflection of both biological and environmental 
differences. The high LC-PUFA biosynthetic ability in freshwater fish may be needed for 
the production of LC-PUFA from shorter chain precursors due to a relative deficiency of 
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LC-PUFA in their native freshwater habitat, whereas wild marine fish have lower 
capacity to biosynthesize LC-PUFA potentially due to relatively high levels of LC-PUFA 
in their diets (Agaba et al., 2005; Tocher et al., 2006; Morais et al., 2009). 
As discussed earlier, Atlantic cod Elovl4 members (especially Elovl4a and 
Elovl4b) might also be involved in the biosynthesis of LC-PUFA in specific tissues that 
have high basal expression (e.g. eye and brain). However, only elovl4c-2 was investigated 
in this study in terms of hepatic transcript expression in response to diets containing 
camelina oil as this was the only elovl4 paralogue that showed constitutive expression in 
liver (Fig. 2-4). QPCR showed that cod elovl4c-2 transcript was increased by 1.8-fold in 
100COSEFM fed fish compared to FO, but this up-regulation was not statistically 
significant due to high biological variability (Fig. 2-5B). Recently, elovl4 genes were 
discovered in zebrafish (Monroig et al., 2010), Atlantic salmon (Carmona-Antoñanzas et 
al., 2011) and cobia (Monroig et al., 2011); the salmon Elovl4, zebrafish Elovl4b as well 
as cobia Elovl4 were capable of converting C20 and C22 LC-PUFA to longer products. 
Hence these Elovl4s found in fish may participate in the biosynthesis of DHA. This 
alternative elongase member for the production of DHA is particularly significant in 
marine fish as it could potentially compensate for the low activity of Elovl5 in the LC-
PUFA biosynthetic pathway. The involvement of Atlantic cod Elovl4 members in LC-
PUFA synthesis warrants further investigation. 
The biosynthesis of LC-PUFA from shorter chain precursors in vertebrates also 
involves desaturation of appropriate fatty acids by desaturase enzymes, Fadsd5 and 
Fadsd6. Except for a bifunctional Δ5/Δ6 desaturase reported from rabbitfish (Siganus 
canaliculatus) (Li et al., 2010), only one fatty acyl desaturase, Fadsd6, has been identified 
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in marine fish including cod (Tocher et al., 2006), cobia (Zheng et al., 2009), gilthead sea 
bream (Seiliez et al., 2003), Asian sea bass (Lates calcarifer) (Mohd-Yusof et al., 2010), 
European sea bass (Dicentrarchus labrax) (González-Rovira et al., 2009), and turbot 
(Zheng et al., 2004). Interestingly, in the current study fadsd6 transcript expression was 
only significantly up-regulated (7.17-fold) in the liver of cod fed 100COSEFM diet 
compared to cod fed FO diet (Fig. 2-5E). It is worthy to note that the LC-PUFA amounts 
in 100COSEFM diet were much lower than that of the FO diet (5.1% vs. 21.9%), whereas 
the amounts of C18 PUFA in these diets exhibited opposite trend (36.5% vs. 7.6%) 
(Hixson and Parrish, 2014). This suggests that the low level of dietary LC-PUFA 
accompanied with a high level of C18 PUFA may have a positive effect on the 
transcriptional response of fadsd6, a critical gene controlling the LC-PUFA biosynthetic 
pathway. However, two previous studies examining the effect of vegetable oils (i.e. blend 
of rapeseed, linseed and palm oils or CO) containing diets on cod fadsd6 gene expression 
had inconclusive results, as the up-regulation (compared to fish fed FO diet) of fadsd6 in 
liver of fish fed vegetable oil diets was not statistically significant, possibly due to high 
biological variability (Tocher et al., 2006; Morais et al., 2012). In addition, in the 
100COSEFM diet included in the current study, the fish meal component was solvent 
extracted to remove residual FO (~8% in fish meal), resulting in extremely low LC-PUFA 
in the current experimental diet (100COSEFM) compared to the diets in those two 
previous cod studies (Tocher et al., 2006; Morais et al., 2012; Hixson and Parrish, 2014); 
this may have contributed to the different responses in desaturase transcript expression 
between studies. 
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2.6. Conclusions 
This study shows that Atlantic cod expresses ten members of the elovl gene family 
(elovl1a, elovl1b, elovl4a, elovl4b, elovl4c-1, elovl4c-2, elovl5, elovl6a, elovl6b and 
elovl7) with high sequence similarity to putative orthologues from other fish species such 
as zebrafish, Atlantic salmon and pufferfish. A study of the constitutive expression of 
elovl family transcripts in fifteen tissues of juvenile cod revealed distinct elovl expression 
profiles in different tissues. For example, elovl1b and elovl5 were ubiquitously expressed 
in all tissues examined, whereas others such as elovl4a and elovl4c-1 had tissue-specific 
expression. Four elovl members, elovl1b, elovl4c-2, elovl5 and elovl6a, showed transcript 
expression in juvenile cod liver, and therefore were selected for the QPCR study on 
hepatic transcript expression responses to diets containing different levels of CO. Cod fed 
100COSEFM showed significantly lower weight gain, with significant up-regulation of 
elovl5 and fadsd6 transcripts, compared with cod on a FO diet. The high ALA and/or low 
ω3 LC-PUFA levels in the diet may be associated with the up-regulation of elovl5 and 
fadsd6 which may be involved in LC-PUFA biosynthesis in cod. It is important for future 
studies to define the specific biochemical functions of Atlantic cod Elovl members, 
especially the newly characterized Elovl4s, in terms of fatty acid biosynthesis. 
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CHAPTER 3: Atlantic salmon (Salmo salar) liver transcriptome 
response to diets containing camelina products 
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3.1 Abstract 
Due to increasing demand for fish oil (FO) and fish meal (FM) in aquafeeds, more 
sustainable alternatives such as plant-derived oils and proteins are needed. Camelina 
sativa products are viable feed ingredients given the high oil and crude protein content in 
the seed and meal, respectively. Atlantic salmon (initial weight ~240 g) were fed diets 
with complete or partial replacement of FO and/or FM with camelina oil (CO) and/or 
camelina meal (CM) in a 16-week feeding trial [Control diet: FO; Test diets: 100% CO 
replacement of FO (100CO), or 100CO with solvent-extracted FM (100COSEFM), 10% 
CM (100CO10CM), or SEFM + 10CM (100COSEFM10CM)]. The weight gain and 
specific growth rate of fish fed the 100CO diet were not significantly reduced compared 
with FO controls, however these growth parameters were significantly lower in fish fed 
all other camelina-containing diets. A 44K microarray experiment was conducted to 
identify transcripts in Atlantic salmon liver that responded to 100COSEFM10CM 
compared to control diet, and yielded 67 differentially expressed features (FDR < 5%). 
Ten microarray-identified genes [cpt1, pcb, bar, igfbp-5b (2 paralogs), btg1, dnph1, lect-
2, clra, klf9, and fadsd6a] and additional genes involved in lipid metabolism [elovl2, 
elovl5 (2 paralogs), and fadsd5] were subjected to QPCR with liver templates from all 5 
dietary treatments; of the microarray-identified genes, only bar was not validated. Both 
igfbp-5b paralogs were significantly downregulated and fadsd6a was significantly 
upregulated in all 4 camelina-containing diet groups compared with controls. This 
nutrigenomics approach revealed several salmon genes involved in lipid metabolism, 
carbohydrate metabolism and immune function that responded to camelina-containing 
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diets. Genes identified in this work could potentially be used as biomarkers to assist with 
the development of novel aquafeeds using camelina products. 
  
 89 
 
3.2 Introduction 
Fish products are a major source of ω3 long chain polyunsaturated fatty acids 
(LC-PUFA) in human diets (Tocher et al., 2006). Dietary LC-PUFA such as 
eicosapentaenoic acid (EPA; 20:5ω3) and docosahexaenoic acid (DHA; 22:6ω3), can 
benefit human health in several ways including enhancing cardiac health and reducing 
risk of inflammatory diseases (Calder and Yaqoob, 2009). The worldwide demand for 
seafood for human consumption, with approximately 50% coming from aquaculture, 
continues to climb due to flat or decreasing global wild fisheries  in the face of rising 
human population (Agaba et al., 2005; Tocher et al., 2006; FAO, 2009; Bell et al., 2010). 
Finfish aquaculture, especially that of carnivorous fish such as Atlantic salmon (Salmo 
salar), relies heavily on fish oil (FO) and fish meal (FM) from wild stocks for the 
production of feeds. Consequently, the increasing demand of FO and FM will exceed the 
wild fishery supplies, threatening the sustainability of fisheries and aquaculture industries 
(Tocher et al., 2006).  
The need to find alternatives to FO and FM in aquafeeds has been recognized as 
one of the most important areas of research in aquaculture (Bell et al., 2010). As an 
oilseed crop, camelina (Camelina sativa) has several characteristics that make it desirable 
for the aquaculture feed industry. Firstly, the oil content of camelina seed is about 40%, 
and camelina oil (CO) is especially rich in LC-PUFA precursors, α-linolenic acid (ALA, 
18:3ω3) and linoleic acid (LNA, 18:2ω6); the levels of these fatty acids in CO are 
approximately 40% and 15%, respectively (Zubr, 1997; Hixson et al., 2013). Moreover, 
the ω3/ω6 ratio of CO, which is closely linked to both fish health as well as to the 
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nutritional value of fish to human consumers, is higher than other plant oils such as 
soybean oil and palm oil (reviewed in Glencross, 2009). Some by-products of camelina 
from the oil extraction process, such as the seed meal, may also be used in the aquaculture 
feed industry. Camelina meal (CM) has a crude protein level of approximately 45%, 
similar to canola and other rapeseed meal (Acamovic et al., 1999; Frame et al., 2007), and 
contains several essential amino acids (Zubr, 2003). 
Research has previously been performed on FO substitutions with linseed oil 
(Torstensen et al., 2008), canola oil (Miller et al., 2007) and rapeseed oil (Jordal et al., 
2005) for various fish species including Atlantic salmon. Studies have demonstrated that 
vegetable oil (either singly or as blends) which is low in LC-PUFA and high in C18 PUFA 
such as ALA and LNA, can be used to replace up to 100% of FO without negatively 
influencing growth in salmonids and marine fish (Bell et al., 2001; Torstensen et al., 
2005; Bell et al., 2010; Morais et al., 2012; Hixson et al., 2013). However, the ω3 LC-
PUFA content in fish fillets can be reduced significantly if FO is replaced by vegetable 
oil completely (Bell et al., 2010; Morais et al., 2012). Moreover, genes involved in the 
LC-PUFA biosynthetic pathway are known to be regulated by vegetable oil diets. 
Particularly, delta-5 fatty acyl desaturase (fadsd5) and fatty acyl elongase [elongation of 
very long chain fatty acids (elovl); e.g. elovl2 and elovl5] genes are often up-regulated in 
the liver of Atlantic salmon fed diets containing vegetable oil (e.g. rapeseed oil) 
(reviewed in Leaver et al., 2008a). Compared to marine fish, freshwater fish and 
salmonids are superior at producing DHA and EPA using ALA (Santigosa et al., 2011). 
Last but not least, the changes in fatty acid profiles in the diets due to the replacement of 
FO by vegetable oil may alter fish metabolism, and could potentially affect various 
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aspects of fish health including susceptibility to infectious diseases (Montero et al., 2003; 
Mourente et al., 2005). 
CO-containing diets have been used in studies involving Atlantic cod (Gadus 
morhua) (Morais et al., 2012; Hixson et al., 2013; Hixson and Parrish, 2014), Atlantic 
salmon (Bell et al., 2010; Leaver et al., 2011; Morais et al., 2011b; Hixson et al., 2014b), 
and rainbow trout (Oncorhynchus mykiss) (Hixson et al., 2014a). Previously in Atlantic 
salmon, CO was included in vegetable oil blends (20% CO) with other plant-based oils to 
study the effect of substituting FO with such oil blends on growth (Bell et al., 2010), ω3 
LC-PUFA deposition in the flesh (Leaver et al., 2011), and cholesterol and lipoprotein 
metabolism (Morais et al., 2011b). In salmon practical diets, both FM and FO have been 
partially replaced with plant materials simultaneously (Pratoomyot et al., 2010). While 
high percentage (i.e. ≥ 60%) replacement of FM with plant proteins (especially soybean 
meal) in the diets of Atlantic salmon has been shown to result in reduced growth 
performance and altered fish immune responses and gut integrity (Baeverfjord and 
Krogdahl, 1996; Espe et al., 2006), inclusion of 20% pea protein concentrate in the diet 
for Atlantic salmon showed no reductions in weight gain and feed intake (Øverland et al., 
2009). Recently, an Atlantic salmon feeding trial was conducted to evaluate the growth 
performance, and the lipid and fatty acid composition in tissues, of fish fed with diets 
containing full replacement of FO with CO and/or partial inclusion of CM (Hixson et al., 
2014b). In the current study, the impact of camelina-containing diets on salmon liver gene 
expression was investigated in parallel with Hixson et al. (2014b) by analyzing samples 
from the same individuals using DNA microarray and quantitative reverse transcription – 
polymerase chain reaction (QPCR). While the diet ingredients and growth performance 
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data for this feeding trial were previously published (Hixson et al., 2014b); we include 
them herein as they pertain to the current study as well. 
Nutrigenomic approaches [e.g. using DNA microarrays and quantitative reverse 
transcription – polymerase chain reaction (QPCR)] have been shown to be useful for the 
identification of genes that are differentially expressed in fish fed altered diet 
formulations, for example, with FO or FM replaced by plant-based ingredients (Jordal et 
al., 2005; Leaver et al., 2008b; Panserat et al., 2008a; Morais et al., 2011a). These 
previous studies focused on hepatic gene expression changes since the liver is the main 
organ involved in metabolizing carbohydrates, lipids, and proteins into biologically useful 
materials in vertebrates, and also plays key roles in detoxification and immunity 
(Vilhelmsson et al., 2004; Panserat et al., 2009). Therefore, the objective of this study was 
to use a 44,000 feature (44K) salmonid oligonucleotide microarray (Jantzen et al., 2011; 
Sahlmann et al., 2013) and QPCR to assess the impacts of CO and/or CM containing diets 
on Atlantic salmon hepatic gene expression in order to identify candidate molecular 
biomarkers for responses to camelina-containing diets. In addition, the current study 
included assessment of: 1) salmon performance (growth) and 2) the effect of changes in 
the fatty acid composition of diets containing different levels of CO on the transcript 
expression of fatty acyl elongases and desaturases involved in LC-PUFA biosynthesis. It 
is anticipated that the molecular biomarkers (i.e. camelina product-responsive genes) 
identified in this study will be useful in the future development of camelina-containing 
diets that do not have deleterious effects on fish performance or physiology. 
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3.3 Materials and methods 
3.3.1 Experimental diets and animals  
The feeding trial, involving Atlantic salmon post-smolts and test diets containing 
camelina products (e.g. CO and CM), was conducted in the Dr. Joe Brown Aquatic 
Research Building (JBARB) at the Ocean Sciences Centre (Memorial University of 
Newfoundland, Canada) during the period from July 2012 to December 2012. This 
research was part of a large-scale collaborative project (The Camelina Project; 
http://www.genomeatlantic.ca/). Experimental diets including the control diet were 
formulated and produced at the Department of Plant and Animal Science, Faculty of 
Agriculture, Dalhousie University, Truro, Nova Scotia, Canada, according to the 
nutritional requirements of Atlantic salmon set by National Research Council (2011) 
(Table 3-1). All diets were approximately iso-nitrogenous and iso-energetic on a crude 
protein and gross energy basis. The experimental treatments in this feeding trial were as 
follows: a control diet with FO and FM (FO); 100% FO replacement with CO (100CO); 
100% FO replacement with CO and including solvent extracted FM (100COSEFM); 
100% FO replacement with CO and including 10% CM (100CO10CM); 100% FO 
replacement with CO and including SEFM and 10% CM (100COSEFM10CM). SEFM 
was employed here to remove FO residue in the FM (about 8%) as much as possible in 
order to evaluate the full effect of total replacement of fish oil in the diet. Further details 
on formulation, proximate and fatty acid compositions of the diets are given in Hixson et 
al. (2014b). 
Atlantic salmon post-smolts (242.1 ± 46.0 g) were randomly distributed among 
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Table 3-1. Compositions of experimental diets used in the Atlantic salmon feeding trial 
(percentage of total weight as fed)a. 
Ingredient FO 100CO 100CO 
SEFM 
100CO 
10CM 
100CO 
SEFM 
10CM 
Fish meal 34.9 34.9 - 31.80 - 
SEFMb - - 32.89 - 29.95 
Fish oil 14.04 - - - - 
Camelina meal - - - 10 10 
Camelina oil - 14.04 17.79 16.08 19.49 
Wheat gluten meal 15 15 15 15 15 
Empyreal 75® 5 5 5 5 5 
D/L Methionine 0.17 0.17 0.17 0.17 0.17 
Vitamin/Mineral premixc 0.2 0.2 0.2 0.2 0.2 
Antioxidant/Pigment 
premixd 0.25 0.25 0.25 0.25 0.25 
Choline chloride 0.5 0.5 0.5 0.5 0.5 
Whey 5 5 5 5 5 
Pregelatinized starch 2.5 2.5 2.5 2.5 2.5 
Wheat 22.42 22.42 20.71 13.50 11.94 
Total 100 100 100 100 100 
Proximate composition analyzed, as-fed basis (n = 3) 
Moisture 8.6 ± 0.2 9.3 ± 0.2 10.9 ± 0.1 8.0 ± 0.04 9.7 ± 0.5 
Ash 2.9 ± 0.1 3.2 ± 0.2 2.0 ± 0.1 2.7 ± 0.4 2.9 ± 0.2 
Protein 41.3 ± 0.2 42.2 ± 0.5 40.7 ± 0.3 42.2 ± 0.8 41.0 ± 0.7 
Lipid 17.6 ± 1.2 18.5 ± 0.2 20.0 ± 0.8 19.3 ± 0.6 22.2 ± 1.2 
aNote that the diet composition data presented here were previously published (Hixson et 
al., 2014b); we include them herein as they pertain to the current study as well. 
bSolvent-extracted fish meal 
cVitamin/Mineral Premix contains per kg: Zinc 77.5 mg, Manganese 125 mg, Iron 84 mg, 
Copper 2.5 mg, Iodine 7.5 mg, Vitamin A 5000IU, Vitamin D 4000IU, Vitamin K 2 mg, 
Vitamin B12 4 µg, Thiamine 8 mg, Riboflavin 18 mg, Pantothenic acid 40 mg, Niacin 
100 mg, Folic acid 4 mg, Biotin 0.6 mg, Pyridoxine 15 mg, Inositol 100 mg, Ethoxyquin 
42 mg, Wheat shorts 1372 mg. 
dAntioxidant/Pigment Premix contains per kg: Selenium 0.220 mg, Vitamin E 250 IU, 
Vitamin C 200 mg, Astaxanthin 60 mg, Wheat shorts 1988 mg. 
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fifteen tanks (500 L) with flow-through seawater (~14°C, dissolved oxygen ≥ 10 mg L-1), 
and all fish were kept on a photoperiod of 12 hours. After the acclimation period (i.e. 1 
week in the experimental tanks), all fish were gradually moved from the commercial diet 
to the control diet (i.e. FO) over 3 days, and were kept on control diet for one week prior 
to initial sampling. Thereafter, fish were gradually moved onto each assigned 
experimental or control diet over another 3 days. Triplicate tanks of fish were fed 
experimental or control diets to apparent satiety, twice each day for a period of 16 weeks. 
At week 0 (the day before experimental diets were fed), week 1 (3 days of acclimation to 
the experimental diets plus a full week of feeding experimental diets), week 8 and week 
16 of the feeding trial, seven fish from each tank at each time point were euthanized with 
400 mg L-1 of tricaine-methane-sulfonate (TMS; Syndel Laboratories, Vancouver, BC) 
after 24 h of fasting. Body weight and fork length of fish were measured and recorded. 
Liver tissues (50-100 mg sample-1) were rapidly dissected from fish, placed in RNase-free 
1.5 mL tubes, flash-frozen in liquid nitrogen, and stored at -80°C until RNA extractions 
were performed. Experimental manipulations and the sampling of the fish tissues were 
conducted following the Canadian Council on Animal Care guidelines. This study was 
approved by the Institutional Animal Care Committee of Memorial University of 
Newfoundland under protocol number 12-50-MR. Further details on fish rearing 
conditions and sampling for lipid analysis are given in Hixson et al. (2014b). 
3.3.2 RNA extraction, DNase treatment, and column purification 
Liver samples collected from the feeding experiment were homogenized 
individually in 2.0 mL tubes containing TRIzol reagent (Invitrogen, Carlsbad, CA) with a 
 96 
 
volume of 0.8 mL sample-1 and a stainless steel bead (2.5 mm; QIAGEN, Mississauga, 
ON) using a TissueLyser (QIAGEN) at 25 Hz for 3 min, and further disrupted using 
QIAshredder spin columns (QIAGEN), and subjected to RNA extraction according to the 
manufacturers’ instructions. After extraction, the quality of total RNA was examined by 
1% agarose/ethidium bromide gel electrophoresis, and RNA quantity and purity were 
measured by NanoDrop spectrophotometry (ThermoFisher, Mississauga, ON). However, 
due to low 260/230 ratios (i.e. less than 1.2) following TRIzol extraction, all RNA 
samples were re-extracted using the following phenol-chloroform phase separation 
method. Thirty µL of each crude RNA sample was diluted 10 times using nuclease-free 
water (Invitrogen), an equal volume of Acid Phenol:Chloroform:IAA (25:24:1, v/v; pH 
6.6; Ambion, Burlington, ON) was added, and after mixing, phases were separated by 
centrifugation at 15,000 × g at 4°C for 20 min. The RNA was then precipitated from the 
aqueous phase with a mixture of 20 µL 3M sodium acetate (pH 5.2; Ambion) and 400 µL 
95% ethanol (Greenfield, Toronto, ON) and incubated at -80°C for one hour, followed by 
centrifugation at 15,000 × g at 4°C for 30 min. The resulting RNA pellet was washed by 
adding 500 µL of 70% ethanol and centrifuging at 15,000 × g at 4°C for 20 min followed 
by removal of the supernatant, and then air-dried at room temperature for 10 min, and 
dissolved in 40 µl of nuclease-free water (Invitrogen). Total RNA of each sample was 
then treated with DNase I (QIAGEN) to degrade residual genomic DNA, and all samples 
were purified from salts, proteins and nucleotides using the RNeasy Mini Kit (QIAGEN) 
following the manufacturer’s protocols. The quantity and quality of cleaned RNA 
samples were assessed as previously described. Only high quality (260/280 ratio > 2.0, 
260/230 > 1.85, with tight 18S and 28S ribosomal RNA bands) total RNA samples were  
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Fig. 3-1. Overview of microarray experimental design (common reference design). 
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used in RNA amplification and cDNA synthesis reactions for microarray and QPCR 
experiments, respectively.  
3.3.3 Choice of dietary treatment for transcriptomic comparison 
The 100COSEFM10CM and control dietary treatments at week 16 were chosen as 
groups to be compared in this microarray experiment (see Fig. 3-1) since fish 
performance [assessed by weight gain, final weight and length, and weight-specific 
growth rate (SGR)] was most different between these groups (Hixson et al., 2014b). Also, 
this 100COSEFM10CM was the most extreme diet in the feeding trial, with a negligible 
amount of FO as well as the inclusion of CM. Therefore, it was hypothesized that the 
100COSEFM10CM dietary treatment was most likely to lead to the identification of new 
molecular biomarkers of hepatic transcript expression response to an extreme camelina 
product-containing diet (associated with significantly reduced growth, see Results 
section) that could be used in the future development of optimized camelina-based diets 
for salmon.  
3.3.4 Microarray hybridization and data acquisition 
Nine individual fish (three from each triplicate tank) each from the 
100COSEFM10CM and control diet groups were used in the microarray analysis using a 
common reference design (Fig. 3-1). Eighteen arrays were used in this study, with one 
array per individual fish (Fig. 3-1). An equal quantity of each DNase I-treated, column-
purified liver total RNA sample involved in the current experiment was pooled to make a 
common reference for the microarray hybridizations. Anti-sense amplified RNA (aRNA) 
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was in vitro transcribed from 1 µg of each experimental RNA or reference pooled RNA 
using Ambion's Amino Allyl MessageAmp II aRNA Amplification kit (Life 
Technologies), following the manufacturer's instructions. The quality and quantity of 
aRNA were assessed using NanoDrop spectrophotometry and agarose gel electrophoresis. 
Twenty µg of aRNA was precipitated overnight following standard molecular biology 
procedures and re-suspended in coupling buffer; the resulting solution was used in a 
labeling reaction following the manufacturer's protocol. Resulting aRNA was labeled 
with either Cy3 (for the common reference) or Cy5 (for the experimental individuals) 
fluor (GE HealthCare, Mississauga, ON) through a dye-coupling reaction, following the 
manufacturer's instructions. The labeling efficiency was measured using the "microarray" 
function of the NanoDrop spectrophotometer. Equal quantities (825 ng) of each labeled 
aRNA from one experimental sample and the common reference were pooled, fragmented 
following the manufacturer's instructions and co-hybridized to a cGRASP-designed 
Agilent 44K salmonid oligonucleotide microarray (GEO accession # GPL11299) as per 
the manufacturer’s instructions (Agilent, Mississauga, ON). The arrays were hybridized 
at 65°C for 17 hours with 10 rpm rotation in an Agilent hybridization oven. The array 
slides were washed immediately following hybridization as per the manufacturer's 
instructions.  
Each microarray was scanned at 5 µm resolution and 90% of laser power using a 
ScanArray Gx Plus scanner and ScanArray Express software (v4.0; Perkin Elmer, 
Woodbridge, ON) with photomultiplier tube (PMT) set to balance fluorescence signal 
between channels. The resulting TIFF images containing raw microarray data were 
extracted using Imagene (v9.0; BioDiscovery Inc., El Segundo, CA). Background 
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correction, data transformation (log2), print-tip Loess normalization, and removal of low-
quality/flagged spots were performed using R and the Bioconductor package mArray 
using scripts adapted from those described in Booman et al. (2011). After spot quality 
filtering, features absent in more than 30% of the arrays (i.e. 5 arrays out of 18) were 
discarded, resulting in a final list of 16,629 probes for statistical analyses. The full 
microarray data is submitted to Gene Expression Omnibus (GEO) under the accession 
GSE56784. 
3.3.5 Microarray data analysis 
The Significance Analysis of Microarrays (SAM) algorithm (Tusher et al., 2001) 
as implemented in the Bioconductor package siggenes (Schwender et al., 2006) was used 
to identify genes that were significantly up-regulated or down-regulated in response to the 
100COSEFM10CM diet compared with the control diet with a false discovery rate (FDR) 
cutoff of 5%. Prior to SAM analysis, missing data points for these 16,629 probes were 
imputed using the EM_array method LSImpute (Bo et al., 2004; Celton et al., 2010). The 
resulting gene lists were annotated using the contiguous sequences (contigs) from which 
informative 60mer oligonucleotide probes on the array were designed. BLASTx 
alignment of these sequences against the NCBI nr database was performed with an E-
value threshold of 10-5. BLASTx results for each probe were mapped to Gene Ontology 
(GO) terms using the Blast2GO program (Conesa et al., 2005). 
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3.3.6 QPCR analysis 
The following microarray-identified genes of interest (GOI) were selected for 
QPCR assay development and analysis: delta-6 fatty acyl desaturase a (fadsd6a) (This 
Atlantic salmon gene represented the putative orthologue of the informative rainbow trout 
feature C023R134 on the microarray; see Appendix XV for the alignment of fadsd 
paralogues); carnitine palmitoyltransferase I-like (cpt1); pyruvate carboxylase (pcb); bile 
acid receptor (bar; also known as farnesoid X receptor); insulin-like growth factor 
binding protein 5 paralogs (igfbp-5b1 and igfbp-5b2) (These Atlantic salmon genes are 
both likely represented by the informative Atlantic salmon feature C116R063; see 
Appendix XVI for the alignment of igfbp-5 paralogues and the associated microarray 
feature probe sequence); B-cell translocation gene 1-like (btg1); 2'-deoxynucleoside 5'-
phosphate N-hydrolase 1 (dnph1); leukocyte cell-derived chemotaxin 2 precursor (lect-2); 
C type lectin receptor A (clra); and kruppel-like factor 9 (klf9). In addition, QPCR assays 
were developed for four genes (elovl2, elovl5a, elovl5b and fadsd5) that play key roles in 
LC-PUFA biosynthesis. In addition to the 100COSEFM10CM and control diets, the 
QPCR experiment also included liver samples from fish fed three other diets containing 
camelina-derived products (100CO, 100COSEFM and 100CO10CM). 
QPCR primers were designed using the Primer 3 program [available at 
http://frodo.wi.mit.edu; (Rozen and Skaletsky, 2000)] either based on contigs/ESTs 
representing the informative microarray probes identified through BLASTn analyses (for 
cpt1, pcb, bar, btg1, dnph1, lect-2, clra, klf9) or sequences from previous publications 
[for fadsd5 (Hastings et al., 2004); fadsd6a (Zheng et al., 2005a); elovl2, elovl5a and 
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elovl5b (Morais et al., 2009); igfbp-5b1 and igfbp-5b2 (Macqueen et al., 2013)] (Table 3-
2). Paralogue-specific QPCR primers were designed for fadsd5 and fadsd6a, igfbp-5b1 
and igfbp-5b2, and elovl5a and elovl5b (see Appendices XV-XVII). All QPCR primer 
sets were quality-checked (QC) using a reference cDNA generated by pooling an equal 
quantity of each individual cDNA involved in this QPCR study. QPCR primer QC 
procedures, including standard curves and dissociation curves, were conducted as 
described elsewhere (Rise et al., 2010; Booman et al., 2011). In brief, the amplification 
efficiency (Pfaffl, 2001) of each primer pair was determined using a 5-point 1:5 dilution 
series starting with cDNA corresponding to 10 ng of input total RNA, except for cpt1 and 
igfbp-5b1 (5-point 1:3) and elovl5a and btg1 (5-point 1:2). Dissociation curves were 
carried out to ensure that the primer pairs amplified single products with no detectable 
primer dimers. Additionally, the expected size of each GOI QPCR amplicon (Table 3-2) 
was checked by agarose gel electrophoresis.  
For each dietary treatment, nine individuals (three from each triplicate tank) were 
used in the QPCR experiment. All cDNAs were prepared by reverse transcription of 1 µg 
DNase-I treated, column-cleaned total RNA for each individual sample using random 
primers (250 ng, Invitrogen) and Moloney murine leukemia virus (M-MLV) reverse 
transcriptase (RT) (200 U, Invitrogen) at 37°C for 50 min in a 20 µL reaction volume 
following the manufacturer’s instructions. A "no-RT" control with pooled total RNA was 
performed by omitting reverse transcriptase. The resulting cDNA was further diluted 10 
times with nuclease-free water (Invitrogen). QPCR reactions were performed in technical 
triplicates using Power SYBR Green I dye chemistry in 384-well format on the ViiA™ 7 
Real-Time PCR System (Applied Biosystems, Foster City, CA). The QPCR reactions 
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Table 3-2. QPCR Primers. 
Gene  Sequence 5'-3'
a Efficiency (%) r
2 Amplicon size (bp) 
Accession 
number 
elovl2 F GATGCCTGCTCTTCCAGTTC 97.5 0.998 113 FJ237532b 
 R GCGACTGGACTTGATGGATT     
elovl5a F CAGTGTGGTGGGGACAAAG 101.0 0.980 115 AY170327b 
 R 
TTCCCTCATGGACAAGCA 
    
elovl5b F GGATAGCAGAGGGAGCACAG 90.6 0.995 120 FJ237531b 
 R 
CCTGTTTGGGTCAAGGTTGCT 
    
fadsd5 F GTCTGGTTGTCCGTTCGTTT 89.1 0.999 135 AF478472b 
 R GAGGCGATCAGCTTGAGAAA     
fadsd6a F CCCCAGACGTTTGTGTCAG 88.9 0.997 181 AY458652b 
 R 
CCTGGATTGTTGCTTTGGAT 
    
btg1 F GGTCAGCTGCAAGGAAGAAC 94.0 0.995 132 DW555767c 
 R 
TGTGGGGCAGAACTGATACA 
    
pcb F CTCCAGGATGAGGTCGTCTC 92.6 1.000 179 GE787967c 
 R CGGGTAAGGTTGTGGAAGTG     
cpt1 F GCACTGCAAAGGAGACATCA 86.0 0.995 136 EG857609c 
 R 
GCTATCACCTTGGCAACCAT 
    
bar F GCCAAGAGGTAAGCATCTCG 102.1 0.999 120 GO063627c 
 R 
TCAGGAGGTTCTGTGCAATG 
    
igfbp-5b1 F GGTGCTTGGGCTCATATGTT 87.0 0.999 209 JX565556b 
 R CTTCTCTTCTCCATTTCGCG     
igfbp-5b2 F GACATTTGTCTTGGGGCTGA 95.2 0.998 127 JX565557b 
 R 
ACAGCCAGGCTCTTTCACG 
    
lect-2 F GCCTTCTTCGGGTCTGTGTA 97.5 0.998 150 BT059281c 
 R 
CAGATGGGGACAAGGACACT 
    
clra F ACTGGGAAGTTCATGGCTTG 97.0 0.999 116 EG910992c 
 R ATTCGCTGACCTGGTTTGAC     
dnph1 F TCTGTGGCAGTATTCGTGGA 89.9 0.995 138 DW471353c 
 R 
GCACAGCATCCTCTCCTTTC 
    
klf9 F CAAAGAAGACGCATGTGGAA 86.0 0.994 132 EG912132c 
 R 
GTTCCCTAAACGGATGCTGA 
    
actb F CCAAAGCCAACAGGGAGAAG 90.2 0.999 91 BG933897b 
 R AGGGACAACACTGCCTGGAT     
rpl32 F AGGCGGTTTAAGGGTCAGAT 88.9 0.997 119 BT043656b 
 R 
TCGAGCTCCTTGATGTTGTG 
    aF: forward primer; R: reverse primer. 
bNucleotide sequence from GenBank was used for the primer design. 
cThe ESTs representing microarray probes (identified through BLASTn analyses) were 
used for primer design. 
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contained 2 µL of 1:10 diluted cDNA (10 ng input total RNA), 50 nM each of forward 
and reverse primer, and 1× Power SYBR Green PCR Master Mix (Applied Biosystems) 
in a final volume of 13 µL. The QPCR program consisted of 1 cycle of 50°C for 2 min, 1 
cycle of 95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 60°C for 1 min, 
with the fluorescence signal data collection after each 60°C step. Before performing 
QPCR expression studies, the absence of genomic DNA contamination in the "no-RT" 
control sample was confirmed by using each QPCR primer set (i.e. to ensure that any 
amplification occurring in the QPCR reaction was derived from the reverse transcribed 
mRNA and not genomic DNA).  
The expression levels of each GOI were normalized to the geometric mean of 60S 
ribosomal protein 32 (rpl32) and β-actin (actb) transcript expression. Rpl32 and actb 
were chosen as the normalizer genes due to their stable transcript expression in the 
current study. Six candidate endogenous controls were selected based on the current liver 
microarray experiment results (for actin-related protein 2/3 complex subunit 1A and 
NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial precursor), 
literature on salmon reference gene evaluation [for eukaryotic elongation factor 1α-1 
(eef1α-1; formerly elongation factor 1α-1), eukaryotic elongation factor 1α-2 (eef1α-2) 
and actb] (Olsvik et al., 2005), or from previous salmon QPCR studies in the lab (for 
rpl32). Two-thirds of individuals (i.e. 6 from each dietary treatment) were included in the 
evaluation of the six potential endogenous controls using the geNorm algorithm 
(Vandesompele et al., 2002). Rpl32 and actb were shown to be the most stable (i.e. lowest 
M-value; a gene-stability measure) across the selected reference genes (data not shown).  
 105 
 
In every multi-plate study, a linker control (a pooled cDNA sample from all 
samples involved in the study) was used to check the inter-plate variability between 
different plates. The ViiA™ 7 Software v1.2 (Applied Biosystems) was used to determine 
CT values over triplicates for each GOI and normalizer. The amplification efficiencies for 
each GOI and normalizer primer pairs (Table 3-2) were incorporated into the calculation 
of GOI relative quantity (RQ) using the 2-ΔΔCT method (Livak and Schmittgen, 2001), 
which is implemented in the same software. The individual with the lowest GOI 
expression was used as the calibrator sample (i.e. RQ = 1) for each GOI study.  
3.3.7 Statistical analyses of growth and QPCR data 
All statistical analyses of growth-relevant and QPCR data were performed using 
Prism v5.0 (GraphPad Software Inc, La Jolla. CA) with one-way ANOVA, followed by 
Tukey post-hoc test for multiple comparisons at the 5% level of significance (i.e. p < 
0.05), to detect differences between dietary treatments. All data were subjected to 
normality testing using the Anderson-Darling test. The growth-relevant data (as shown in 
Table 3-3) were presented as mean ± standard deviation (SD). RQ data were log2 
transformed in Excel in order to meet with statistical assumption (i.e. normality), and 
were presented as mean ± standard error (SE). For QPCR fold-change calculation, overall 
fold up-regulation was calculated as 2A-B, where A is the mean of log2 transformed RQ 
from an experimental diet (e.g. 100CO or 100COSEFM) group, and B is the mean of log2 
transformed RQ from the control diet (FO) group (Cui and Churchill, 2003). 
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3.4 Results 
3.4.1 Growth performance 
The growth performance and fatty acid data for this feeding trial were reported in 
Hixson et al. (2014b). However, since the growth data are also relevant to the current 
study, they are briefly described and included in this chapter. Atlantic salmon fed the 
experimental diets increased in weight from 230-255 g fish-1 initially to 529-691 g fish-1 
after 16 weeks (Table 3-3). The growth performance of salmon, as measured by weight 
gain and SGR, was significantly reduced in all camelina-containing diet fed groups 
except fish fed 100CO, compared with the control diet (i.e. FO) group (weight gain, 281-
320 g fish-1 vs. 471 g fish-1; SGR, 0.68-0.76% day-1 vs. 0.99% day-1) (Table 3-3). The 
weight gain in the 100COSEFM10CM group, the lowest among all dietary treatments, 
was 40% less than that of the FO group. The apparent feed intake (AFI) per fish 
throughout the feeding trial was affected by diet with fish fed FO diet consuming more 
than fish fed the CO-containing diets (Table 3-3). However, fish fed all diets had 
comparable feed conversion ratio (FCR; 1.0-1.25) and condition factor (CF; 1.46-1.53) 
after 16 weeks of feeding. Additional details on growth and feed efficiency for fish in this 
feeding trial are reported in Hixson et al. (2014b), which focuses on lipid and fatty acid 
analyses of diets and tissues. 
3.4.2 Liver transcriptome analysis 
An experiment involving 18 arrays was conducted to identify transcripts in 
Atlantic salmon liver that respond to a camelina-based test diet (i.e. 100COSEFM10CM) 
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Table 3-3. Growth performance of Atlantic salmon after 16 week feeding experiment1. 
 FO 100CO 100CO 
SEFM 
100CO 
10CM 
100CO 
SEFM 
10CM 
Initial weight (g) 230 ± 41 236 ± 56 231 ± 46 255 ± 45 247 ± 11 
Final weight (g) 691 ± 153a 613 ± 117b 537 ± 113c 573 ± 136bc 529 ± 121c 
Weight gain (g) 471 ± 39a 378 ± 31ab 306 ± 44b 320 ± 57b 281 ± 33b 
Initial length (cm) 26.2 ± 2.4 26.8 ± 2.1 26.3 ± 2.3 27.3 ± 1.4 27.6 ± 1.2 
Final length (cm) 35.0 ± 4.1a 34.3 ± 2.1ab 33.1 ± 2.4bc 33.3 ± 2.8bc 32.6 ± 2.6c 
SGR2 0.99 ± 0.1a 0.86 ± 0.1ab 0.76 ± 0.1b 0.73 ± 0.1b 0.68 ± 0.1b 
Condition factor3 1.53 ± 0.1 1.50 ± 0.1 1.46 ± 0.1 1.53 ± 0.1 1.51 ± 0.1 
VSI4 (%) 9.8 ± 1.1a 10.1 ± 3.6 a 11.1 ± 1.2ab 11.1 ± 1.5ab 12.0 ± 1.6b 
AFI5 515 ± 7.6a 436 ± 11b 400 ± 29b 391 ± 15b 381 ± 46b 
FCR6 1.01 ± 0.1 1.06 ± 0.1 1.21 ± 0.1 1.14 ± 0.2 1.25 ± 0.1 
1Data are presented as mean ± standard deviation. Means with different letters are 
significantly different (p < 0.05), determined by one-way ANOVA (Minitab 16). Initial 
measurements, n = 9. n is variable depending on number of fish remaining in tank for 
final measurements: FO = 48, 100CO = 48, 100COSEFM = 67, 100CO10CM = 66 and 
100COSEFM10CM = 66. Weight gain, SGR and FCR were calculated using tank mean, 
n = 3. Note that all data presented here were previously published (Hixson et al., 2014b); 
we include them herein as they pertain to the current study as well. 
2SGR, Specific growth rate (%/day) = 100*[ln(final weight) - ln(initial weight)]/days.  
3Condition factor = 100*final weight/final length3.  
4VSI, Viscera somatic index = 100*(viscera weight/body weight).  
5AFI, Apparent feed intake (g/fish). 
6FCR, Feed conversion ratio = AFI/weight gain. 
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compared to a control diet (i.e. FO) after a 16 week feeding trial. The microarray 
experiment detected 67 significant differentially expressed features (i.e. oligonucleotide 
probes representing transcripts) with a FDR less than 5% (26 more highly expressed in 
the salmon fed 100COSEFM10CM diet and 41 more highly expressed in the salmon fed 
control diet). Of the 67 differentially expressed features, putative identities could be 
determined for 62 based on sequence similarity using BLASTx searches against protein 
sequences in the GenBank nr database (cutoff E-value = 0.00001; Tables 3-4 and 3-5).  
Three genes related to lipid metabolism [long chain fatty acyl-CoA ligase 4 (facl4), 
fadsd6 and aquaporin-8] were identified as up-regulated in the liver of salmon fed 
100COSEFM10CM diet compared to control (Table 3-4). Six genes that are known to be 
involved in cell differentiation and proliferation (e.g. dnph1 and nucleosome assembly 
protein 1-like 1) were also represented in the up-regulated gene list (Table 3-4). Other 
genes identified in the microarray experiment as up-regulated by the camelina-containing 
test diet play important roles in immune function, DNA synthesis and repair and 
regulation of transcription (Table 3-4).  
Several of the down-regulated genes in the 100COSEFM10CM group compared 
with the control group were found to be related to carbohydrate, lipid, and/or protein 
metabolism (Table 3-5). Examples of biological processes associated with genes that 
were down-regulated by the camelina-containing test diet are gluconeogenesis (pcb, 
glucose-6-phosphatase), fatty acid β-oxidation (cpt1), and bile acid metabolism (bar). 
Interestingly, 4 genes involved in protein metabolism (branched-chain-amino-acid 
aminotransferase, syntaxin-16, tectonin beta-propeller repeat-containing protein 2, and 
eukaryotic translation initiation factor 4E-binding protein 2) were identified as
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Table 3-4. Genes that were significantly up-regulated in the liver of salmon fed 
100COSEFM10CM treatment compared to control (FO). 
Probe 
identifier2 
BLASTx identification1 Fold 
change Gene name (species)3 Accession # E-value ID (AA %) 
Lipid metabolism     
C104R106 Aquaporin-8 [Salmo salar] NP_001167386 4e-171 259/259 (100%) 2.93 
C015R068 Long chain fatty acid-CoA ligase 4 
(facl4) [Salmo salar] 
NP_001167160 0 669/669 (100%) 2.90 
C023R1344 PREDICTED: fatty acid desaturase 
2 isoform 3 (Alias: delta-6 fatty 
acyl desaturase, fadsd6) [Otolemur 
garnettii] 
XP_003798786 1e-87 85/113 (75%) 2.04 
Cell differentiation and proliferation     
C014R096 2'-deoxynucleoside 5'-phosphate N-
hydrolase 1 (dnph1; alias: rcl) 
[Esox lucius]  
C1BW56 1e-77 129/144 (90%) 2.29 
C170R067 Baculoviral IAP repeat-containing 
protein 5 [Salmo salar] 
ACI66178 6e-89 142/142 (100%) 1.80 
C174R002 Ubiquitin-conjugating enzyme E2 
C [Salmo salar] 
ACI69073 1e-111 160/171 (94%) 1.78 
C244R160 Nucleosome assembly protein 1-
like 1 [Salmo salar] 
ACM08320 2e-169 394/394 (100%) 1.53 
C186R092 Ubiquitin-conjugating enzyme E2 
D2 isoform 1 [Homo sapiens] 
NP_003330 1e-98 147/147 (100%) 1.46 
C029R131 FGF2 [Salmo salar] ACJ02099 6e-09 31/45 (69%) 1.44 
Immune-relevant     
C263R062 CD200 [Oncorhynchus mykiss] ADV36649 3e-100 148/163 (91%) 2.20 
C256R079 SLAM family member 8 precursor 
[Salmo salar] 
ACI67051 0 312/312 (100%) 1.82 
DNA synthesis and repair     
C040R057 Thymidylate synthase [Salmo 
salar] 
NP_001134715 0 333/333 (100%) 2.25 
C041R003 Structural maintenance of 
chromosomes protein 2 [Cricetulus 
griseus] 
EGV97289 7e-71 130/155 (84%) 2.13 
C187R082 PREDICTED: kinesin-like protein 
KIF2C-like [Oreochromis 
niloticus] 
XP_003437970 2e-41 90/152 (59%) 2.06 
C116R127 Adenylosuccinate lyase 
[Ctenopharyngodon idella] 
ACB72735 7e-180 249/276 (90%) 1.78 
C135R006 DENN domain-containing protein 
2D [Salmo salar] 
ACN11415 0 422/471 (90%) 1.72 
C124R122 Deoxyuridine 5'-triphosphate 
nucleotidohydrolase, 
mitochondrial-like [Oryzias latipes] 
XP_004067019 7e-90 133/164 (81%) 1.59 
Regulation of transcription     
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C234R025 Kruppel-like factor 9 (klf9) 
[Oplegnathus fasciatus] 
BAM36382 7e-29 49/89 (55%) 2.06 
C043R148 Chromobox protein homolog 3 
[Salmo salar] 
NP_001134084 2e-98 179/183 (98%) 1.77 
Others      
C188R061 Kinesin family member C1/zinc 
finger protein [Salmo salar] 
ABO13867 0 625/625 (100%) 2.20 
C009R108 PREDICTED: WD repeat-
containing protein C2orf44 
homolog isoform X1 [Maylandia 
zebra] 
XP_004542243 6e-39 74/111 (67%) 1.59 
C027R063 PREDICTED: T-complex protein 1 
subunit zeta isoform 1 
[Oreochromis niloticus] 
XP_003447022 1e-113 112/130 (86%) 1.55 
C218R117 Eukaryotic translation initiation 
factor 3 subunit I [Salmo salar] 
NP_001133273 0 325/325 (100%) 1.41 
C230R050 Unknown N/A N/A N/A 2.24 
C232R105 Unknown N/A N/A N/A 2.11 
C213R142 Unknown N/A N/A N/A 1.60 
1Each gene was identified by BLASTx of the contig from which the informative 
microarray probe was designed against the NCBI nr database. The best BLASTx hit with 
E-value <10-5 and an informative gene or protein name is presented in this table with 
GenBank accession number species affiliation. 
2Refers to the identity of the probe on the 44K array. 
3Gene names with bold font are genes of interest for the QPCR analysis. 
4Delta-6 fatty acyl desaturase a (fadsd6a) (This Atlantic salmon gene represented the 
putative orthologue of the informative rainbow trout feature C023R134 on the 
microarray; see Appendix XV for the alignment of fadsd paralogues). 
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Table 3-5. Genes that were significantly down-regulated in the liver of salmon fed 
100COSEFM10CM treatment compared to control (FO). 
Probe 
identifier2 
BLASTx identification1 Fold 
change Gene name (species)3 Accession # E-value ID (AA %) 
Carbohydrate metabolism     
C110R017 Glucose-6-phosphatase [Salmo 
marmoratus] 
ACF75920 1e-86 128/128 (100%) -1.72 
C114R043 Pyruvate carboxylase (pcb) [Danio 
rerio] 
CAD61259 3e-82 149/167 (89%) -1.51 
Lipid metabolism     
C079R110 Adipophilin [Salmo salar] ACN60305 1e-27 62/85 (73%) -2.15 
C052R093 PREDICTED: lysoplasmalogenase-
like 
[Oreochromis niloticus] 
XP_003454022 3e-24 52/70 (74%) -2.10 
C118R106 PREDICTED: ATP-binding cassette 
sub-family A member 1-like 
[Oreochromis niloticus] 
XP_003449992 0 233/258 (90%) -1.96 
C089R096 Bile acid receptor (bar; Alias: 
farnesoid X receptor) 
[Oncorhynchus mykiss] 
BAN16587 2e-30 72/74 (97%) -1.86 
C144R021 Carnitine palmitoyltransferase I-like 
(cpt1) [Oncorhynchus mykiss] 
NP_001165326 8e-92 147/159 (92%) -1.84 
Protein metabolism     
C113R049 Branched-chain-amino-acid 
aminotransferase, cytosolic [Salmo 
salar] 
ACN11196 0 396/396 (100%) -3.75 
C123R018 Syntaxin-16 [Salmo salar] NP_001167314 0 306/306 (100%) -1.94 
C088R082 Tectonin beta-propeller repeat-
containing protein 2 [Danio rerio] 
NP_001038644 0 274/341 (80%) -1.71 
C110R072 Eukaryotic translation initiation 
factor 4E-binding protein 2 [Salmo 
salar] 
ACI33150 4e-63 106/106 (100%) -1.51 
Cell differentiation, proliferation and apoptosis     
C263R103 Lymphocyte G0/G1 switch protein 2 
[Salmo salar] 
ACM08302 1e-60 116/116 (100%) -2.37 
C116R063 IGF binding protein 5 precursor 
(igfbp-5) [Salmo salar] 
NP_001117121 0 270/270 (100%) -1.92 
C135R154 Metalloproteinase inhibitor 3 
precursor [Salmo salar] 
NP_001135315 9e-127 215/215 (100%) -1.83 
C123R147 Steroid receptor RNA activator 1 
[Salmo salar] 
ACM08712 2e-143 238/238 (100%) -1.62 
C089R032 B-cell translocation gene 1-like 
(btg1) [Salmo salar] 
ACI66378 5e-100 146/146 (100%) -1.47 
Immune or stress-relevant     
C134R121 Leukocyte cell-derived chemotaxin 
2 precursor (lect-2) [Salmo salar] 
ACI66408 4e-102 156/156 (100%) -3.03 
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C158R024 Eggshell protein [Salmo salar] CAA04221 0 413/427 (97%) -2.93 
C159R112 Leukocyte cell-derived chemotaxin 
2 precursor (lect-2) [Salmo salar] 
ACI66408 4e-102 156/156 (100%) -2.92 
C055R131 Chitinase 3 [Thunnus orientalis] BAL14138 7e-18 58/99 (59%) -2.23 
C130R087 PREDICTED: junctional adhesion 
molecule B-like [Maylandia zebra] 
XP_004551457 8e-106 165/226 (73%) -1.85 
C108R044 Serum paraoxonase/arylesterase 2 
[Anoplopoma fimbria] 
ACQ58263 4e-163 232/330 (70%) -1.81 
C103R112 CD209 antigen-like protein E (Alias: 
C type lectin receptor A, clra) 
[Salmo salar] 
ACI33556 0 255/255 (100%) -1.69 
Signal transduction     
C129R088 Small GTPase Ras-dva-2 [Takifugu 
rubripes] 
ABB84860 1e-24 68/90 (76%) -2.36 
C128R001 PREDICTED: mitogen-activated 
protein kinase 12-like [Takifugu 
rubripes] 
XP_003967582 2e-173 159/192 (83%) -1.63 
Regulation of transcription     
C035R026 PREDICTED: WW domain-binding 
protein 4-like [Maylandia zebra] 
XP_004571287 9e-119 242/430 (56%) -2.02 
C161R038 DnaJ homolog subfamily C member 
8 [Salmo salar] 
NP_001134671 6e-152 256/257 (99%) -1.81 
C078R124 PREDICTED: zinc finger and BTB 
domain-containing protein 10-like 
[Oreochromis niloticus] 
XP_003444217 4e-32 92/124 (74%) -1.58 
C198R123 Cold shock domain-containing 
protein E1 [Salmo salar] 
NP_001167093 0 541/563 (96%) -1.5 
Others      
C112R144 PREDICTED: lysoplasmalogenase-
like protein TMEM86A-like 
[Maylandia zebra] 
XP_004573768 5e-34 65/106 (61%) -2.08 
C110R007 Voltage-dependent calcium channel 
gamma-like subunit [Danio rerio] 
NP_998339 3e-22 69/106 (65%) -1.98 
C129R054 TRNA-splicing ligase RtcB 
homolog [Danio rerio] 
NP_998268 0 483/505 (96%) -1.94 
C131R073 PREDICTED: protein FAM84A-like 
[Maylandia zebra] 
XP_004542015 2e-106 111/142 (78%) -1.81 
C252R049 PREDICTED: lysoplasmalogenase-
like [Oryzias latipes] 
XP_004071563 2e-27 64/99 (65%) -1.8 
C098R023 SLEI family protein [Leptolyngbya 
sp. PCC 7376] 
YP_007072112 3e-13 41/124 (33%) -1.7 
C111R024 PREDICTED: solute carrier family 
25 member 36-A-like [Oryzias 
latipes] 
XP_004079206 6e-119 169/186 (91%) -1.67 
C131R070 RAD21 homolog [Danio rerio] NP_001038585 0 368/423 (87%) -1.45 
C139R027 PREDICTED: zinc finger protein 
384-like isoform X3 [Maylandia 
zebra] 
XP_004550902 1e-18 43/57 (75%) -1.42 
C060R006 Hemoglobin subunit beta-1 [Salmo 
salar] 
ACI66559 2e-42 77/77 (100%) -1.4 
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C123R012 Unknown N/A N/A N/A -1.76 
C107R016 Unknown N/A N/A N/A -1.7 
1Each gene was identified by BLASTx of the contig from which the informative 
microarray probe was designed against the NCBI nr database. The best BLASTx hit with 
E-value <10-5 and an informative gene or protein name is presented in this Table with 
GenBank accession number species affiliation. 
2Refers to the identity of the probe on the 44K array. 
3Gene names with bold font are genes of interest for the QPCR analysis. 
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down-regulated in the liver of salmon fed 100COSEFM10CM diet compared to control 
(Table 3-5). Transcripts expression of lymphocyte G0/G1 switch protein 2, btg1, steroid 
receptor RNA activator 1, and igfbp-5, which encode protein that are involved in cell 
differentiation and growth, were more highly expressed in fish fed the control diet. In 
addition, a number of immune-relevant genes (e.g. lect-2, chitinase 3, and clra) were 
down-regulated in the liver of salmon fed the experimental diet (i.e. 100COSEFM10CM). 
Lastly, the microarray experiment identified several genes that play roles in signal 
transduction (e.g. small GTPase Ras-dva-2) and regulation of transcription (e.g. dnaJ 
homology subfamily C member 8) as down-regulated by the camelina-containing test diet 
(Table 3-5).  
3.4.3 QPCR studies 
Ten microarray-identified putative camelina-responsive biomarker genes [cpt1, 
pcb, bar, igfbp-5b (2 paralogs), btg1, dnph1, lect-2, clra, klf9, and fadsd6a] were selected 
for QPCR validation based on their important functional annotations (e.g. carbohydrate 
and/or lipid metabolism, immune response). In addition, the transcript expression of 
another fatty acyl desaturase gene (fadsd5) and three fatty acyl elongase genes (elovl2, 
elovl5a and elovl5b), which are likely to respond to diets containing ω3 PUFA in Atlantic 
salmon based on Morais et al. (2009), was determined using QPCR. Finally, QPCR 
assays developed in this study were used to analyze liver templates not only from fish fed 
the diets used in the microarray experiment but also from fish fed the additional dietary 
treatments (100CO, 100COSEFM and 100CO10CM) to study the impact of various 
camelina product-containing diets on biomarker gene expression at week 16 in the 
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feeding trial. All microarray-identified genes except bar were validated by QPCR as 
being significantly (p < 0.05) differentially expressed in the dietary treatment groups that 
were included in the microarray comparison (i.e. control vs. 100COSEFM10CM) (Figs. 
3-2 and 3-3). 
3.4.3.1 Genes involved in fatty acid biosynthesis 
Elovl2 was significantly up-regulated (2.38-fold) in salmon fed 
100COSEFM10CM compared with control diet fed fish, and showed 1.51 to 1.79-fold 
up-regulation trends (not significant) in 100CO, 100COSEFM and 100CO10CM groups 
as shown by QPCR (Fig. 3-2A). Interestingly, elovl5a exhibited significant down- 
regulation in the 100COSEFM10CM group compared with both the control and the 
100CO groups (Fig. 3-2B). There was a slight (but not significant) down-regulation, in 
elovl5b mRNA expression in all experimental diet fed groups compared to control (Fig. 
3-2C). Fadsd5 mRNA expression was significantly up-regulated in 100CO, 100COSEFM 
and 100COSEFM10CM groups (2.38, 1.82 and 1.84-fold, respectively) compared with 
the control group (Fig. 3-2D). In addition, the QPCR experiment showed that the 
transcript expression level of fadsd6a was increased significantly in all four CO-
containing dietary treatments (i.e. 100CO, 100COSEFM, 100CO10CM, and 
100COSEFM10CM) compared to the control group by 2.56, 2.12, 1.76 and 2.17-fold, 
respectively (Fig. 3-2E).  
 3.4.3.2 Other genes involved in metabolism 
The microarray experiment showed that cpt1, pcb, and bar transcript expression
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Fig. 3-2. QPCR analysis of transcripts with putative roles in LC-PUFA biosynthesis in 
liver of salmon fed camelina product-containing test diets [100% camelina oil (CO) 
replacement of fish oil (100CO); 100CO with solvent-extracted fish meal (100COSEFM); 
100CO with 10% camelina meal (100CO10CM); 100CO with SEFM and 10CM 
inclusion (100COSEFM10CM)] or control diet (FO) at week 16. Transcript relative 
quantity (RQ) data, presented as mean log2 transformed data ± standard error. Bars with 
different letters are significantly different (p < 0.05). For each condition, fold up-
regulation was calculated as 2A-B, where A is the mean log2 transformed RQ from an 
experimental group (e.g. 100CO or 100COSEFM), and B is the mean log2 transformed 
RQ from control group (see materials and methods for details); fold down-regulation 
where appropriate was calculated as the inverse of fold up-regulation, which is shown in a 
black box. 
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was significantly down-regulated in 100COSEFM10CM compared with the control group 
(Table 3-5). QPCR validated the cpt1 and pcb results, and also showed significant down-
regulation of cpt1 in 100CO10CM and of pcb in 100COSEFM compared with control 
fish (Fig. 3-3A,B). QPCR did not validate the bar results; while QPCR and microarray 
showed the same direction of change for bar (i.e. down-regulated in the 
100COSEFM10CM compared with control), this was not statistically significant for the 
QPCR data. Interestingly, bar was significantly down-regulated in fish fed 100CO10CM 
compared with fish fed control, 100CO, and 100COSEFM diets (Fig. 3-3C). 
3.4.3.3 Genes involved in cell differentiation and proliferation 
Two separate paralogue-specific QPCR assays that distinguish igfbp-5b1 and 
igfbp-5b2 were developed and utilized in the QPCR validation study. Both igfbp-5b1 and 
igfbp-5b2 showed similar expression profiles at the mRNA level. These two genes were 
significantly down-regulated by all four camelina product-containing diets compared to 
controls by at least 1.59 fold in the QPCR experiment (Fig. 3-3D,E). Btg1 was subtle 
(1.16-fold) but significantly down-regulated in 100COSEFM10CM compared with 
control fish (Fig. 3-3F). Dnph1 transcript was significantly higher expressed in 
100COSEFM10CM compared to control and 100COSEFM groups (Fig. 3-3G).  
3.4.3.4 Genes involved in immune response or regulation of transcription 
The QPCR experiment showed that the hepatic expression of lect-2 transcript was 
significantly lower in 100COSEFM10CM compared with both control and 100CO groups 
(Fig. 3-3H). Lect-2 had the highest fold change of the down-regulated camelina product- 
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Fig. 3-3. QPCR analysis of transcripts with putative roles in metabolism, cell 
differentiation and growth, immune function or regulation of transcription in liver of 
salmon fed camelina product-containing test diets [100% camelina oil (CO) replacement 
of fish oil (100CO); 100CO with solvent-extracted fish meal (100COSEFM); 100CO with 
10% camelina meal (100CO10CM); 100CO with SEFM and 10CM inclusion 
(100COSEFM10CM)] or control diet (FO) at week 16. Transcript relative quantity (RQ) 
data, presented as mean log2 transformed data ± standard error. Bars with different letters 
are significantly different (p < 0.05). For each condition, fold up-regulation was 
calculated as 2A-B, where A is the mean log2 transformed RQ from an experimental group 
(e.g. 100CO or 100COSEFM), and B is the mean log2 transformed RQ from control 
group (see materials and methods for details); fold down-regulation where appropriate 
was calculated as the inverse of fold up-regulation, which is shown in a black box. 
 
 
 
 
 
 
 120 
 
 
 
 121 
 
responsive biomarker genes in the QPCR study (3.22-fold down-regulated in 
100COSEFM10CM compared with the control diet) (Fig. 3-3H). Clra was significantly 
down-regulated in both 100COSEFM and 100COSEFM10CM groups compared to 
control by 1.32 and 1.61-fold, respectively (Fig. 3-3I). It is important to note that the 
hepatic transcript expression of both lect-2 and clra was not affected by feeding the 
100CO test diet. The mRNA expression of klf9 was increased in fish fed 100COSEFM 
and 100COSEFM10CM diets compared to control fed fish by 1.53 and 1.57-fold, 
respectively (Fig. 3-3J). 
3.5 Discussion 
3.5.1 Growth performance of salmon 
The feeding experiment conducted in this study included evaluation of the growth 
performance of Atlantic salmon fed diets containing camelina products (CO and/or CM) 
with either FM or SEFM, versus salmon fed a control diet containing FO and FM (Table 
3-1). Atlantic salmon fed a diet with 100% of FO replaced with CO (i.e. 100CO) did not 
show significantly lower weight gain or SGR compared to FO fed control fish (Table 3-
3). Previous studies have also demonstrated that vegetable oil such as linseed oil, canola 
oil and rapeseed oil (either singly or as blends) can be used to replace up to 100% of FO 
in the diet without negatively influencing growth in salmonids (Bell et al., 2001; 
Torstensen et al., 2005; Bell et al., 2010). In contrast, removing lipid residue from FM by 
solvent extraction and/or adding 10% CM in the experimental diets significantly affected 
the growth of salmon fed those diets compared to FO fed fish. The growth rate responses 
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of salmon fed different camelina product-containing diets (e.g. 100CO or 100COSEFM) 
compared with FO control (Table 3-3) may be related to the amount of essential fatty 
acids such DHA and EPA provided in the diets. The lipid residue in FM, which is present 
in the 100CO diet but virtually absent in the 100COSEFM diet (Table 3-1), may provide 
sufficient amounts of essential fatty acids needed for good growth.  
In terms of the impact of plant meal inclusion, a previous study reported that 
Atlantic salmon fed a diet containing 20% pea protein concentrate showed no reduction in 
weight gain or feed intake (Øverland et al., 2009). This was not the case in the current 
study, where the impact of a “double replacement” diet (i.e. 100CO10CM) on Atlantic 
salmon growth was investigated and showed significantly lower weight gain and SGR 
compared to the control group (Table 3-3). As mentioned above, 100CO dietary treatment 
did not significantly reduce weight gain or SGR compared to FO fed control fish. 
Collectively, these results show that the combination of total replacement of the lipid and 
relatively low inclusion of camelina meal (10%) resulted in suboptimal growth 
performance of the salmon. It is important to note that fish fed all five test diets had 
comparable feed conversion ratios after 16 weeks of feeding (Table 3-3). This suggests 
that salmon fed camelina-containing diets were able to utilize nutrients as efficiently as 
fish fed the control diet. The reduction in growth of salmon fed some of the camelina 
product-containing test diets was deemed to be affected by lower feed intake. 
3.5.2 The impact of camelina-containing diets on salmon liver gene expression 
A set of 67 informative microarray probes was identified that responded 
significantly (FDR < 5%) in the liver of Atlantic salmon fed a camelina-containing diet 
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(100COSEFM10CM) compared to a control diet after a 16-week feeding trial (see Tables 
3-4 and 3-5). To confirm the data set and further study camelina-responsive biomarker 
gene expression, all microarray-identified transcripts, except bar, were validated by 
QPCR. Based on these results, I am confident that the data set is accurate and the genes 
reported in this chapter represent a trustworthy catalog of camelina-responsive genes in 
Atlantic salmon liver. The microarray experiment showed that the 100COSEFM10CM 
diet influenced the expression of genes involved in lipid, energy and protein metabolism, 
cell differentiation and proliferation, DNA synthesis and repair, immune function, and 
regulation of transcription. While all of these modulated biological processes are 
important for a complete understanding of the physiological impact of camelina-
containing diets on salmon, the remainder of the discussion is focused on the 
differentially expressed genes related to metabolism, cell differentiation and proliferation, 
and immune function, several of which were QPCR validated.  
3.5.2.1 Fatty acid biosynthesis 
With respect to lipid-related genes, facl4 encodes an enzyme that is essential for 
fatty acid metabolism as it converts free fatty acid into fatty acyl-CoA esters, key 
intermediates for the production of complex lipids (Cao et al., 1998). Previous studies in 
rainbow trout showed that the removal of dietary fish oil was associated with higher 
mRNA expression of facl4 (Panserat et al., 2008a; Panserat et al., 2008b), agreeing with 
the up-regulation of facl4 expression from the present microarray study (Table 3-4) and 
suggesting higher capacity of fatty acid biosynthesis in the liver of salmon fed the 
100COSEFM10CM diet. Fadsd6a, which is involved in LC-PUFA biosynthesis, was also 
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shown by microarray to be up-regulated in fish fed the 100COSEFM10CM diet compared 
with fish fed the control diet (Table 3-4). The transcript expression responses of Atlantic 
salmon genes involved in LC-PUFA biosynthesis to vegetable oil-containing diets have 
been studied previously (Zheng et al., 2004; Zheng et al., 2005a; Zheng et al., 2005b; 
Morais et al., 2009; Monroig et al., 2010; Morais et al., 2011a). Among the Atlantic 
salmon fatty acyl desaturase and elongase genes involved in these previously published 
studies, two desaturases (fadsd5 and fadsd6a) and three elongases (elovl2, elovl5a and 
elovl5b) were selected for QPCR analyses in the current investigation to determine if 
these transcripts in Atlantic salmon liver were inducible by feeding CO-containing test 
diets that were low in LC-PUFA and high in C18 PUFA (Hixson et al., 2014b). 
QPCR-based transcript analysis showed that, of the three elovl genes investigated 
here, only elovl2 was significantly up-regulated (2.38-fold) in salmon fed the 
100COSEFM10CM diet compared with the control diet fed fish. While the hepatic 
expression of elovl2 in salmon fed other camelina-containing diets (100CO, 100COSEFM 
and 100CO10CM) exhibited 1.51 to 1.79-fold up-regulation compared with controls, 
these trends were not statistically significant. In fact, the LC-PUFA amounts in diets 
100CO, 100COSEFM and 100CO10CM were higher than that of 100COSEFM10CM 
(3.3%, 2.1% and 2.5% vs. 1.5%, respectively) (Hixson et al., 2014b); it is possible that 
this may be linked to the different magnitude of hepatic elovl2 expression responses to the 
diets. Atlantic salmon Elovl2, functionally characterized in yeast, demonstrated capacity 
to lengthen ω3 and ω6 PUFA (chain length from C20 to C24) with low activity toward C18 
(Morais et al., 2009). Based on the "Sprecher pathway", Elovl2 is a critical enzyme for 
producing DHA from fatty acid precursors since it is able to elongate 20:5ω3 to 24:5ω3 
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following a chain shortening step (Sprecher, 2000). Interestingly, in the current study, 
elovl5a exhibited significant down-regulation (1.6-fold) in the 100COSEFM10CM group 
compared with the control group. Previous studies evaluating the effect of replacing up to 
100% of dietary FO with vegetable oil on Atlantic salmon hepatic elovl5a gene 
expression have yielded inconsistent results (Zheng et al., 2004; Zheng et al., 2005a; 
Zheng et al., 2005b; Morais et al., 2009). The reason for the varied responses in the 
elovl5a gene expression to different vegetable oil-containing diets is not clear. In the 
current QPCR study, no significant differences were detected between hepatic transcript 
expression of elovl5b in FO fed fish and any CO-containing diet fed fish. However, a 
previous study reported that the expression of elovl5b was significantly up-regulated in 
the liver of Atlantic salmon fed rapeseed or soybean oil containing diets, but not linseed 
oil containing diet, compared to FO fed fish (Morais et al., 2009). Previous functional 
characterization of Atlantic salmon Elovl5a and Elovl5b suggested that both enzymes are 
capable of elongating C18 to C22 with very limited activity towards C22 (Morais et al., 
2009). The fatty acid analysis of samples from the current feeding experiment, conducted 
by Hixson et al. (2014b), showed apparent elongated products of 20:3ω3 and 20:4ω3 as 
they were significantly higher in various tissues (e.g. white muscle) of salmon fed all CO-
containing diets compared with FO fed fish. Based on the current QPCR analysis of 
salmon elovl5a and elovl5b, it is still not clear whether these two genes have participated 
in the elongation of C18 to C20 when salmon were fed CO-containing diets. In order to 
gain a complete picture of how CO-containing diets influence the fatty acid elongation 
process in Atlantic salmon, the responses of all fatty acyl elongases at the enzymatic level 
to CO-containing diets must be investigated. 
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The biosynthesis of LC-PUFA from C18 PUFA in vertebrates also involves Δ5 and 
Δ6 desaturation of appropriate fatty acids by desaturase enzymes, Fadsd5 and Fadsd6, 
respectively (Sprecher, 2000). The Atlantic salmon Fadsd5 and Fadsd6a, as functionally 
characterized in yeast, demonstrated distinct Δ5 and Δ6 desaturation activities, 
respectively (Hastings et al., 2004; Zheng et al., 2005a). For example, Fadsd5 was more 
active towards 20:4ω3 for producing 20:5ω3 (Δ5 activity) with very low activity towards 
18:3ω3 for producing 18:4ω3 (Δ6 activity). Fadsd6a, on the other hand, showed much 
higher Δ6 desaturase activity compared to Δ5 activity (Hastings et al., 2004; Zheng et al., 
2005a). In the current QPCR study, both fadsd5 and fadsd6a transcripts were significantly 
up-regulated in the salmon fed all of the CO-containing diets (except for fadsd5 in 
100CO10CM) compared to the control group. The up-regulation of both fadsd5 and 
fadsd6a agrees with previous studies on the responses of these two genes to vegetable oil 
replacement diets (Zheng et al., 2005a; Zheng et al., 2005b; Monroig et al., 2010; Morais 
et al., 2011a). Collectively, these studies show that a low level of dietary LC-PUFA 
accompanied with a high level of C18 PUFA causes the transcriptional induction of 
Atlantic salmon fadsd5 and fadsd6a, which are critical genes controlling the LC-PUFA 
biosynthetic pathway. 
3.5.2.2 Other metabolism-relevant genes 
It is worth noting that in the current microarray experiment, several energy 
metabolism-relevant transcripts including adipophilin, lysoplasmalogenase-like, ATP-
binding cassette sub-family A member 1, pcb, cpt1 and bar showed decreased expression 
in response to the camelina product-containing experimental diet. Replacing FO with CO 
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or other plant oils may also affect the β-oxidation capacity in response to the changes in 
fatty acid composition of the diet (Stubhaug et al., 2007; Leaver et al., 2008a). Cpt1 is 
considered to be the key enzyme in the regulation of mitochondrial fatty acid oxidation 
since it catalyses the conversion of fatty acyl-CoAs into fatty acyl-carnitines, which are 
then transported into the mitochondrial matrix followed by oxidation (Leaver et al., 
2008a; Morash et al., 2009). In the current QPCR study, cpt1 transcript was down-
regulated in salmon fed all camelina-containing diets (although only significant for 
100CO10CM and 100COSEFM10CM) compared to salmon fed the control diet. The 
pattern of cpt1 expression reported here is similar to that reported for rainbow trout; fish 
fed with a high PUFA (especially LC-PUFA) diet significantly increased cpt1 transcript 
expression in red muscle, liver and adipose tissue (Morash et al., 2009). Collectively, 
these results suggest that dietary LC-PUFA are responsible for the modulation of cpt1 
transcript expression in salmonids, possibly through activation of the transcription factor 
peroxisome proliferator activated receptor (ppar) as reported in mammals (Price et al., 
2000; Morash et al., 2009). Given the above, it was hypothesized that reduced cpt1 
expression in response to CO-containing diets may be needed to prevent the oxidation of 
newly formed fatty acids through the fatty acid biosynthesis pathway. 
Previous microarray studies have indicated that genes involved in the cholesterol 
biosynthetic pathway (e.g. squalene epoxidase and lathosterol oxidase) and lipoprotein 
metabolism (e.g. apolipoprotein B-100) were up-regulated following vegetable oil 
feeding in Atlantic salmon liver, as a result of low cholesterol present in the plant-based 
diets compared to the FO based diets (Leaver et al., 2008b; Morais et al., 2011b). From 
the microarray data, a clear influence of the CO-containing diets on transcript expression 
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of genes linked to the cholesterol biosynthetic pathway and lipoprotein metabolism was 
not observed (see below). However, the mRNA expression of ATP-binding cassette sub-
family A member 1, which is involved in intracellular cholesterol transport and reverse 
cholesterol transport (e.g. from peripheral tissues to liver), was shown to be decreased in 
fish fed the camelina product-containing diet in the present microarray experiment. This 
is in agreement with results obtained previously in salmon fed a vegetable oil-containing 
diet (Morais et al., 2011b). In addition, the current microarray experiment identified bar 
as 1.86-fold down-regulated in salmon fed the 100COSEFM10CM diet, and QPCR 
showed that bar was 1.15-fold down-regulated (not significant) and 1.38-fold down-
regulated (significant) in fish fed 100COSEFM10CO and 100CO10CM diets, 
respectively, compared to fish fed the FO control diet. Mammalian Bar is a nuclear 
receptor whose role involves maintaining not only bile acid homeostasis, but also 
lipoprotein and cholesterol metabolism (Lefebvre et al., 2009). The hepatic gene 
expression of bar was increased 2-fold in mice fed a diet supplemented with krill protein 
hydrolysate, which is high in ω3 LC-PUFA (Ramsvik et al., 2013). Based on the current 
QPCR analysis of bar expression, which showed significant response to only one of the 
camelina product-containing diets (100CO10CM), it is not possible to conclude whether 
or not camelina-containing diets influence cholesterol biosynthesis and lipoprotein 
metabolism in the salmon liver. The response of candidate genes involved in these 
pathways to camelina-containing diets warrants further investigation using QPCR. 
Among the metabolism-relevant genes that were identified by the current 
microarray analysis, two genes (glucose 6-phosphatase and pcb, both down-regulated in 
fish fed the 100COSEFM10CO diet with pcb confirmed by QPCR) were related to 
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carbohydrate metabolism (Suarez and Mommsen, 1987), Both of these genes encode 
enzymes involved in gluconeogenesis; the responses of these transcripts suggest 
decreased gluconeogenesis (i.e. glucose production) in the livers of salmon fed the 
100COSEFM10CM diet compared with the control diet. This is not surprising given that 
the pathways of lipogenesis, lipolysis, glycolysis and gluconeogenesis are all interrelated 
and co-regulate body energy homeostasis (Morais et al., 2011a). Previous studies have 
shown that salmonids fed plant oil and/or plant protein-containing diets have altered 
hepatic expression of genes involved in carbohydrate metabolism (Panserat et al., 2009; 
Morais et al., 2011a). For example, Panserat et al. (2009) reported that the complete 
replacement of FM and FO by vegetable alternatives in rainbow trout resulted in a 
decreased hepatic transcript expression of hexokinase and phosphoenolpyruvate 
carboxykinase, which are involved in catalyzing the first steps of glycolysis and 
gluconeogenesis, respectively. Interestingly, the current QPCR experiment showed that 
pcb was significantly ~1.4-fold down-regulated in both 100COSEFM and 
100COSEFM10CM fed fish compared with controls. This suggests that pcb transcript 
expression likely responded to the near complete removal of marine lipid and/or the 
inclusion of camelina oil (i.e. "100COSEFM") rather than to the inclusion of 10% 
camelina meal in the 100COSEFM10CM diet. 
3.5.2.3 Cell differentiation and proliferation 
In recent years, the effect of the replacement of FO with plant oil on hepatic gene 
expression in fish has been studied using microarrays and QPCR (Jordal et al., 2005; 
Leaver et al., 2008b; Panserat et al., 2008b; Morais et al., 2011a; Morais et al., 2011b). 
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Most of these studies, like the current functional genomics study, have shown that 
replacing FO with plant alternatives has a major impact on metabolism-relevant pathways 
(e.g. lipid, carbohydrate, protein/amino acid metabolism) in the fish liver tissue. In 
addition to these well-known diet-responsive pathways in liver, the current microarray 
analysis also revealed that a number of genes related to other pathways (e.g. cell 
differentiation and proliferation; apoptosis) responded to the 100COSEFM10CM diet. For 
example, dnph1 (alias rcl) and nucleosome assembly protein 1-like 1, both of which play 
roles in cell proliferation in mammals (Simon et al., 1994; Lewis et al., 1997), were 
shown by microarray (with dnph1 confirmed by QPCR) to be significantly up-regulated 
in the livers of salmon fed the 100COSEFM10CM test diet compared to controls. 
Furthermore, the down-regulation of btg1 (shown by both microarray and QPCR), which 
in humans encodes a protein that exhibits anti-proliferative function (Rouault et al., 
1992), appears to be consistent with the higher expression of genes involved in cell 
proliferation in the livers of salmon fed the camelina product-containing test diet. In 
addition, the current microarray experiment also revealed that some genes involved in the 
induction of apoptosis [lymphocyte G0/G1 switch protein 2 (Welch et al., 2009) and 
metalloproteinase inhibitor 3 (Baker et al., 1998)] had lower hepatic transcript expression 
in salmon fed the 100COSEFM10CM diet compared with the control diet. Collectively, 
these data support the hypothesis that there was higher cell proliferation and/or lower 
apoptosis in the livers of salmon fed 100COSEFM10CM, the most extreme camelina 
product-containing test diet involved in this study.  
Higher cell proliferation in the liver does not necessarily correlate with higher 
somatic growth of the animal. Among various factors that regulate the growth of animals 
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including mammals and teleost fishes, the insulin-like growth factors (IGFs) and 
associated signalling pathways play a central role in controlling skeletal muscle growth 
(Bower and Johnston, 2010). The IGF system includes the following components: the 
hormones IGF-I, IGF-II, their corresponding receptors, and the IGF binding proteins 
(IGFBPs) (Picha et al., 2008; Bower and Johnston, 2010). It is well known that IGFBPs 
can influence the function and activity of IGFs in animals (Picha et al., 2008; Bower and 
Johnston, 2010). For example, the availability of IGFs is regulated by IGFBPs since 
proteolytic degradation of IGFBPs by specific proteases can result in release of IGF-I to 
target tissues (Bower and Johnston, 2010). Based on the current QPCR analysis, 
transcript expression of both igfbp-5b1 and igfbp-5b2 was significantly reduced in the 
livers of salmon fed all camelina-containing diets compared with the controls. A previous 
study reported that fast growth in Atlantic salmon muscle was correlated with the up-
regulation of several genes within the IGF pathway including igfbp-5.2 (currently named 
igfbp-5a) (Bower et al., 2008). Furthermore, in gilthead seabream (Sparus aurata), the 
full replacement of FO with vegetable oil resulted in decreased growth and lower plasma 
IGF-I, indicating an impact on the IGF pathway (reviewed in Picha et al., 2008). Assessed 
by weight gain and SGR, the growth performance of salmon in the current feeding trial 
was likewise reduced in all camelina-containing diet groups except 100CO compared 
with the FO control group. Given the above, I propose that the hepatic expression of 
igfbp-5b1 and igfbp-5b2 may be a potential growth indicator in Atlantic salmon when fed 
camelina-containing diets.  
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3.5.2.4 Immune response 
The changes in the fatty acid profiles of diets due to the replacement of FO by 
vegetable oil may alter fish metabolism, which could potentially affect fish health, 
immune function and pathogen resistance (Montero et al., 2003; Mourente et al., 2005). 
Although the liver is a primary metabolic organ for metabolizing carbohydrates, lipids, 
and proteins in animals, it also has other functions such as detoxification and modulation 
of immune responses, as well as the production of inflammatory mediators (Knolle and 
Gerken, 2000). Two immune-related genes [CD200 (also known as OX-2 membrane 
glycoprotein) and SLAM family member 8 precursor] were identified by microarray as 
being up-regulated in liver of salmon fed 100COSEFM10CM diet compared with FO 
controls. CD200, encoding a membrane glycoprotein belonging to the immunoglobulin 
superfamily, has been shown to deliver negative signals to T cells and macrophages upon 
antigen recognition, suggesting a role in immune suppression in animals (Chung et al., 
2002). In addition, the microarray-identified and QPCR-validated down-regulation of clra 
(also known as CD209 antigen-like protein E) in fish fed 100COSEFM10CM might 
suggest a decrease in innate immunity in these fish. The transcript expression of this gene 
was up-regulated in response to infection by Aeromonas salmonicida in salmon liver 
(Soanes et al., 2004), and by Piscirickettsia salmonis in salmon macrophage and 
hematopoietic kidney (Rise et al., 2004). 
Additional immune-relevant hepatic transcripts including lect-2 and chitinase 3 
were microarray-identified as down-regulated in response to the 100COSEFM10CM diet. 
Both lect-2 and chitinase 3 genes are involved in inflammation (Kawada et al., 2007; Li 
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et al., 2008). Lect-2 acts as a chemotactic factor to activate neutrophils, whose transcript 
expression was shown to be induced in the liver and spleen of Vibrio alginolyticus-
infected croceine croaker (Pseudosciaena crocea) (Li et al., 2008). Mammalian chitinases 
are involved in positively regulating the inflammatory response (Kawada et al., 2007). 
For example, mice treated with anti-chitinase 3-like-1 antibody had a significantly lower 
load of Salmonella typhimurium in peripheral tissues (Kawada et al., 2007). The basal 
expression (i.e. pre-infection) of both of the pro-inflammatory genes (tumor necrosis 
factor-α and interleukin 1-β) studied by Montero and colleagues (2010) was reduced in 
the intestine and head kidney of gilthead seabream fed soybean oil based diets. However, 
after induced infection, fish fed vegetable oil containing diets showed over-expression of 
the transcripts encoding both pro-inflammatory cytokines (Montero et al., 2010). 
Therefore, in order to gain a complete picture of the impact of camelina-containing diets 
on salmon immune responses, live pathogen challenge experiments after feeding trails are 
needed. It is also worth noting that the current QPCR experiment showed that the 
expression of clra and lect-2 was significantly down-regulated in the liver of fish fed 
100COSEFM10CM and/or 100COSEFM diets; this result suggests that the near complete 
removal of marine lipid (as indicated by "100COSEFM") had a suppressive effect on 
immune-relevant genes and may therefore negatively influence immune function. 
3.6. Conclusions 
The present study demonstrates the use of functional genomics tools and 
techniques (DNA microarrays and QPCR) to identify and validate hepatic molecular 
biomarkers of salmon response to a camelina-containing diet (100COSEFM10CM) that 
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was associated with reduced growth. I anticipate that these biomarkers will be useful in 
the future development of camelina-containing diets that do not have deleterious effects 
on fish growth or physiology. This study revealed several salmon genes involved in lipid 
metabolism, carbohydrate metabolism, cell differentiation and proliferation, and immune 
function that responded to camelina-containing diets, particularly in 100COSEFM10CM. 
Although the total removal of marine lipids is not essential for sustainable aquaculture 
practice, this study explored the impact of extreme diets with little or no fish oil (i.e. 
100COSEFM and 100COSEFM10CM) on Atlantic salmon growth, gene expression, and 
physiology (based on functional annotations of diet-responsive transcripts). Importantly, 
most microarray-identified biomarkers of negative effects of an extreme camelina 
product-containing diet were shown by QPCR to be non-responsive to the more practical 
100CO diet; also, weight gain and specific growth rate of fish fed the 100CO diet were 
not significantly reduced compared with FO controls. Hence, the 100% replacement of 
FO with CO could be a good option for developing more sustainable diets for Atlantic 
salmon aquaculture. However, further research is warranted involving the use of 
candidate biomarkers identified here to evaluate the impact of additional camelina 
product-containing diets on salmon of different life stages and different genetic 
backgrounds.  
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 CHAPTER 4: Summary 
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4.1 Summary of findings 
This thesis research, part of a large-scale collaborative project (The Camelina 
Project; http://www.genomeatlantic.ca/), aimed to assess the growth performance and 
hepatic transcript expression responses of Atlantic cod and Atlantic salmon to camelina 
product-containing diets. Briefly, juvenile cod fed diets with a 100% FO replacement 
with CO (100CO) or 100CO with solvent extracted fish meal (100COSEFM) had a 
significantly lower weight gain than cod fed FO, by 21% and 12% respectively, after a 
13-week trial. In contrast, the weight gain and SGR of Atlantic salmon were not 
significantly affected by feeding 100CO after a 16-week trial; however, salmon fed 
100COSEFM diet which contains essentially no marine lipid, showed significant 
reduction in growth. Additionally, the impact of adding 10% CM to 100CO test diets 
(100CO10CM and 100COSEFM10CM) on Atlantic salmon growth was investigated, and 
the results showed significantly lower weight gain in both groups, compared to control 
group. Liver tissues from these cod and salmon feeding trials were used in the subsequent 
expression analyses. 
Only one Atlantic cod fatty acyl elongase transcript (i.e. elovl5) had been 
characterized prior to the current study (Agaba et al., 2005). A primary goal of this thesis 
was to characterize elovl family member transcripts in Atlantic cod due to their 
significance in the LC-PUFA biosynthetic pathway. The publicly available Atlantic cod 
genomic resources, including a draft genome assembly, allowed the use of bioinformatic 
techniques to mine sequence databases to identify partial cDNA sequences for ten 
members of the cod elovl gene family; these cod transcripts were further characterized 
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using RACE and other molecular biology techniques. Additionally, only one fatty acyl 
desaturase, fadsd6, which is also involved in the LC-PUFA biosynthetic pathway, has 
been identified in Atlantic cod (Tocher et al., 2006) (see Chapter 2 for details). In 
contrast, several elovl (Hastings et al., 2004; Morais et al., 2009) and fadsd (Hastings et 
al., 2004; Zheng et al., 2005; Monroig et al., 2010) genes (see Chapter 3 for details) have 
been characterized previously in Atlantic salmon. All of these gene sequence resources 
(i.e. publicly available sequences, and cod elovl RACE product sequences from the 
current research) were useful in the present studies of the effect of replacing dietary FO 
with CO on the hepatic transcript expression of these genes in cod and salmon. 
In both Chapters 2 and 3, QPCR was used to investigate how camelina-containing 
diets affected the hepatic transcript expression of genes related to LC-PUFA biosynthesis 
in Atlantic cod and Atlantic salmon. This is a very important question for the aquaculture 
industry, since finding plant oil alternatives to FO is needed to support the sustainability 
of aquaculture. Briefly, Atlantic cod fed an extreme test diet (100COSEFM), which 
contains essentially no marine lipid, showed significant up-regulation of both elovl5 and 
fadsd6 transcripts in liver, compared with cod fed control diet after a 13-week trial; 
however, the transcript expression of other elovls (i.e. elovl1b, elovl4c-2, and elovl6a) 
was not affected. In Atlantic salmon, elovl2 was significantly up-regulated in salmon fed 
100COSEFM10CM compared with the control fish, while elovl5a exhibited the opposite 
direction of change to the 100COSEFM10CM dietary treatment. The transcript 
expression of Atlantic salmon fadsd5 and fadsd6a was significantly up-regulated in most 
of the CO-containing diets compared with the control group. Collectively, the high ALA 
and/or low ω3 LC-PUFA levels in CO-containing diets may associate with the up-
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regulation of some fatty acyl elongase and desaturase genes in Atlantic cod (i.e. elovl5, 
fadsd6) and Atlantic salmon (i.e. elovl2, fadsd5, fadsd6a) but not the other members. 
Finally, in Chapter 3, the cGRASP-designed Agilent 44K salmonid 
oligonucleotide microarray was used to study the impact of an extreme camelina-
containing diet (100COSEFM10CM; i.e. not a practical camelina-based diet) on liver 
transcriptome of Atlantic salmon, and to identify biomarkers of hepatic transcript 
expression response to this extreme test diet that caused a significant decrease in growth. 
Genes with putative roles in lipid (e.g. cpt1) and carbohydrate metabolism (e.g. pcb), cell 
differentiation and proliferation (e.g. igfbp-5b1, btg1), and immune function (e.g. lect-2), 
were significantly differentially expressed (confirmed by QPCR analysis) in the liver of 
salmon fed 100COSEFM10CM diet. It is important to note that QPCR showed that 
100CO, a more practical test diet, did not significantly alter the expression of most of the 
biomarkers of response to the more extreme test diet (100COSEFM10CM). It is 
anticipated that these biomarkers and QPCR assays will be valuable tools for the 
development of optimal camelina product-containing diets (i.e. diets that do not 
negatively affect metabolism or immunity). For example, the camelina-responsive 
biomarkers and associated QPCR assays could be used to assess the impact of graded 
levels of camelina product inclusion in novel aquafeeds on Atlantic salmon to determine 
the maximum inclusion level that will not cause deleterious effects on fish growth, 
physiology and health. 
Generally, the 100% replacement of FO with CO (100CO) could be a good option 
for developing more sustainable diets for Atlantic salmon aquaculture, since this diet did 
not significantly alter the growth performance nor the hepatic transcript expression of 
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most microarray-identified camelina-responsive biomarkers. In contrast, Atlantic cod 
growth was negatively affected by the 100CO diet, indicating that cod in this feeding trial 
were not able to tolerate full replacement of dietary FO with CO. An earlier experiment in 
the Camelina Project (not in the current thesis) showed that cod can tolerate up to 80% 
replacement of FO with CO (80CO) without decreasing growth (Hixson et al., 2013). 
Since cod can grow optimally with 80CO (Hixson et al., 2013) but not 100CO (current 
study), then 80CO should potentially be the maximum recommended replacement level of 
FO with CO for cod aquaculture. In summary, this thesis includes the characterization of 
cod elovl gene family transcripts, the development and application of QPCR assays for 
genes involved in cod and salmon LC-PUFA biosynthesis, as well as the identification 
and validation of novel camelina-responsive hepatic molecular biomarkers in Atlantic 
salmon. The resources and data generated by this research will be valuable in the future 
development of novel aquafeeds using camelina products. 
4.2 Perspectives and future research 
I have successfully characterized ten members of the cod elovl gene family at the 
cDNA level; and two out of ten members (elovl4a, elovl4b) were partially characterized. 
However, it will be important in future studies to define the specific biochemical 
functions of each Atlantic cod Elovl member (especially the newly characterized Elovl4 
paralogues) in terms of fatty acid biosynthesis. For example, functional characterization 
of fish elovl cDNAs by heterologous expression of ORFs in yeast (e.g. Saccharomyces 
cerevisiae) has previously been used to investigate the efficiency of these enzymes in the 
LC-PUFA biosynthetic pathway in vitro (Hastings et al., 2004; Zheng et al., 2004; Zheng 
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et al., 2005; Tocher et al., 2006; Monroig et al., 2010). Furthermore, to build on our 
understanding of the regulation of transcript expression of genes involved in the LC-
PUFA biosynthetic pathway in response to CO-containing diets in Atlantic cod and 
Atlantic salmon, compound-specific stable isotope analysis [which is able to distinguish 
the source of fatty acids (i.e. marine or terrestrial)], could be utilized to quantify the 
amount of LC-PUFA (e.g. DHA, EPA) synthesized from ALA provided in the diets from 
CO. 
The use of microarray- and QPCR-based experimentation allowed me to identify 
and validate several biomarkers of Atlantic salmon hepatic transcript expression response 
to an extreme test diet (100COSEFM10CM) that caused a significant decrease in growth. 
Further research is warranted for evaluating the use of these biomarkers in Atlantic 
salmon by conducting additional feeding trials involving camelina-containing diets for 
different life stages of salmon (e.g. first-feeding fry, juveniles, adults) and different 
genetic backgrounds (e.g. selected for superior performance on plant-based diets), to 
improve the generality of the results. Moreover, the constitutive hepatic transcript 
expression of several immune-relevant genes was shown by microarray experiment (with 
lect-2 and clra validated by QPCR) to be significantly reduced in salmon fed the extreme 
camelina-containing diet (100COSEFM10CM). In order to gain a complete picture of the 
impact of camelina-containing diets on salmon immune function, future feeding trials can 
include live pathogen challenge experiments. Finally, to develop a complete 
understanding of how camelina product-containing diets affect fish metabolism and 
physiology, it will be important for future studies to investigate how these diets affect 
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hepatic protein expression and enzyme activity, and to compare the protein data with 
transcriptome or QPCR-based transcript expression data.  
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APPENDICES 
Appendix I. Database mining for putative Atlantic cod elovl transcript sequences. 
Gene Zebrafish Protein1 Atlantic cod Genomic sequences2 
elovl1 Elovl1a NP_001005989 elovl1a GeneScaffold_4551: 490856-497948 
 Elovl1b NP_998581 elovl1b ENSGMOT00000020099 
elovl2 Elovl2 NP_001035452 - - 
elovl4 Elovl4a NP_957090 elovl4a ENSGMOT00000002680 
 Elovl4b NP_001191453 elovl4b ENSGMOT00000015387 
 Elovl4c AAH60897 elovl4c-1 GeneScaffold_1484: 569043-573000 
 - - elovl4c-2 GeneScaffold_1484: 565000-570000 
elovl5 Elovl5 NP_956747 elovl5 AY660881 
elovl6 Elovl6a NP_955826 elovl6a ENSGMOT00000003128 
 Elovl6b AAH46901 elovl6b GeneScaffold_2788: 6095-10463 
elovl7 Elovl7a NP_956072 elovl7 ENSGMOT00000008618 
 Elovl7b AAH45481 - - 
1Accession numbers of zebrafish Elovl protein sequences obtained from NCBI. 
2Putative cod elovl transcripts or associated genomic scaffolds obtained through 
tBLASTn query the Atlantic cod genome (gadMor1 v73.1) or cDNA collection predicted 
based on their genomic sequences (i.e. GeneScaffolds; available through Ensembl website: 
http://www.ensembl.org) databases, using zebrafish Elovl protein sequences. These 
genomic sequences were used in RACE primer design (except elovl5, which had 
available cDNA sequence for primer design). 
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Appendix II. Primers used for gene cloning and transcript expression studies of Atlantic 
cod. 
Gene Primer1 Primer sequence (5'-3') Application2 
elovl1a ELOVL1a-f1 ACGCCCTCGTTATACAGAGAACTG 3' RACE 
 ELOVL1a-r1 AGACGAGAGCCCGTAGTAGAAGTACA 5' RACE 
 ELOVL1a-f2 CTTGTTGACCTACGTCTTCCTCTC 3' nested RACE 
 ELOVL1a-r2 CTGGCTCTGTTTCTTTCTCAGGAC 5' nested RACE 
 ELOVL1a-f3 ACTCCAGATTGGGGGACATATAG ORF PCR 
 ELOVL1a-r3 CTGTCAATCGAGTCTGGGAATAC ORF PCR 
 ELOVL1a-f4 CCTCCATGTCTTCCACCACT RT-PCR (111 bp) 
 ELOVL1a-r4 TGGACCCCTGCATTTATCAT RT-PCR (111 bp) 
 ELOVL1a-f5 CTGCAAGAAATCATGGCAAA RT-PCR (146 bp) 
 ELOVL1a-r5 GCGTACACCGAGAGGAAGAC RT-PCR (146 bp) 
elovl1b ELOVL1b-f1 GATATCTACGACTACCTCCTGAGTGG 3' RACE 
 ELOVL1b-r1 GGTAGTCACAGGTGTCCATGAAGTAG 5' RACE 
 ELOVL1b-f2 GTTCTTTGTACTGTACCTCGGACCTC 3' nested RACE 
 ELOVL1b-r2 GAGGCCGTAGTAGAAGTACATGACG 5' nested RACE 
 ELOVL1b-f3 CTTATTTCGCCTCCTTCTTTCA ORF PCR 
 ELOVL1b-r3 GCTGCACATGTATGTATCCTTCA ORF PCR 
 ELOVL1b-f4 AAACCGCCAAGATGAATGAC RT-PCR and QPCR (109%, 199 bp) 
 ELOVL1b-r4 ACATTGGCAACATCAGTGGA RT-PCR and QPCR (109%, 199 bp) 
 ELOVL1b-f5 TCTGGGTATACGGCACCTTC RT-PCR (101 bp) 
 ELOVL1b-r5 GCTTCGCTTCAAGTCTTGCT RT-PCR (101 bp) 
elovl4a ELOVL4a-f1 AGCAGCTCGTACCTGCTGTTCCTCTG 3' RACE 
 ELOVL4a-r1 CAGGTACTTCTTCCACCACAGGTA 5' RACE 
 ELOVL4a-f2 TCCGCAAGACCCTCATCGTCTACAAC 3' nested RACE 
 ELOVL4a-r2 GAGGTACTCTACCCCCTTGGAGAC 5' nested RACE 
 ELOVL4a-f3 CTTGTGGGCTGCTGATCGTCCTCATTA Assembly confirmation PCR 
 ELOVL4a-r3 CAGGTACTTCTTCCACCACAGGTA Assembly confirmation PCR 
 ELOVL4a-f4 TTTATCCATCGACACGGACA RT-PCR (184 bp) 
 ELOVL4a-r4 AGCCAGAGGAACAGCAGGTA RT-PCR (184 bp) 
 ELOVL4a-f5 ACCTCGACACGGTGTTCTTC RT-PCR (173 bp) 
 ELOVL4a-r5 GTACATCAGCACGTGGATGG RT-PCR (173 bp) 
elovl4b ELOVL4b-f1 CGTCCTTAGGAAGACCCTCATAGT 3' RACE 
 ELOVL4b-r1 GTAGTAGAAGTTGGCGAAGAGGAC 5' RACE 
 ELOVL4b-f2 GGTGGTACTACATCTCCAAGGGAGT 3' nested RACE 
 ELOVL4b-r2 CAGACCATAGTAGCCGTACATCAG 5' nested RACE 
 ELOVL4b-f3 AAAGTTGACTGAACACGGTGACT Assembly confirmation PCR 
 ELOVL4b-r3 TGGTAGTAGAAGTTGGCGAAGAG Assembly confirmation PCR 
 ELOVL4b-f4 CGCCAAAGAGCTCCTGATAG RT-PCR (150 bp) 
 ELOVL4b-r4 ACCGTGTCCAGAAACTCCAC RT-PCR (150 bp) 
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 ELOVL4b-f5 GCCTGTACCTGCTCTTCCTG RT-PCR (107 bp) 
 ELOVL4b-r5 GAGGACCACCATGCTGAAGT RT-PCR (107 bp) 
elovl4c-1 ELOVL4c-1-f1 GTACTCTCCGGTCCCAATAGTAGTC 3' RACE 
 ELOVL4c-1-r1 CGTGTCACTGAGTTCTATGACCTTG 5' RACE 
 ELOVL4c-1-f2 GGTCATAGAACTCAGTGACACGGTA 3' nested RACE 
 ELOVL4c-1-r2 GGAGGAGAACTCCTTTCAGATCAAC 5' nested RACE 
 ELOVL4c-1-f3 CTTTCAGGGCGACTACAGAGTT ORF PCR 
 ELOVL4c-1-r3 GCCCAACTTTAGGATGGACAGA ORF PCR 
 ELOVL4c-1-f4 TGAAGATGGCCAATGTGTGT RT-PCR (146 bp) 
 ELOVL4c-1-r4 CCAACAGTTGACGATCATGG RT-PCR (146 bp) 
 ELOVL4c-1-f5 GACCCCGATTGATGAAACAC RT-PCR (197 bp) 
 ELOVL4c-1-r5 ACACACATTGGCCATCTTCA RT-PCR (197 bp) 
elovl4c-2 ELOVL4c-2-f1 GGAGAACGGAGATAAGAGGACAGAC 3' RACE 
 ELOVL4c-2-r1 CTGTAGTCTACTGGCTGACAGAGGTA 5' RACE 
 ELOVL4c-2-f2 GTCTACTCTCCGGTCCCAGTAATAGT 3' nested RACE 
 ELOVL4c-2-r2 ACTATTACTGGGACCGGAGAGTAGAC 5' nested RACE 
 ELOVL4c-2-f3 TGATTAAGGGGTCTTAAGGGAGA ORF PCR 
 ELOVL4c-2-r3 GGAAAATGAGGCTGACACAATAG ORF PCR 
 ELOVL4c-2-f4 GGTTATCAGGCCAGGTCAAA RT-PCR (169 bp) 
 ELOVL4c-2-r4 GAGTAGACCAGCAGCCAAGG RT-PCR (169 bp) 
 ELOVL4c-2-f5 ACTAGGCCCCACTGGAAGAT RT-PCR and QPCR (103%, 136 bp) 
 ELOVL4c-2-r5 CTGGCCTGATAACCTTTGGA RT-PCR and QPCR (103%, 136 bp) 
elovl5 ELOVL5-f1 AAGACACACACAGCGATGACGAGACC 3' RACE 
 ELOVL5-r1 GGAGAGAGAGAGCCATCATACCC 5' RACE 
 ELOVL5-f2 TGTACTCCTACTACGGCCTGTCC 3' nested RACE 
 ELOVL5-r2 GGACAGGCCGTAGTAGGAGTACA 5' nested RACE 
 ELOVL5-f3 AAGCCAAGGTTACACAGCGACT ORF PCR 
 ELOVL5-r3 GAAGCTTGTGTTTAATGGTCTGG ORF PCR 
 ELOVL5-f4 CTCCTGCTCGACAACTACCC RT-PCR and QPCR (89%, 172 bp) 
 ELOVL5-r4 TCGTACCCTCCACTCCTCAC RT-PCR and QPCR (89%, 172 bp) 
elovl6a ELOVL6a-f1 CTGCTCTACTCCTGGTACTCCTACA 3' RACE 
 ELOVL6a-r1 CATCCAGGAGTAGACCAGGTAGTT 5' RACE 
 ELOVL6a-f2 GGGCTGTGTGGTCAACTACCTGGTCTACT 3' nested RACE 
 ELOVL6a-r2 GTAGACCAGGTAGTTGACCACACAG 5' nested RACE 
 ELOVL6a-f3 GAGAGGCAGTTTAACGAAGATGA ORF PCR 
 ELOVL6a-r3 GACTTTAACTTCCCTCCTGCTGT ORF PCR 
 ELOVL6a-f4 TAACGAAGATGAGGCGATCC RT-PCR and QPCR (95%, 138 bp) 
 ELOVL6a-r4 AGCGGTTTCCTCAGTTCAAA RT-PCR and QPCR (95%, 138 bp) 
 ELOVL6a-f5 GGATGCAGGAGAACTGGAAG RT-PCR (137 bp) 
 ELOVL6a-r5 TAGCGTTAGCGACCATAGCA RT-PCR (137 bp) 
elovl6b ELOVL6b-f1 ATCTGTGACCAGGGCTTCTACTAC 3' RACE 
 ELOVL6b-r1 GTCTGGTAGAAGAACTGGGTGAAC 5' RACE 
 ELOVL6b-f2 CTACTCCTGGTACTCCTACAAGGACAC 3' nested RACE 
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 ELOVL6b-r2 GTCCTTGTAGGAGTACCAGGAGTAGAG 5' nested RACE 
 ELOVL6b-f3 AGCAGCAGCAGAAACAGAATAAG ORF PCR 
 ELOVL6b-r3 GCCTTCCATTGCTCTTCAATACT ORF PCR 
 ELOVL6b-f4 GATCAGCAGCAGCAGAAACA RT-PCR (110 bp) 
 ELOVL6b-r4 GTCGAAGCTCCTCTCGAATG RT-PCR (110 bp) 
 ELOVL6b-f5 AAAGGAAGAAGCAGCAGCAG RT-PCR (114 bp) 
 ELOVL6b-r5 CAGTGGTTCTGCATCCAGTC RT-PCR (114 bp) 
elovl7 ELOVL7-f1 CCCTCTCGCTATACATGTGCTATG 3' RACE 
 ELOVL7-r1 GGTGTAGGCATGGTACCAGAAGTT 5' RACE 
 ELOVL7-f2 GTCATGTACACTTACTACGGCCTGAC 3' nested RACE 
 ELOVL7-r2 GGTACTTCTTCCACCACAGGTACTTC 5' nested RACE 
 ELOVL7-f3 GTTGTCGTTGTAACGGTAGGTTT ORF PCR 
 ELOVL7-r3 GCTCAACACAAAGTGGTTTAAGG ORF PCR 
 ELOVL7-f4 ACAGCATAGTGCACGTCGTC RT-PCR (176 bp) 
 ELOVL7-r4 AAACTGGTAGGGGCAGTCCT RT-PCR (176 bp) 
 ELOVL7-f5 CTGGGGAACAGGCTACACAT RT-PCR (190 bp) 
 ELOVL7-r5 GAAGGGCATGATTGAGTGGT RT-PCR (190 bp) 
eef1α EEF1α-f1 CCTCAAACTCACCAACACCA RT-PCR (170 bp) 
 EEF1α-r1 GCGTGGTATCACCATTGACA RT-PCR (170 bp) 
fadsd6 FADSD6-f1 ATTGCCATAGGAACGACCAG QPCR (114%, 178 bp) 
 FADSD6-r1 GGCTTCAGGAACTTCTGCAC QPCR (114%, 178 bp) 
rplp1 RPLP1-f1 GGCGACTAGCACCGTTAAAT QPCR (89%, 118 bp) 
 RPLP1-r1 ATCGTCGTGGAGGATCAGAG QPCR (89%, 118 bp) 
1Primer orientation is denoted by “f” or “r” following the gene name for forward or 
reverse, respectively. Eef1α and rplp1 primer sets were designed based the cod 20K 
microarray probes: numbers 37006 and 35667, respectively (Booman et al., 2011). The 
fadsd6 (delta-6 fatty acyl desaturase) primer pair was designed based on the GenBank 
sequence DQ054840. 
2For QPCR primers pairs, the amplification efficiency of the primer pair and the size of 
the amplicon are in parentheses. 
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Appendix III. Pairwise percent identity (at the amino acid level) of cod and zebrafish Elovls. 
 
 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
1. Cod Elovl1a *** 55 39 40 40 41 36 27 27 52 65 58 37 37 40 42 35 26 27 50 51
2. Cod Elovl1b *** 37 36 40 41 35 22 23 48 61 67 33 39 36 40 35 22 22 50 50
3. Cod Elovl4a *** 70 49 52 45 26 28 43 40 39 50 79 72 52 43 29 29 46 42
4. Cod Elovl4b *** 47 50 47 28 27 45 40 39 45 68 79 49 44 26 26 46 44
5. Cod Elovl4c-1 *** 86 45 30 34 48 38 41 53 44 45 80 44 35 35 52 50
6. Cod Elovl4c-2 *** 46 31 34 50 40 41 54 46 47 87 45 35 36 54 51
7. Cod Elovl5 *** 28 31 42 34 38 56 43 45 46 75 28 29 41 43
8. Cod Elovl6a *** 70 31 23 23 29 23 26 31 29 83 68 33 32
9. Cod Elovl6b *** 32 23 24 34 24 26 34 30 70 76 36 32
10. Cod Elovl7 *** 53 53 43 39 42 49 42 31 31 73 72
11. Zebrafish Elovl1a *** 66 33 41 41 39 35 22 23 54 51
12. Zebrafish Elovl1b *** 34 41 40 41 37 22 23 54 51
13. Zebrafish Elovl2 *** 44 45 55 58 34 34 46 45
14. Zebrafish Elovl4a *** 75 46 42 23 24 43 38
15. Zebrafish Elovl4b *** 47 44 25 24 44 41
16. Zebrafish Elovl4c *** 47 35 37 53 51
17. Zebrafish Elovl5 *** 28 30 42 43
18. Zebrafish Elovl6a *** 71 33 31
19. Zebrafish Elovl6b *** 34.6 32
20. Zebrafish Elovl7a *** 72
21. Zebrafish Elovl7b ***
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Appendix IV. Nucleotide and hypothetical amino acid sequences of the Atlantic cod 
elovl1a gene (GenBank accession number KF964005). The translation is shown below 
the putative open reading frame (ORF), with a period indicating the stop codon. The 
exons are shown in upper case letters, while the introns are shown in lower case letters. 
The locations and sizes of the introns are indicated. The polyadenylation signal 
(AATAAA) is underlined in the 3' UTR.  
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Appendix V. Nucleotide and hypothetical amino acid sequences of the Atlantic cod 
elovl1b gene (GenBank accession numbers KF964006 and KF964007). The translation is 
shown below the putative open reading frame (ORF), with a period indicating the stop 
codon. The exons are shown in upper case letters, while the introns are shown in lower 
case letters. The locations and sizes of the introns are indicated. Two transcript variants 
that differed at the 3' UTR were identified through the RACE study (short isoform, 
KF964007; longer isoform, KF964006), and their polyadenylation signals are underlined 
(i.e. AATAAA for the short isoform and ATTAAA for the longer isoform).  
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Appendix VI. Nucleotide and hypothetical amino acid sequences of the Atlantic cod 
elovl4a gene (GenBank accession number KF964008). The translation is shown below 
the putative open reading frame (ORF), with a period indicating the stop codon. The 
exons are shown in upper case letters, while the introns are shown in lower case letters. 
The locations and sizes of the introns are indicated. The 3' UTR of elovl4a has not yet 
been fully characterized as indicated by multiple periods. 
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Appendix VII. Nucleotide and hypothetical amino acid sequences of the Atlantic cod 
elovl4b gene (GenBank accession number KF964009). The translation is shown below 
the putative open reading frame (ORF), with a period indicating the stop codon. The 
exons are shown in upper case letters, while the introns are shown in lower case letters. 
The locations and sizes of the introns are indicated. The 3' UTR of elovl4b has not yet 
been fully characterized as indicated by multiple periods. 
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Appendix VIII. Nucleotide and hypothetical amino acid sequences of the Atlantic cod 
elovl4c-1 gene (GenBank accession number KF964010). The translation is shown below 
the putative open reading frame (ORF), with a period indicating the stop codon. The 
exons are shown in upper case letters, while the introns are shown in lower case letters. 
The locations and sizes of the introns are indicated. The polyadenylation signal 
(ATTAAA) is underlined in the 3' UTR. 
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Appendix IX. Nucleotide and hypothetical amino acid sequences of the Atlantic cod 
elovl4c-2 gene (GenBank accession number KF964011). The translation is shown below 
the putative open reading frame (ORF), with a period indicating the stop codon. The 
exons are shown in upper case letters, while the introns are shown in lower case letters. 
The locations and sizes of the introns are indicated. The polyadenylation signal 
(AATAAA) is underlined in the 3' UTR. 
 
 
 
 
 
 
 
 
 
 173 
 
 
 
 
 
 
  
 174 
 
 
 
 
 
 
 
 
 
Appendix X. Nucleotide and hypothetical amino acid sequences of the Atlantic cod 
elovl5 gene (GenBank accession number KF964012). The translation is shown below the 
putative open reading frame (ORF), with a period indicating the stop codon. The exons 
are shown in upper case letters, while the introns are shown in lower case letters. The 
locations and sizes of the introns are indicated. 
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Appendix XI. Nucleotide and hypothetical amino acid sequences of the Atlantic cod 
elovl6a gene (GenBank accession number KF964013). The translation is shown below 
the putative open reading frame (ORF), with a period indicating the stop codon. The 
exons are shown in upper case letters, while the introns are shown in lower case letters. 
The locations and sizes of the introns are indicated. The polyadenylation signal 
(AATAAA) is underlined in the 3' UTR. 
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Appendix XII. Nucleotide and hypothetical amino acid sequences of the Atlantic cod 
elovl6b gene (GenBank accession number KF964014). The translation is shown below 
the putative open reading frame (ORF), with a period indicating the stop codon. The 
exons are shown in upper case letters, while the introns are shown in lower case letters. 
The locations and sizes of the introns are indicated. The polyadenylation signal 
(AATAAA) is underlined in the 3' UTR. 
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Appendix XIII. Nucleotide and hypothetical amino acid sequences of the Atlantic cod 
elovl7 gene (GenBank accession number KF964015). The translation is shown below the 
putative open reading frame (ORF), with a period indicating the stop codon. The exons 
are shown in upper case letters, while the introns are shown in lower case letters. The 
locations and sizes of the introns are indicated. The polyadenylation signal (ATTAAA) is 
underlined in the 3' UTR. 
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Appendix XIV. RT-PCR assessment of tissue distribution of elovl1a, elovl1b, elovl4a, 
elovl4b, elovl4c-1, elovl4c-2, elovl6a, elovl6b and elovl7 transcripts in Atlantic cod for 
various tissues including skeletal muscle (Mu), skin (Sk), eye (Ey), brain (Br), head 
kidney (HK), posterior kidney (PK), spleen (Sp), pyloric caecum (PC), midgut (Mg), 
hindgut (Hg), stomach (St), liver (Li), blood (Bl), heart (He), and gill (Gi). These tissues 
were collected from two juvenile cod. Expression of the housekeeping/reference gene 
elongation factor 1α (eef1α) was re-run to ensure the quality of cDNA samples, using the 
same primer set as shown in Fig. 2-4. NT, no-template control. The primer pairs used in 
these RT-PCRs were elovl1a (f4, r4), elovl1b (f5, r5), elovl4a (f4, r4), elovl4b (f5, r5), 
elovl4c-1 (f4, r4), elovl4c-2 (f4, r4), elovl6a (f5, r5), elovl6b (f4, r4) and elovl7 (f5, r5) as 
listed in Appendix II. 
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Appendix XV. The design of paralogue-specific primers based on nucleotide sequence 
alignment (partial) of fadsd5 (GenBank accession number AF478472), fadsd6a 
(AY458652), fadsd6b (GU207400) and fadsd6c (GU207401). The locations of primers 
are marked by shading with each primer pair shaded with the same colour. The alignment 
was done through the MegAlign function of the Lasergene 7.20 software (DNASTAR, 
Madison, WI), using the ClustalW method. 
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Appendix XVI. The design of paralogue-specific primers based on nucleotide sequence 
alignment of igfbp-5a (GenBank accession number JX565555), igfbp-5b1 (JX565556) 
and igfbp-5b2 (JX565557). The locations of primers are marked by shading with each 
primer pair shaded with the same colour. The alignment was done through the MegAlign 
function of the Lasergene 7.20 software (DNASTAR, Madison, WI), using the ClustalW 
method. The microarray probe sequence (i.e. 60mer) representing microarray feature 
C116R063 was also incorporated in this alignment. Nucleotides that are different between 
the microarray probe (C116R063) and igfbp-5a are indicated with arrows. Based on the 
aligned region between three transcripts and the microarray probe (C116R063), the 
microarray probe (C116R063) more likely represents both igfbp-5b1 and igfbp-5b2. 
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Appendix XVII. The design of paralogue-specific primers based on nucleotide sequence 
alignment of elovl5a (GenBank accession number AY170327) and elovl5b (FJ237531). 
The locations of primers are marked by shading with each primer pair shaded with the 
same colour. The alignment was done through the MegAlign function of the Lasergene 
7.20 software (DNASTAR, Madison, WI), using the ClustalW method.  
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